A	DT	det	O
putative	JJ	amod	O
progestin	NN	compound	B-Simple_chemical
-	HYPH	punct	O
response	NN	compound	O
element	NN	nsubjpass	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoter	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
consistent	JJ	acl:relcl	O
with	IN	case	O
the	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
a	DT	det	O
progestin	NN	compound	B-Simple_chemical
-	HYPH	punct	O
PR	NN	compound	B-Gene_or_gene_product
complex	NN	nsubj	O
might	MD	aux	O
directly	RB	advmod	O
regulate	VB	ccomp	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
gene	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
cells	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
MVD	NN	nsubj	O
and	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
LI	NN	conj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
01	CD	dep	O
and	CC	cc	O
p	NN	conj	O
less	JJR	amod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
AI	NN	nsubj	O
was	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	conj	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
SCC	NN	nmod	B-Cancer
with	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
SCC	NN	nmod	B-Cancer
without	IN	case	O
it	PRP	nmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Calretinin	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
very	RB	advmod	O
useful	JJ	amod	O
marker	NN	ROOT	O
for	IN	case	O
positive	JJ	amod	O
identification	NN	nmod	O
of	IN	case	O
normal	JJ	nmod	O
and	CC	cc	O
tumor	NN	conj	B-Cell
mesothelial	JJ	amod	I-Cell
cells	NNS	dep	I-Cell
in	IN	case	O
serous	JJ	amod	B-Organism_substance
effusions	NNS	nmod	I-Organism_substance
.	.	punct	O

As	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
the	DT	det	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
juxtaposed	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-Gene_or_gene_product
heavy	JJ	amod	I-Gene_or_gene_product
chain	NN	compound	I-Gene_or_gene_product
enhancer	NN	compound	I-Gene_or_gene_product
E	NN	compound	I-Gene_or_gene_product
mu	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Viability	NN	nsubjpass	O
,	,	punct	O
measured	VBN	acl	O
by	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
dehydrogenases	NNS	nmod	O
,	,	punct	O
was	VBD	auxpass	O
reduced	VBN	ROOT	O
significantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
treated	VBN	acl	O
with	IN	case	O
Sim	NN	nmod	B-Simple_chemical
at	IN	case	O
50	CD	nummod	O
and	CC	cc	O
100	CD	conj	O
microM	NN	nmod	O
for	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
005	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
KISS1	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
serve	VB	ccomp	O
as	IN	case	O
potential	JJ	amod	O
prognostic	JJ	amod	O
and	CC	cc	O
therapeutic	JJ	conj	O
markers	NNS	nmod	O
in	IN	case	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
hypermethylation	NN	nsubjpass	O
of	IN	case	O
CpG	NN	compound	O
islands	NNS	nmod	O
in	IN	case	O
the	DT	det	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
91	CD	nummod	O
%	NN	nmod	O
(	-LRB-	punct	O
75	CD	nummod	O
/	SYM	punct	O
82	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
breast	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
was	VBD	auxpass	O
associated	VBN	conj	O
with	IN	case	O
lack	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
GR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
activation	NN	nsubjpass	O
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
apoptosis	NN	dobj	O
in	IN	case	O
breast	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
support	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
multiple	JJ	amod	O
signals	NNS	nmod	O
could	MD	aux	O
enhance	VB	ccomp	O
apoptotic	JJ	amod	O
response	NN	dobj	O
and	CC	cc	O
suggest	VBP	conj	O
the	DT	det	O
therapeutic	JJ	amod	O
interest	NN	dobj	O
of	IN	case	O
the	DT	det	O
TRAIL	NN	compound	B-Gene_or_gene_product
/	:	punct	O
camptothecin	NN	compound	B-Simple_chemical
combination	NN	nmod	O
.	.	punct	O

Participation	NN	ROOT	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
cellular	JJ	amod	B-Cell
tumour	NN	compound	B-Cancer
antigen	NN	nmod	O
in	IN	case	O
transformation	NN	nmod	O
of	IN	case	O
normal	JJ	amod	O
embryonic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
gammaIFN	JJ	nsubj	B-Gene_or_gene_product
decreases	VBZ	ccomp	O
metastatic	JJ	amod	O
hepatic	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
growth	NN	dobj	O
by	IN	mark	O
stimulating	VBG	advcl	O
Kupffer	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
(	-LRB-	punct	O
KC	NN	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
chapter	NN	compound	O
describes	VBZ	amod	O
intravital	JJ	amod	O
microscopy	NN	ROOT	O
as	IN	case	O
a	DT	det	O
new	JJ	amod	O
imaging	NN	amod	O
technique	NN	nmod	O
for	IN	mark	O
detecting	VBG	acl	O
NO	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
dependent	JJ	amod	O
angiogenesis	NN	dobj	O
in	IN	case	O
an	DT	det	O
animal	NN	compound	O
model	NN	nmod	O
.	.	punct	O

All	DT	nsubj	O
of	IN	case	O
these	DT	det	O
results	NNS	nmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
Akt	NNP	nmod:npmod	B-Gene_or_gene_product
/	SYM	punct	O
mTOR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
translation	NN	nsubj	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
postirradiation	NN	compound	O
up	RB	dep	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
intratumoral	JJ	amod	B-Cancer
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activity	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
radiation	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
alterations	NNS	nmod	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
and	CC	cc	O
oxygen	NN	compound	B-Simple_chemical
availability	NN	conj	O
in	IN	case	O
a	DT	det	O
solid	JJ	amod	B-Cancer
tumor	NN	nmod	I-Cancer
.	.	punct	O

Both	CC	cc:preconj	O
PLD1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
PLD2	NN	conj	B-Gene_or_gene_product
also	RB	advmod	O
induced	VBD	ROOT	O
an	DT	det	O
up	RB	amod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloprotease	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
as	IN	mark	O
detected	VBN	advcl	O
by	IN	case	O
zymograms	NNS	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
development	NN	nmod	O
has	VBZ	ROOT	O
a	DT	det	O
direct	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

One	CD	nummod	O
additional	JJ	amod	O
event	NN	nsubj	O
that	WDT	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
is	VBZ	cop	O
integration	NN	ROOT	O
of	IN	case	O
HPV	NN	compound	B-Organism
DNA	NN	nmod	B-Cellular_component
into	IN	case	O
the	DT	det	O
host	NN	compound	O
genome	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
upregulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
secreted	VBN	amod	O
FGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BP	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
during	IN	case	O
early	JJ	amod	O
phases	NNS	nmod	O
of	IN	case	O
pancreas	NN	nmod	B-Cancer
and	CC	cc	O
colon	NN	compound	B-Cancer
cancer	NN	conj	I-Cancer
could	MD	aux	O
make	VB	ccomp	O
this	DT	det	O
protein	NN	dobj	O
a	DT	det	O
possible	JJ	amod	O
serum	NN	compound	B-Organism_substance
marker	NN	dobj	O
indicating	VBG	acl	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
high	JJ	amod	O
-	HYPH	punct	O
risk	NN	amod	O
premalignant	JJ	amod	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
relationship	NN	dobj	O
among	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
spontaneous	JJ	amod	O
apoptosis	NN	conj	O
and	CC	cc	O
clinicopathological	JJ	amod	O
parameters	NNS	conj	O
in	IN	case	O
laryngeal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
LSCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
is	VBZ	ROOT	O
to	TO	mark	O
compare	VB	xcomp	O
behavior	NN	amod	O
and	CC	cc	O
tissue	NN	conj	B-Tissue
response	NN	dobj	O
between	IN	case	O
two	CD	nummod	O
new	JJ	amod	O
polyester	NN	compound	B-Simple_chemical
prostheses	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
commonly	RB	advmod	O
used	VBN	amod	O
polypropylene	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
PP	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
mesh	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
showed	VBD	ROOT	O
ICAM	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
and	CC	cc	O
invasion	NN	conj	O
in	IN	case	O
NCI	NN	compound	B-Cell
-	:	punct	I-Cell
H460	NN	compound	I-Cell
NSCLC	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
p53	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
PTEN	NN	compound	B-Gene_or_gene_product
cell	NN	conj	O
)	-RRB-	punct	O
through	IN	case	O
the	DT	det	O
same	JJ	amod	O
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

In	IN	case	O
cell	NN	compound	B-Cell
culture	NN	nmod	O
,	,	punct	O
the	DT	det	O
compound	NN	nsubj	O
317615	CD	nummod	B-Simple_chemical
2HCl	CD	dep	I-Simple_chemical
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
VEGF	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
stimulated	VBN	amod	O
HUVEC	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
was	VBD	cop	O
not	RB	neg	O
very	RB	advmod	O
effective	JJ	ROOT	O
against	IN	case	O
MX	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
1	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	acl:relcl	O
8	CD	dobj	O
.	.	punct	O
1	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
or	CC	cc	O
SKOV	NN	compound	B-Cell
-	:	punct	I-Cell
3	CD	nummod	I-Cell
ovarian	JJ	amod	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	conj	I-Cell
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	acl:relcl	O
9	CD	dobj	O
.	.	punct	O
5	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

[	-LRB-	punct	O
Clinical	JJ	amod	O
significance	NN	ROOT	O
of	IN	case	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
as	IN	case	O
a	DT	det	O
prognostic	JJ	amod	O
factor	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cancer
disease	NN	nmod	O
]	-RRB-	punct	O

Thus	RB	advmod	O
,	,	punct	O
a	DT	det	O
distinct	JJ	amod	O
WNT	NN	compound	B-Gene_or_gene_product
/	:	punct	O
TCF	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
program	NN	nsubj	O
through	IN	case	O
LEF1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
HOXB9	NN	conj	B-Gene_or_gene_product
enhances	VBZ	ROOT	O
the	DT	det	O
competence	NN	dobj	O
of	IN	case	O
lung	NN	compound	B-Cell
adenocarcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
to	TO	mark	O
colonize	VB	acl	O
the	DT	det	O
bones	NNS	dobj	B-Organ
and	CC	cc	O
the	DT	det	O
brain	NN	conj	B-Organ
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
incubation	NN	nsubj	O
of	IN	case	O
HepG2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
a	DT	det	O
low	JJ	amod	O
concentration	NN	nmod	O
of	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nmod	I-Simple_chemical
for	IN	case	O
a	DT	det	O
short	JJ	amod	O
period	NN	nmod	O
(	-LRB-	punct	O
150	CD	nummod	O
microM	NN	dep	O
for	IN	case	O
30	CD	nummod	O
min	NN	nmod	O
)	-RRB-	punct	O
significantly	RB	advmod	O
affected	VBD	ccomp	O
both	CC	cc:preconj	O
glycolysis	NN	dobj	O
and	CC	cc	O
mitochondrial	JJ	amod	B-Cellular_component
respiratory	JJ	amod	O
functions	NNS	conj	O
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
summarizes	VBZ	ROOT	O
the	DT	det	O
current	JJ	amod	O
state	NN	dobj	O
of	IN	prep	O
the	DT	det	O
art	NN	pobj	O
concerning	VBG	case	O
the	DT	det	O
involvement	NN	nmod	O
of	IN	case	O
aberrant	JJ	amod	O
Pten	NNP	compound	B-Gene_or_gene_product
function	NN	nmod	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
biologic	JJ	amod	O
features	NNS	nmod	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
gliomas	NNS	nmod	I-Cancer
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
loss	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cycle	NN	compound	O
control	NN	nmod	O
and	CC	cc	O
uncontrolled	JJ	amod	O
cell	NN	compound	B-Cell
proliferation	NN	conj	O
,	,	punct	O
escape	VBP	xcomp	O
from	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
brain	NN	compound	B-Organ
invasion	NN	conj	O
,	,	punct	O
and	CC	cc	O
aberrant	JJ	amod	O
neoangiogenesis	NN	conj	O
.	.	punct	O

A	DT	det	O
panel	NN	nsubjpass	O
of	IN	case	O
antibodies	NNS	nmod	O
was	VBD	auxpass	O
used	VBN	ROOT	O
for	IN	case	O
immunohistochemistry	NN	nmod	O
:	:	punct	O
CD34	NN	dep	B-Gene_or_gene_product
/	:	punct	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	conj	I-Gene_or_gene_product
,	,	punct	O
carbonic	JJ	amod	B-Gene_or_gene_product
anhydrase	NN	appos	I-Gene_or_gene_product
IX	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

(	-LRB-	punct	O
1999	CD	ROOT	O
,	,	punct	O
Proc	NNP	appos	O
.	.	punct	O
Natl	NN	ROOT	O
.	.	punct	O
Acad	NNP	ROOT	O
.	.	punct	O
Sci	NNP	ROOT	O
.	.	punct	O
USA	NNP	ROOT	O
2645	CD	nummod	O
-	SYM	punct	O
2650	CD	nummod	O
)	-RRB-	punct	O
to	TO	mark	O
inhibit	VB	acl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
,	,	punct	O
both	CC	cc:preconj	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	cc	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
inhibit	VB	conj	O
metastasis	NN	dobj	O
of	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

ARD1	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-Organism
PCa	NNS	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
biopsies	NNS	conj	I-Cancer
.	.	punct	O

Lewis	JJ	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinomas	NNS	ROOT	I-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
by	IN	case	O
up	RB	advmod	O
to	TO	quantmod	O
65	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

Mean	NNP	amod	O
tumour	NN	compound	B-Cancer
volume	NN	nsubj	O
was	VBD	ROOT	O
significantly	RB	advmod	O
lower	JJR	acomp	O
in	IN	case	O
the	DT	det	O
DMBA	NNP	compound	B-Simple_chemical
-	HYPH	punct	O
vitamin	NN	compound	B-Simple_chemical
E	NN	compound	I-Simple_chemical
group	NN	nmod	O
compared	VBN	prep	O
to	TO	prep	O
the	DT	det	O
tumour	NN	compound	B-Cancer
control	NN	compound	O
group	NN	pobj	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
reported	VBD	ROOT	O
the	DT	dep	O
cloning	NN	dobj	O
and	CC	cc	O
characterization	NN	conj	O
of	IN	case	O
a	DT	det	O
HBV	NN	compound	B-Organism
insert	NN	nmod	O
from	IN	case	O
a	DT	det	O
Chinese	JJ	amod	B-Organism
HCC	NN	nmod	B-Cancer
.	.	punct	O

Female	JJ	amod	O
double	JJ	amod	O
Smad1	NN	compound	B-Gene_or_gene_product
Smad5	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
triple	JJ	amod	O
Smad1	NN	compound	B-Gene_or_gene_product
Smad5	NN	compound	B-Gene_or_gene_product
Smad8	NN	compound	B-Gene_or_gene_product
conditional	JJ	amod	O
knockout	JJ	amod	O
mice	NNS	conj	O
become	VBP	ROOT	O
infertile	NN	xcomp	O
and	CC	cc	O
develop	VB	conj	O
metastatic	JJ	amod	O
granulosa	NN	compound	B-Cancer
cell	NN	compound	I-Cancer
tumors	NNS	dobj	I-Cancer
.	.	punct	O

The	DT	det	O
experimental	JJ	amod	O
approach	NN	nsubj	O
includes	VBZ	ROOT	O
:	:	punct	O
estimation	NN	dep	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
NAD	NN	compound	B-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
P	NN	appos	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
+	CC	cc	O
-	HYPH	punct	O
dependent	JJ	amod	O
malic	JJ	amod	O
enzyme	NN	compound	O
activity	NN	nmod	O
;	:	punct	O
respiratory	JJ	amod	O
activity	NN	dep	O
of	IN	case	O
freshly	RB	advmod	O
harvested	VBN	amod	O
or	CC	cc	O
fasted	VBN	conj	O
cells	NNS	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
of	IN	case	O
isolated	VBN	amod	O
mitochondria	NN	conj	B-Cellular_component
;	:	punct	O
and	CC	cc	O
determination	NN	conj	O
of	IN	case	O
the	DT	det	O
metabolites	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
glycolytic	JJ	amod	O
and	CC	cc	O
glutaminolytic	JJ	conj	O
pathways	NNS	nmod	O
.	.	punct	O

In	IN	case	O
each	DT	det	O
experimental	JJ	amod	O
situation	NN	nmod	O
,	,	punct	O
the	DT	det	O
casts	NNS	nsubj	O
provided	VBD	ROOT	O
a	DT	det	O
valuable	JJ	amod	O
three	CD	nummod	O
dimensional	JJ	amod	O
representation	NN	dobj	O
of	IN	case	O
the	DT	det	O
newly	RB	advmod	O
formed	VBN	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
permitted	VBN	amod	O
subclassification	NN	conj	O
of	IN	case	O
the	DT	det	O
vessels	NNS	nmod	B-Multi-tissue_structure
within	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
proliferating	VBG	conj	O
vascular	JJ	amod	B-Multi-tissue_structure
networks	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
clarify	VB	advcl	O
the	DT	det	O
influence	NN	dobj	O
of	IN	case	O
mechanical	JJ	amod	O
strain	NN	nmod	O
on	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
bone	NN	compound	B-Organ
formation	NN	nmod	O
,	,	punct	O
bone	NN	compound	B-Organ
growth	NN	compound	O
factors	NNS	conj	O
(	-LRB-	punct	O
insulin	NN	nsubjpass	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	appos	I-Gene_or_gene_product
[	-LRB-	punct	I-Gene_or_gene_product
IGF	NNP	appos	I-Gene_or_gene_product
]	-RRB-	punct	I-Gene_or_gene_product
I	PRP	dep	I-Gene_or_gene_product
,	,	punct	O
IGF	NN	compound	B-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
protein	NN	conj	I-Gene_or_gene_product
[	-LRB-	punct	I-Gene_or_gene_product
IGFBP	NN	dep	I-Gene_or_gene_product
]	-RRB-	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
,	,	punct	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
[	-LRB-	punct	I-Gene_or_gene_product
TGF	NN	dep	I-Gene_or_gene_product
]	-RRB-	punct	I-Gene_or_gene_product
beta1	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
basic	JJ	amod	B-Gene_or_gene_product
FGF	NN	conj	I-Gene_or_gene_product
[	-LRB-	punct	O
bFGF	NN	appos	B-Gene_or_gene_product
]	-RRB-	punct	O
)	-RRB-	punct	O
,	,	punct	O
bone	NN	compound	B-Cellular_component
matrix	NN	compound	I-Cellular_component
degrading	VBG	compound	O
enzymes	NNS	conj	O
(	-LRB-	punct	O
matrix	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
metalloproteinases	NNS	dep	I-Gene_or_gene_product
[	-LRB-	punct	I-Gene_or_gene_product
MMPs	NNS	dep	I-Gene_or_gene_product
]	-RRB-	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
,	,	punct	O
2	CD	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
3	LS	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
human	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
hormone	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
hGH	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
bone	NN	compound	B-Organ
formation	NN	compound	O
markers	NNS	conj	O
(	-LRB-	punct	O
ALP	NN	dep	B-Gene_or_gene_product
,	,	punct	O
bone	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
specific	JJ	amod	I-Gene_or_gene_product
ALP	NNP	compound	I-Gene_or_gene_product
[	-LRB-	punct	O
BAP	NN	appos	B-Gene_or_gene_product
]	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
osteocalcin	NN	conj	B-Gene_or_gene_product
[	-LRB-	punct	O
OC	NNP	appos	B-Gene_or_gene_product
]	-RRB-	punct	O
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
serum	NN	compound	B-Organism_substance
samples	NNS	nmod	I-Organism_substance
from	IN	case	O
10	CD	nummod	O
patients	NNS	nmod	B-Organism
in	IN	case	O
each	DT	det	O
group	NN	compound	O
pre	JJ	dep	O
-	HYPH	punct	O
and	CC	cc	O
postoperatively	RB	advmod	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
described	VBD	ROOT	O
the	DT	det	O
isolation	NN	dobj	O
of	IN	case	O
non	JJ	advmod	O
-	HYPH	punct	O
tumorigenic	JJ	amod	O
revertants	NNS	nmod	O
from	IN	case	O
mutagenized	VBN	amod	O
populations	NNS	nmod	O
of	IN	case	O
v	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
Rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
Zarbl	NNP	dep	O
et	FW	dep	O
al	FW	conj	O
.	NNP	punct	O
,	,	punct	O
1987	CD	amod	O
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
thought	VBN	ROOT	O
that	IN	mark	O
potent	JJ	amod	O
antiangiogenic	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HL	NN	nmod	I-Simple_chemical
was	VBD	cop	O
probably	RB	advmod	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
interference	NN	ccomp	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
v	LS	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
interaction	NN	nmod	O
,	,	punct	O
resulting	VBG	acl	O
in	IN	case	O
the	DT	det	O
enhanced	VBN	amod	O
antitumoral	JJ	amod	B-Cancer
activity	NN	nmod	O
against	IN	case	O
SCC7	NN	compound	B-Cancer
tumor	NN	nmod	I-Cancer
.	.	punct	O

Additional	JJ	amod	O
mechanistic	JJ	amod	O
studies	NNS	nsubj	O
further	RB	advmod	O
suggested	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
circulating	VBG	amod	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	mark	O
extravasate	VB	acl	O
to	TO	case	O
surrounding	VBG	amod	O
lung	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
was	VBD	auxpass	O
linked	VBN	ccomp	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Tissue
endothelium	NN	nmod	I-Tissue
via	IN	case	O
one	CD	nmod	O
or	CC	cc	O
more	JJR	conj	O
Galpha	NNP	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
i	LS	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	O
coupled	VBN	amod	O
receptors	NNS	dep	O
.	.	punct	O

To	IN	case	O
this	DT	det	O
end	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
lines	NNS	dobj	I-Cell
stably	RB	advmod	O
expressing	VBG	acl	O
vGPCR	NN	dobj	B-Gene_or_gene_product
or	CC	cc	O
key	JJ	amod	O
KSHV	NN	conj	B-Organism
latently	RB	advmod	O
expressed	VBD	amod	O
proteins	NNS	dobj	O
(	-LRB-	punct	O
vCyclin	NN	dep	B-Gene_or_gene_product
,	,	punct	O
vFlip	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
LANA1	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Such	JJ	amod	O
cases	NNS	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
considered	VBN	ROOT	O
either	CC	det	O
examples	NNS	dobj	O
of	IN	case	O
a	DT	det	O
single	JJ	amod	O
primary	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
with	IN	case	O
metastasis	NN	nmod	O
or	CC	cc	O
as	IN	case	O
synchronous	JJ	amod	B-Cancer
primary	JJ	amod	I-Cancer
neoplasms	NNS	conj	I-Cancer
.	.	punct	O

Preventing	VBG	csubj	O
VEGFR1	NN	compound	B-Gene_or_gene_product
function	NN	dobj	O
using	VBG	acl	O
antibodies	NNS	dobj	O
or	CC	cc	O
by	IN	case	O
the	DT	det	O
removal	NN	conj	O
of	IN	case	O
VEGFR1	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
cells	NNS	dobj	O
from	IN	case	O
the	DT	det	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
mice	NNS	nmod	B-Organism
abrogates	VBZ	ROOT	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
these	DT	det	O
pre	JJ	npadvmod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
clusters	NNS	nmod	B-Cell
and	CC	cc	O
prevents	VBZ	conj	O
tumour	NN	compound	B-Cancer
metastasis	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
reconstitution	NN	nsubj	O
with	IN	case	O
selected	VBN	amod	O
Id3	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
inhibitor	NN	dep	B-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
differentiation	NN	nmod	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
competent	JJ	amod	O
VEGFR1	NN	dep	B-Gene_or_gene_product
+	CC	cc	O
cells	NNS	conj	O
establishes	VBZ	parataxis	O
cluster	NN	compound	B-Cell
formation	NN	dobj	O
and	CC	cc	O
tumour	NN	compound	B-Cancer
metastasis	NN	conj	O
in	IN	case	O
Id3	NN	compound	B-Gene_or_gene_product
knockout	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
assess	VB	advcl	O
its	PRP$	nmod:poss	O
role	NN	dobj	O
on	IN	case	O
human	JJ	amod	B-Organism
vascular	JJ	amod	B-Multi-tissue_structure
lung	NN	compound	B-Organ
development	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
first	RB	advmod	O
examined	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NNP	intj	I-Gene_or_gene_product
/	SYM	punct	O
II	CD	conj	B-Gene_or_gene_product
and	CC	cc	O
IGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
type	NN	conj	I-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
IR	NNP	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
human	JJ	amod	B-Organism
embryonic	JJ	amod	B-Tissue
and	CC	cc	O
fetal	JJ	conj	B-Tissue
lung	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
at	IN	case	O
4	CD	compound	O
-	SYM	punct	O
12	CD	nummod	O
wk	NN	nmod	O
of	IN	prep	O
gestation	NN	pobj	O
.	.	punct	O

A	DT	det	O
major	JJ	amod	O
step	NN	compound	O
forwards	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
is	VBZ	cop	O
the	DT	det	O
recognition	NN	ROOT	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
associated	VBN	amod	O
vasculature	NN	nmod	B-Multi-tissue_structure
as	IN	case	O
an	DT	det	O
important	JJ	amod	O
target	NN	nmod	O
for	IN	case	O
therapy	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	ROOT	O
therefore	RB	advmod	O
highly	RB	advmod	O
likely	JJ	acomp	O
that	IN	mark	O
these	DT	det	O
alterations	NNS	nsubj	O
are	VBP	cop	O
an	DT	det	O
important	JJ	amod	O
component	NN	ccomp	O
in	IN	case	O
tumor	NN	compound	B-Cancer
resistance	NN	nmod	O
to	TO	case	O
therapy	NN	nmod	O
.	.	punct	O

Angiogenesis	NN	ROOT	O
-	HYPH	punct	O
a	DT	det	O
novel	JJ	amod	O
therapeutic	JJ	amod	O
approach	NN	appos	O
for	IN	case	O
ischemic	JJ	amod	O
heart	NN	compound	B-Organ
disease	NN	nmod	O
.	.	punct	O

Macrophages	NNS	nsubjpass	B-Cell
can	MD	aux	O
be	VB	auxpass	O
activated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
classical	JJ	amod	O
or	CC	cc	O
alternative	JJ	conj	O
manner	NN	nmod	O
in	IN	case	O
parallel	NN	nmod	O
with	IN	case	O
the	DT	det	O
T	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
H	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
1	CD	nummod	I-Cell
/	:	punct	O
T	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
H	NN	appos	I-Cell
)	-RRB-	punct	I-Cell
2	CD	nummod	I-Cell
dichotomy	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
AND	CC	cc	O
RESULTS	NNS	conj	O
:	:	punct	O
Purified	VBN	amod	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
CLL	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
from	IN	case	O
15	CD	nummod	O
patients	NNS	nmod	B-Organism
were	VBD	auxpass	O
cultured	VBN	dep	O
either	CC	cc:preconj	O
alone	RB	advmod	O
or	CC	cc	O
with	IN	case	O
Sim	NN	conj	B-Simple_chemical
at	IN	case	O
concentrations	NNS	nmod	O
of	IN	case	O
10	CD	nummod	O
,	,	punct	O
50	CD	nummod	O
,	,	punct	O
and	CC	cc	O
100	CD	nummod	O
microM	NN	nmod	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
multivariate	JJ	amod	O
analysis	NN	nmod	O
,	,	punct	O
N	NN	compound	O
-	HYPH	punct	O
stage	NN	nsubjpass	O
and	CC	cc	O
vascular	JJ	amod	B-Multi-tissue_structure
grade	NN	conj	O
were	VBD	auxpass	O
not	RB	neg	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
independent	JJ	amod	O
prognostic	JJ	amod	O
factors	NNS	xcomp	O
,	,	punct	O
since	IN	mark	O
they	PRP	nsubj	O
were	VBD	cop	O
strongly	RB	advmod	O
related	JJ	advcl	O
to	TO	case	O
each	DT	det	O
other	JJ	nmod	O
.	.	punct	O

Coexpression	NN	ROOT	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	conj	O
in	IN	case	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	B-Organ
.	.	punct	O

Elevated	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
junB	NN	compound	B-Gene_or_gene_product
proto	NN	compound	O
-	:	punct	O
oncogene	NN	nmod	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	nmod:npmod	I-Gene_or_gene_product
induced	VBD	amod	O
transformation	NN	nmod	O
of	IN	case	O
Rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Experimental	JJ	amod	O
drug	NN	compound	O
therapy	NN	ROOT	O
of	IN	case	O
peritumoral	JJ	amod	B-Pathological_formation
brain	NN	compound	I-Pathological_formation
edema	NN	nmod	I-Pathological_formation
.	.	punct	O

Though	IN	mark	O
less	RBR	advmod	O
efficient	JJ	advcl	O
in	IN	prep	O
energy	NN	compound	O
production	NN	pobj	O
,	,	punct	O
it	PRP	nsubj	O
ensures	VBZ	ROOT	O
continuous	JJ	amod	O
supply	NN	dobj	O
of	IN	prep	O
energy	NN	pobj	O
and	CC	cc	O
phosphometabolites	VBZ	conj	O
for	IN	case	O
biosynthesis	NN	nmod	O
enabling	VBG	acl	O
metastatic	JJ	amod	B-Cell
and	CC	cc	O
less	RBR	advmod	O
vascularized	JJ	conj	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
to	TO	mark	O
proliferate	VB	xcomp	O
even	RB	advmod	O
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	dobj	O
.	.	punct	O

Associations	NNS	nsubj	O
of	IN	case	O
KISS1	NN	compound	B-Gene_or_gene_product
methylation	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
expression	NN	conj	O
with	IN	case	O
histopathological	JJ	amod	O
variables	NNS	nmod	O
and	CC	cc	O
poor	JJ	amod	O
survival	NN	conj	O
suggest	VBP	ROOT	O
the	DT	det	O
utility	NN	dobj	O
of	IN	mark	O
incorporating	VBG	acl	O
KISS1	NN	compound	B-Gene_or_gene_product
measurement	NN	dobj	O
using	VBG	acl	O
paraffin	NN	amod	B-Simple_chemical
-	HYPH	punct	O
embedded	JJ	amod	O
material	NN	dobj	O
for	IN	case	O
tumor	NN	compound	B-Cancer
stratification	NN	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
outcome	NN	compound	O
prognosis	NN	conj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
uroepithelial	JJ	amod	B-Cancer
neoplasias	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
systemic	JJ	amod	O
increase	NN	nsubj	O
in	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
might	MD	aux	O
reflect	VB	ROOT	O
an	DT	det	O
increased	VBN	amod	O
local	JJ	amod	O
stimulation	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
during	IN	case	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
coexpression	NN	dobj	O
of	IN	case	O
CD40	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
CD154	NN	conj	B-Gene_or_gene_product
in	IN	case	O
most	JJS	nmod	O
of	IN	case	O
the	DT	det	O
renal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
treatment	NN	dobj	O
for	IN	case	O
RDEB	NN	nmod	O
,	,	punct	O
namely	RB	advmod	O
,	,	punct	O
angiogenesis	NN	compound	O
inhibitors	NNS	conj	O
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
antagonize	VB	acl:relcl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
this	DT	det	O
disorder	NN	nmod	O
.	.	punct	O

Bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nsubj	I-Multi-tissue_structure
with	IN	case	O
its	PRP$	nmod:poss	O
unique	JJ	amod	O
native	JJ	amod	O
properties	NNS	nmod	O
produced	VBD	ROOT	O
autocrine	JJ	amod	O
angiogenicity	NN	dobj	O
in	IN	case	O
the	DT	det	O
graft	NN	nmod	O
.	.	punct	O

PP	NNS	nsubj	B-Simple_chemical
also	RB	advmod	O
resulted	VBD	ROOT	O
in	IN	case	O
less	RBR	advmod	O
connective	JJ	amod	B-Tissue
tissue	NN	compound	I-Tissue
formation	NN	nmod	O
and	CC	cc	O
foreign	JJ	amod	O
-	HYPH	punct	O
body	NN	compound	O
reaction	NN	conj	O
than	IN	case	O
PF	NN	compound	O
and	CC	cc	O
PS	NN	conj	O
prostheses	NNS	nmod	O
.	.	punct	O

Unlike	IN	prep	O
wounds	NNS	pobj	B-Pathological_formation
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
that	DT	nsubj	O
turn	VBP	advcl	O
off	RP	case	O
VPF	NNP	compound	B-Gene_or_gene_product
production	NN	nmod	O
after	IN	case	O
healing	NN	nmod	O
,	,	punct	O
tumors	NNS	nsubj	B-Cancer
did	VBD	aux	O
not	RB	neg	O
turn	VB	ROOT	O
off	RP	prt	O
their	PRP$	nmod:poss	O
VPF	NN	compound	B-Gene_or_gene_product
production	NN	dobj	O
and	CC	cc	O
instead	RB	advmod	O
continued	VBD	conj	O
to	TO	aux	O
make	VB	xcomp	O
large	JJ	amod	O
amounts	NNS	dobj	O
of	IN	case	O
VPF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
allowing	VBG	advcl	O
malignant	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
to	TO	mark	O
continue	VB	ccomp	O
to	TO	mark	O
induce	VB	xcomp	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
and	CC	cc	O
so	RB	advmod	O
to	TO	aux	O
grow	VB	conj	O
and	CC	cc	O
spread	VB	conj	O
.	.	punct	O

The	DT	det	O
patterns	NNS	nsubjpass	O
of	IN	case	O
lymphatic	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
the	DT	det	O
expression	NN	appos	O
of	IN	case	O
VEGFs	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
correlation	NN	conj	O
with	IN	case	O
neck	NN	compound	B-Organism_subdivision
metastases	NNS	nmod	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
.	.	punct	O

CXCR4	NN	compound	B-Gene_or_gene_product
transcripts	NNS	nsubj	O
and	CC	cc	O
proteins	NNS	conj	O
were	VBD	cop	O
detectable	JJ	ROOT	O
in	IN	case	O
all	DT	det	O
five	CD	nummod	O
gastric	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
this	DT	det	O
sequence	NN	nsubj	O
shares	VBZ	ROOT	O
some	DT	det	O
homology	NN	dobj	O
with	IN	case	O
the	DT	det	O
DNA	NN	compound	B-Cellular_component
binding	NN	compound	O
domain	NN	nmod	O
of	IN	case	O
GCN4	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
jun	NN	compound	I-Gene_or_gene_product
protein	NN	conj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
analysed	VBN	ROOT	O
using	VBG	xcomp	O
quantitative	JJ	amod	O
immunohistochemical	JJ	amod	O
analysis	NN	dobj	O
.	.	punct	O

A	DT	det	O
prefabricated	JJ	amod	O
composite	JJ	amod	B-Multi-tissue_structure
fat	NN	compound	I-Multi-tissue_structure
flap	JJ	nsubjpass	I-Multi-tissue_structure
consisting	VBG	acl	O
of	IN	case	O
muscle	NN	nmod	B-Tissue
woven	VBD	acl	O
into	IN	case	O
an	DT	det	O
anatomically	RB	advmod	O
distinct	JJ	amod	O
fat	NN	compound	B-Tissue
pad	NN	nmod	I-Tissue
was	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
rabbit	NN	compound	B-Organism
model	NN	nmod	O
.	.	punct	O

DNA	NN	compound	B-Cellular_component
damage	NN	nsubj	O
induces	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
survivin	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	dobj	O
regulating	VBG	acl	O
cell	NN	compound	B-Cell
cycle	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
acute	JJ	amod	B-Cell
lymphoblastic	JJ	amod	I-Cell
leukemia	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

AIMS	NNS	dep	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
cisplatin	NN	nmod	B-Simple_chemical
on	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
,	,	punct	O
an	DT	det	O
essential	JJ	amod	O
process	NN	appos	O
for	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
remodeling	NN	nmod	O
and	CC	cc	O
regeneration	NN	conj	O
in	IN	case	O
several	JJ	amod	O
physiological	JJ	amod	O
and	CC	cc	O
pathological	JJ	conj	O
situations	NNS	nmod	O
.	.	punct	O

Compared	VBN	case	O
to	TO	case	O
cRGDyK	NN	nmod	B-Simple_chemical
and	CC	cc	O
HL	NN	conj	B-Simple_chemical
,	,	punct	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HL	NN	nsubj	I-Simple_chemical
has	VBZ	ROOT	O
high	JJ	amod	O
binding	NN	compound	O
affinity	NN	dobj	O
to	TO	case	O
purified	VBN	amod	O
alpha	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
v	LS	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
3	LS	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
accord	NN	nmod	O
with	IN	case	O
our	PRP$	nmod:poss	O
hypothesis	NN	nmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
FH	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
tissues	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
a	DT	det	O
novel	JJ	amod	O
murine	JJ	amod	B-Organism
model	NN	nmod	O
of	IN	case	O
Fh1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
smooth	NN	amod	O
muscle	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
a	DT	det	O
striking	JJ	amod	O
and	CC	cc	O
progressive	JJ	conj	O
upregulation	NN	dobj	O
of	IN	case	O
a	DT	det	O
tumorigenic	JJ	amod	O
metabolic	JJ	amod	O
profile	NN	nmod	O
,	,	punct	O
as	IN	mark	O
manifested	VBN	advcl	O
by	IN	case	O
increased	VBN	amod	O
PKM2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
LDHA	NN	compound	B-Gene_or_gene_product
protein	NN	conj	O
.	.	punct	O

bFGF	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
loaded	VBN	ROOT	O
into	IN	case	O
the	DT	det	O
heparin	NN	compound	B-Simple_chemical
functionalized	NN	compound	O
(	-LRB-	punct	O
PLGA	NN	compound	B-Simple_chemical
-	:	punct	O
heparin	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
microspheres	VBZ	nmod	O
by	IN	case	O
a	DT	det	O
simple	JJ	amod	O
dipping	NN	compound	O
method	NN	nmod	O
.	.	punct	O

METHOD	NN	ROOT	O
:	:	punct	O
Dideoxy	NN	compound	O
sequencing	NN	nsubjpass	O
and	CC	cc	O
fluorescent	JJ	amod	O
single	JJ	amod	O
strand	NN	compound	O
conformation	NN	compound	O
analysis	NN	conj	O
were	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
screen	VB	xcomp	O
for	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
exon	NN	nmod	O
15	CD	nummod	O
of	IN	case	O
BRAF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
183	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
metastatic	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
Apc	NN	compound	B-Gene_or_gene_product
mutation	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
intestinal	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
inactivation	NN	nsubj	O
of	IN	case	O
Hes1	NN	nmod	B-Gene_or_gene_product
alone	RB	advmod	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
for	IN	mark	O
reducing	VBG	advcl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
inducing	VBG	conj	O
differentiation	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
into	IN	case	O
all	DT	det	O
types	NNS	nmod	O
of	IN	case	O
intestinal	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
without	IN	mark	O
affecting	VBG	conj	O
the	DT	det	O
homeostasis	NN	dobj	O
of	IN	case	O
normal	JJ	amod	O
crypts	NNS	nmod	B-Multi-tissue_structure
owing	VBG	acl	O
to	TO	case	O
genetic	JJ	amod	O
redundancy	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
MEK	NN	nmod	B-Gene_or_gene_product
also	RB	advmod	O
blocked	VBD	ROOT	O
growth	NN	compound	O
factor	NN	nmod:npmod	O
induced	VBD	amod	O
migration	NN	dobj	O
but	CC	cc	O
not	RB	cc	O
adhesion	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
E2F	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	nsubj	O
is	VBZ	cop	O
able	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
generalized	VBN	amod	O
apoptosis	NN	dobj	O
in	IN	case	O
gliomas	NNS	nmod	B-Cancer
independently	RB	advmod	O
of	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
,	,	punct	O
p16	NN	conj	B-Gene_or_gene_product
or	CC	cc	O
Rb	NN	conj	B-Gene_or_gene_product
status	NN	nmod	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
14	CD	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
final	JJ	amod	I-Gene_or_gene_product
sigma	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
DNA	NN	compound	B-Cellular_component
damage	NN	nmod	O
,	,	punct	O
and	CC	cc	O
causes	VBZ	conj	O
cells	NNS	dobj	B-Cell
to	TO	mark	O
arrest	VB	xcomp	O
in	IN	case	O
G	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
diagnosis	NN	nsubj	O
reached	VBD	acl	O
was	VBD	cop	O
retinochoroiditis	NN	ROOT	O
as	IN	case	O
an	DT	det	O
occult	JJ	amod	O
manifestation	NN	nmod	O
of	IN	case	O
sarcoidosis	NN	nmod	O
,	,	punct	O
possibly	RB	advmod	O
resulting	VBG	advcl	O
from	IN	prep	O
an	DT	det	O
intravitreal	JJ	amod	O
injection	NN	pobj	O
of	IN	prep	O
bevacizumab	NN	pobj	B-Simple_chemical
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
HS	NN	compound	O
chains	NNS	nmod	O
of	IN	case	O
perlecan	NN	nmod	B-Gene_or_gene_product
in	IN	mark	O
improving	VBG	acl	O
graft	NN	compound	B-Multi-tissue_structure
patency	NN	dobj	O
by	IN	mark	O
selectively	RB	advmod	O
promoting	VBG	advcl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
while	IN	mark	O
modulating	VBG	advcl	O
platelet	NN	compound	B-Cell
adhesion	NN	dobj	O
.	.	punct	O

Dogs	NNS	nsubj	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
had	VBD	ROOT	O
similar	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
tolerance	NN	compound	O
curves	NNS	dobj	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

Management	NN	ROOT	O
of	IN	case	O
early	JJ	amod	O
and	CC	cc	O
advanced	JJ	conj	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
:	:	punct	O
therapeutic	JJ	amod	O
issues	NNS	dep	O
.	.	punct	O

The	DT	det	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	nsubj	O
encodes	VBZ	ROOT	O
a	DT	det	O
transcription	NN	compound	O
factor	NN	dobj	O
which	WDT	nsubj	O
regulates	VBZ	acl:relcl	O
cell	NN	dobj	B-Cell
growth	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
these	DT	det	O
agents	NNS	nsubjpass	O
are	VBP	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
different	JJ	amod	O
pathways	NNS	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
concept	NN	nsubj	O
of	IN	case	O
the	DT	det	O
neurovascular	JJ	amod	B-Multi-tissue_structure
unit	NN	nmod	O
emphasizes	VBZ	ROOT	O
that	IN	mark	O
common	JJ	amod	O
signals	NNS	nsubj	O
and	CC	cc	O
substrates	NNS	conj	O
underlie	VBP	ccomp	O
the	DT	det	O
physiology	NN	dobj	O
and	CC	cc	O
pathophysiology	NN	conj	O
of	IN	case	O
neuronal	JJ	amod	B-Multi-tissue_structure
and	CC	cc	O
endothelial	JJ	conj	B-Multi-tissue_structure
compartments	NNS	nmod	I-Multi-tissue_structure
in	IN	case	O
brain	NN	nmod	B-Organ
.	.	punct	O

Lysophosphatidic	NN	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
LPA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
levels	NNS	nsubj	O
are	VBP	aux	O
elevated	JJ	ROOT	O
in	IN	case	O
ascites	NNS	nmod	B-Organism_substance
from	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
potential	JJ	amod	O
role	NN	nsubj	O
in	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
metastasis	NN	nmod	O
has	VBZ	aux	O
just	RB	advmod	O
begun	VBN	conj	O
to	TO	mark	O
be	VB	auxpass	O
revealed	VBN	xcomp	O
.	.	punct	O

Angiogenesis	NN	nsubj	O
depends	VBZ	ROOT	O
on	IN	case	O
growth	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
vascular	JJ	amod	B-Cell
cell	NN	compound	I-Cell
adhesion	NN	compound	O
events	NNS	conj	O
.	.	punct	O

The	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
type	NN	compound	B-Gene_or_gene_product
IV	CD	nummod	I-Gene_or_gene_product
collagenase	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
enables	VBZ	acl:relcl	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
to	TO	mark	O
degrade	VB	xcomp	O
collagen	NN	compound	B-Gene_or_gene_product
type	NN	dobj	I-Gene_or_gene_product
IV	CD	nummod	I-Gene_or_gene_product
found	VBN	acl	O
in	IN	case	O
the	DT	det	O
subendothelial	JJ	amod	B-Cellular_component
basement	NN	compound	I-Cellular_component
membrane	NN	nmod	I-Cellular_component
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
potential	NN	nmod	O
in	IN	case	O
several	JJ	amod	O
tumor	NN	compound	B-Cancer
types	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
rat	NN	compound	B-Organism
13762NF	NN	nummod	B-Cell
mammary	JJ	amod	I-Cell
adenocarcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
and	CC	cc	O
its	PRP$	nmod:poss	O
clones	NNS	conj	B-Cell
.	.	punct	O

Groups	NNS	ROOT	O
1	CD	nummod	O
and	CC	cc	O
2	CD	conj	O
consisted	VBD	dep	O
of	IN	case	O
48	CD	nummod	O
patients	NNS	nmod	B-Organism
without	IN	case	O
DR	NN	nmod	O
and	CC	cc	O
42	CD	nummod	O
patients	NNS	conj	B-Organism
with	IN	case	O
PDR	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Blockage	NNP	nsubj	O
of	IN	case	O
the	DT	det	O
Akt	NNP	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
attenuated	VBD	ROOT	O
CREB	NN	compound	B-Gene_or_gene_product
activation	NN	dobj	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
decrease	NN	nsubj	O
in	IN	case	O
CREB	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
reduced	VBD	conj	O
cellular	JJ	amod	B-Cell
migration	NN	dobj	O
/	:	punct	O
invasion	NN	conj	O
and	CC	cc	O
activity	NN	conj	O
of	IN	case	O
MMPs	NNS	nmod	B-Gene_or_gene_product
.	.	punct	O

Enhanced	VBN	amod	O
expression	NN	ROOT	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
periodontal	JJ	amod	B-Organism_subdivision
pathogens	NNS	nmod	O
in	IN	case	O
gingival	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
.	.	punct	O

They	PRP	nsubj	O
defined	VBD	ROOT	O
also	RB	advmod	O
the	DT	det	O
predominant	JJ	amod	O
origin	NN	dobj	O
of	IN	case	O
new	JJ	amod	O
vessels	NNS	nmod	B-Multi-tissue_structure
from	IN	case	O
venules	NNS	nmod	B-Multi-tissue_structure
and	CC	cc	O
capillaries	NNS	conj	B-Tissue
,	,	punct	O
and	CC	cc	O
enabled	VBD	conj	O
the	DT	det	O
evolution	NN	dobj	O
of	IN	case	O
proliferating	VBG	amod	O
vessels	NNS	nmod	B-Multi-tissue_structure
into	IN	case	O
arterioles	NNS	nmod	B-Multi-tissue_structure
and	CC	cc	O
venules	NNS	conj	B-Multi-tissue_structure
to	TO	mark	O
be	VB	auxpass	O
documented	VBN	acl	O
.	.	punct	O

DMBA	JJ	compound	B-Simple_chemical
maxima	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
those	DT	nmod	O
of	IN	case	O
DMBA	NN	nmod	B-Simple_chemical
+	CC	cc	O
radiation	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
Cox	NN	compound	O
regression	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
CYR61	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
CTGF	NN	conj	B-Gene_or_gene_product
expression	NN	nsubj	O
had	VBD	ccomp	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	dobj	O
with	IN	case	O
patient	NN	compound	B-Organism
survival	NN	nmod	O
.	.	punct	O

Insulin	NNP	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	acl	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	pobj	I-Gene_or_gene_product
I	NN	nsubj	I-Gene_or_gene_product
induces	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
hexokinase	NN	compound	B-Gene_or_gene_product
RNA	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Therefore	RB	advmod	O
we	PRP	nsubj	O
aimed	VBD	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
simvastatin	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
Sim	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
on	IN	case	O
malignant	JJ	amod	B-Cell
B	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
derived	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
CLL	NN	nmod	B-Cancer
and	CC	cc	O
mechanisms	NNS	conj	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
the	DT	det	O
drug	NN	nmod	O
.	.	punct	O

Tumour	NN	compound	B-Cancer
angiogenesis	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
factor	NN	ROOT	O
for	IN	case	O
tumour	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Ecotropic	JJ	amod	B-Gene_or_gene_product
viral	JJ	amod	I-Gene_or_gene_product
integration	NN	compound	I-Gene_or_gene_product
site	NN	nsubj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
nuclear	JJ	amod	B-Cellular_component
transcription	NN	compound	O
factor	NN	ROOT	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
essential	JJ	acl:relcl	O
for	IN	case	O
the	DT	det	O
proliferation	NN	nmod	O
/	:	punct	O
maintenance	NN	conj	O
of	IN	case	O
hematopoietic	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
HSCs	NNS	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
overexpression	NN	nsubjpass	O
of	IN	case	O
IGF1	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
R	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
IGF1	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
R	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
activation	NN	nmod	O
of	IN	case	O
Akt	NNP	compound	B-Gene_or_gene_product
and	CC	cc	O
up	RB	conj	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
antiapoptotic	JJ	amod	O
protein	NN	compound	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
L	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
.	.	punct	O

In	IN	prep	O
all	DT	det	O
cases	NNS	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
complete	JJ	amod	O
concordance	NN	nsubj	O
between	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
of	IN	case	O
hypoxia	NN	nmod	O
and	CC	cc	O
AdCA5	NN	conj	B-Organism
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
gene	NN	compound	O
transfer	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
p75	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
expression	NN	nsubj	O
impairs	VBZ	ccomp	O
the	DT	det	O
survival	NN	dobj	O
,	,	punct	O
proliferation	NN	conj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
adhesion	NN	compound	O
capacities	NNS	conj	O
of	IN	case	O
cultured	VBN	amod	O
ECs	NNS	nmod	B-Cell
and	CC	cc	O
endothelial	JJ	amod	B-Cell
progenitor	NN	compound	I-Cell
cells	NNS	conj	I-Cell
(	-LRB-	punct	O
EPCs	NNS	appos	B-Cell
)	-RRB-	punct	O
and	CC	cc	O
inhibits	VBZ	conj	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Oxygen	NN	compound	B-Simple_chemical
consumption	NN	nsubjpass	O
of	IN	case	O
HepG2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
supported	VBN	acl	O
by	IN	case	O
either	DT	cc:preconj	O
pyruvate	NN	nmod	B-Simple_chemical
/	SYM	punct	O
malate	NN	conj	B-Simple_chemical
or	CC	cc	O
succinate	NN	conj	B-Simple_chemical
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
when	WRB	advmod	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
pre	JJ	advmod	O
-	HYPH	punct	O
incubated	VBN	advcl	O
with	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nmod	I-Simple_chemical
in	IN	prep	O
glucose	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
free	JJ	amod	O
medium	NN	pobj	O
.	.	punct	O

The	DT	det	O
putative	JJ	amod	O
metastasis	NN	compound	O
suppressor	NN	compound	O
genes	NNS	nsubjpass	O
,	,	punct	O
NME1	NN	appos	B-Gene_or_gene_product
(	-LRB-	punct	O
nm23	NN	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
NME2	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
model	NN	compound	O
system	NN	nmod	O
we	PRP	nsubj	O
developed	VBD	conj	O
to	TO	mark	O
approximate	VB	xcomp	O
the	DT	det	O
dissemination	NN	dobj	O
of	IN	case	O
melanoma	NN	nmod	B-Cancer
from	IN	case	O
a	DT	det	O
primary	JJ	amod	O
skin	NN	compound	B-Cancer
tumor	NN	nmod	I-Cancer
.	.	punct	O

These	DT	det	O
new	JJ	amod	O
insights	NNS	nsubj	O
into	IN	case	O
the	DT	det	O
involvement	NN	nmod	O
of	IN	case	O
syndecans	NNS	nmod	B-Gene_or_gene_product
in	IN	case	O
disease	NN	compound	O
and	CC	cc	O
tissue	NN	conj	B-Tissue
repair	NN	nmod	O
coupled	VBN	acl	O
with	IN	case	O
the	DT	det	O
emergence	NN	nmod	O
of	IN	case	O
syndecan	JJ	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
specific	JJ	amod	O
molecular	JJ	amod	O
tools	NNS	nmod	O
may	MD	aux	O
lead	VB	ROOT	O
to	TO	case	O
novel	JJ	amod	O
therapies	NNS	nmod	O
for	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
diseases	NNS	nmod	O
.	.	punct	O

The	DT	det	O
structural	JJ	amod	O
and	CC	cc	O
functional	JJ	conj	O
development	NN	nsubj	O
of	IN	case	O
the	DT	det	O
pulmonary	JJ	amod	B-Anatomical_system
system	NN	nmod	I-Anatomical_system
is	VBZ	cop	O
dependent	JJ	ROOT	O
upon	IN	case	O
appropriate	JJ	amod	O
early	JJ	amod	O
vascularization	NN	nmod	O
of	IN	case	O
the	DT	det	O
embryonic	JJ	amod	B-Organ
lung	NN	nmod	I-Organ
.	.	punct	O

The	DT	det	O
apparent	JJ	amod	O
mesenchymal	JJ	nsubj	B-Cell
to	TO	case	O
epithelial	JJ	amod	B-Cell
conversion	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
mimics	VBZ	ROOT	O
the	DT	det	O
conversion	NN	dobj	O
that	WDT	nsubj	O
occurs	VBZ	acl:relcl	O
during	IN	case	O
embryonic	JJ	amod	B-Organ
kidney	NN	compound	I-Organ
development	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
Met	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
HGF	NN	compound	B-Gene_or_gene_product
/	:	punct	O
SF	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
tumors	NNS	conj	B-Cancer
that	WDT	nsubj	O
express	VBP	acl:relcl	O
both	CC	cc:preconj	O
epithelial	JJ	amod	B-Cell
and	CC	cc	O
mesenchymal	JJ	conj	B-Cell
markers	NNS	dobj	O
.	.	punct	O

The	DT	det	O
end	NN	nsubj	O
result	NN	nsubj	O
in	IN	prep	O
individuals	NNS	compound	O
surviving	VBG	compound	O
burn	NN	compound	O
shock	NN	pobj	O
is	VBZ	cop	O
immunosuppression	NN	ROOT	O
,	,	punct	O
with	IN	case	O
increased	VBN	amod	O
susceptibility	NN	nmod	O
to	TO	case	O
potentially	RB	advmod	O
fatal	JJ	amod	O
systemic	JJ	amod	O
burn	NN	nmod	B-Pathological_formation
wound	NN	dep	I-Pathological_formation
or	CC	cc	O
pulmonary	JJ	amod	B-Organ
sepsis	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
VEGF121	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
bind	VB	acl:relcl	O
to	TO	case	O
NRP1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
support	VB	ROOT	O
complex	NN	compound	O
formation	NN	dobj	O
.	.	punct	O

The	DT	det	O
concentrations	NNS	nsubj	O
of	IN	case	O
urine	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
Cr	NN	nmod	B-Simple_chemical
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
than	IN	case	O
in	IN	case	O
controls	NNS	nmod	O
(	-LRB-	punct	O
48	CD	dep	O
.	.	punct	O
9	CD	nmod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
194	CD	dep	O
.	.	punct	O
4	CD	dep	O
vs	CC	cc	O
.	.	punct	O
5	LS	nummod	O
.	.	punct	O
2	CD	ROOT	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
13	CD	dep	O
.	.	punct	O
8	CD	nummod	O
pg	CC	dep	O
/	SYM	punct	O
mg	NN	compound	O
Cr	NN	dep	B-Simple_chemical
,	,	punct	O
P	NN	appos	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
001	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
mice	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
then	RB	advmod	O
treated	VBN	ROOT	O
with	IN	mark	O
ganciclovir	NN	advcl	B-Simple_chemical
to	TO	mark	O
specifically	RB	advmod	O
target	VB	xcomp	O
only	RB	advmod	O
the	DT	det	O
vGPCR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	dobj	B-Cell
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
were	VBD	cop	O
comparative	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
of	IN	case	O
Northern	NN	compound	O
blotting	NN	nmod	O
of	IN	case	O
the	DT	det	O
same	JJ	amod	O
cases	NNS	nmod	O
.	.	punct	O

KISS1	NN	compound	B-Gene_or_gene_product
transcript	NN	compound	O
expression	NN	nsubj	O
remained	VBD	ROOT	O
an	DT	det	O
independent	JJ	amod	O
prognosticator	NN	dobj	O
in	IN	case	O
multivariate	JJ	amod	O
analyses	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
017	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
mast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
angiogenesis	NN	nmod	O
may	MD	aux	O
be	VB	ccomp	O
to	TO	mark	O
enhance	VB	xcomp	O
migration	NN	dobj	O
of	IN	case	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
growing	VBG	amod	O
capillaries	NNS	nmod	B-Tissue
.	.	punct	O

In	IN	case	O
the	DT	det	O
colon	NN	compound	B-Cancer
carcinoma	NN	compound	I-Cancer
experiment	NN	nmod	O
,	,	punct	O
mean	NN	amod	O
permeability	NN	nsubj	O
and	CC	cc	O
perfusion	NN	conj	O
decreased	VBD	ROOT	O
by	IN	case	O
51	CD	nummod	O
%	NN	nmod	O
(	-LRB-	punct	O
from	IN	prep	O
5	CD	pobj	O
.	.	punct	O
2	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
1	CD	ROOT	O
.	.	punct	O
1	CD	meta	O
to	TO	dep	O
2	CD	dep	O
.	.	punct	O
5	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
8	CD	nummod	O
ml	NN	dep	O
/	SYM	punct	O
100	CD	nummod	O
ml	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
59	CD	nummod	O
%	NN	conj	O
(	-LRB-	punct	O
from	IN	prep	O
0	CD	pobj	O
.	.	punct	O
00165	CD	ROOT	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
5	CD	dep	O
.	.	punct	O
1	CD	meta	O
to	TO	dep	O
0	CD	dep	O
.	.	punct	O
0067	CD	ROOT	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
4	CD	dep	O
.	.	punct	O
8	CD	nummod	O
ml	NN	compound	O
/	:	punct	O
min	NN	ROOT	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	dep	O
)	-RRB-	punct	O
/	:	punct	O
ml	NN	dep	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
of	IN	case	O
tissue	NN	nmod	B-Tissue
)	-RRB-	punct	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
in	IN	case	O
all	DT	det	O
animals	NNS	nmod	O
after	IN	case	O
antiangiogenic	JJ	amod	O
drug	NN	compound	O
administration	NN	nmod	O
.	.	punct	O

Histological	JJ	amod	O
venous	JJ	amod	B-Multi-tissue_structure
invasion	NN	nsubjpass	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
01	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
distant	JJ	amod	O
metastasis	NN	conj	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Following	VBG	case	O
cotransfection	NN	nmod	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
null	NN	amod	O
EU	NNP	compound	O
-	HYPH	punct	O
4	CD	nummod	O
cells	NNS	nmod	O
with	IN	case	O
survivin	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
-	HYPH	punct	O
luciferase	NN	compound	B-Gene_or_gene_product
constructs	NNS	nmod	O
and	CC	cc	O
either	CC	cc:preconj	O
wt	RB	advmod	O
-	HYPH	punct	O
p53	NN	dep	B-Gene_or_gene_product
or	CC	cc	O
different	JJ	amod	O
mut	NN	compound	O
-	HYPH	punct	O
p53	NN	compound	B-Gene_or_gene_product
expression	NN	compound	O
vectors	NNS	conj	O
,	,	punct	O
wt	RB	compound	O
-	HYPH	punct	O
p53	NN	nsubj	B-Gene_or_gene_product
inhibited	VBD	ROOT	O
survivin	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
activity	NN	dobj	O
;	:	punct	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
inhibition	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
abrogated	VBN	parataxis	O
by	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
murine	JJ	amod	B-Gene_or_gene_product
double	JJ	amod	I-Gene_or_gene_product
minute2	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
MDM2	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
protein	NN	nmod	O
.	.	punct	O

This	DT	det	O
desensitization	NN	nsubj	O
was	VBD	cop	O
without	IN	case	O
effect	NN	ROOT	O
upon	IN	case	O
the	DT	det	O
concentration	NN	nmod	O
causing	VBG	acl	O
half	NN	nummod	O
-	HYPH	punct	O
maximal	JJ	amod	O
effect	NN	dobj	O
(	-LRB-	punct	O
EC50	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
dissociation	NN	compound	O
constant	NN	conj	O
(	-LRB-	punct	O
Kd	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
number	NN	conj	O
of	IN	case	O
PGF2	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cell	NN	compound	I-Cell
fate	NN	compound	O
determinant	NN	nsubj	O
TLX	NN	nsubj	B-Gene_or_gene_product
promotes	VBZ	ROOT	O
tumorigenesis	NN	dobj	O
and	CC	cc	O
genesis	NN	conj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
resembling	VBG	acl	O
glioma	NN	compound	B-Cell
stem	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

We	PRP	nsubj	O
attempted	VBD	ROOT	O
to	TO	mark	O
correlate	VB	xcomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Gene_or_gene_product
leukocyte	NN	compound	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
DR	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
HLA	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
DR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
infiltration	NN	conj	O
by	IN	case	O
S	NNP	nmod:npmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
100	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	O
protein	NN	nmod:npmod	O
-	HYPH	punct	O
positive	JJ	amod	O
dendritic	JJ	amod	O
cells	NNS	nmod	O
with	IN	case	O
clinicopathologic	JJ	amod	O
features	NNS	nmod	O
in	IN	case	O
165	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Perfusion	NN	nsubjpass	O
and	CC	cc	O
permeability	NN	conj	O
parameters	NNS	conj	O
of	IN	case	O
the	DT	det	O
implanted	VBN	amod	O
tumours	NNS	nmod	B-Cancer
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	mark	O
using	VBG	advcl	O
two	CD	nummod	O
contrast	NN	compound	O
media	NNS	dobj	O
(	-LRB-	punct	O
B22956	NN	compound	B-Simple_chemical
/	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
and	CC	cc	O
Gd	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DTPA37	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
albumin	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
to	TO	mark	O
establish	VB	advcl	O
response	NN	dobj	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
antiangiogenic	JJ	amod	O
drugs	NNS	nmod	O
(	-LRB-	punct	O
tamoxifen	NN	dep	B-Simple_chemical
and	CC	cc	O
SU6668	NN	conj	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
VEGF	NN	nsubjpass	B-Gene_or_gene_product
might	MD	aux	O
be	VB	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
etiology	NN	nmod	O
of	IN	case	O
periodontitis	NN	nmod	O
in	IN	case	O
its	PRP$	nmod:poss	O
early	JJ	amod	O
stages	NNS	nmod	O
according	VBG	case	O
to	IN	case	O
neovascularization	NN	nmod	O
stimulated	VBN	acl	O
by	IN	case	O
periodontal	JJ	amod	B-Organism_subdivision
pathogens	NNS	nmod	O
causing	VBG	acl	O
swelling	NN	dobj	O
and	CC	cc	O
edema	NN	conj	B-Pathological_formation
.	.	punct	O

Endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
expression	NN	nsubjpass	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	nmod	I-Gene_or_gene_product
was	VBD	cop	O
constitutively	RB	advmod	O
elevated	JJ	ROOT	O
after	IN	case	O
stable	JJ	amod	O
infection	NN	nmod	O
with	IN	case	O
a	DT	det	O
retroviral	JJ	amod	O
vector	NN	nmod	O
containing	VBG	acl	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
coding	VBG	compound	O
sequence	NN	dobj	O
.	.	punct	O

Recent	JJ	amod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vivo	FW	dep	O
evidence	NN	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
may	MD	aux	O
also	RB	advmod	O
have	VB	ccomp	O
direct	JJ	amod	O
antitumor	JJ	compound	B-Cancer
effects	NNS	dobj	O
via	IN	case	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
inhibition	NN	dobj	O
of	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
potential	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
inhibition	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
reduction	NN	conj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
indirectly	RB	advmod	O
via	IN	case	O
effects	NNS	nmod	O
on	IN	case	O
accessory	NN	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Host	NN	npadvmod	O
-	HYPH	punct	O
derived	VBN	amod	O
angiopoietin	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
affects	VBZ	ROOT	O
early	JJ	amod	O
stages	NNS	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
and	CC	cc	O
vessel	NN	compound	B-Multi-tissue_structure
maturation	NN	conj	O
but	CC	cc	O
is	VBZ	cop	O
dispensable	JJ	conj	O
for	IN	case	O
later	JJR	amod	O
stages	NNS	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
.	.	punct	O

In	IN	case	O
humans	NNS	nmod	B-Organism
with	IN	case	O
AMD	NN	nmod	O
,	,	punct	O
MCs	NNS	ROOT	B-Cell
accumulated	VBD	acl	O
in	IN	case	O
the	DT	det	O
subretinal	JJ	amod	B-Immaterial_anatomical_entity
space	NN	nmod	I-Immaterial_anatomical_entity
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
retinal	JJ	amod	B-Multi-tissue_structure
degeneration	NN	nmod	O
and	CC	cc	O
choroidal	JJ	amod	B-Multi-tissue_structure
neovascularization	NN	conj	O
(	-LRB-	punct	O
CNV	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Knocking	VBG	ROOT	O
down	RP	prt	O
p24delta1	NN	dobj	B-Gene_or_gene_product
in	IN	case	O
insulinoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
also	RB	advmod	O
resulted	VBD	acl:relcl	O
in	IN	case	O
the	DT	det	O
concomitant	JJ	amod	O
knock	NN	compound	O
-	HYPH	punct	O
down	RB	nmod	O
of	IN	case	O
other	JJ	amod	O
family	NN	compound	O
members	NNS	nmod	O
,	,	punct	O
impaired	JJ	amod	O
glucose	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
stimulated	VBN	amod	O
insulin	NN	compound	B-Gene_or_gene_product
secretion	NN	conj	O
,	,	punct	O
decreased	VBD	conj	O
total	JJ	amod	O
cellular	JJ	amod	B-Cell
insulin	NN	compound	B-Gene_or_gene_product
content	NN	dobj	O
and	CC	cc	O
reduced	VBD	amod	O
proinsulin	NN	compound	B-Gene_or_gene_product
biosynthesis	NN	conj	O
.	.	punct	O

Only	RB	advmod	O
3	CD	nsubj	O
of	IN	case	O
the	DT	det	O
13	CD	nummod	O
adenocarcinomas	NNS	nmod	B-Cancer
metastatic	JJ	amod	O
to	TO	case	O
the	DT	det	O
serous	JJ	amod	B-Organism_substance
membranes	NNS	nmod	I-Organism_substance
included	VBN	acl	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
were	VBD	cop	O
weakly	RB	advmod	O
reactive	JJ	ROOT	O
,	,	punct	O
accounting	VBG	advcl	O
for	IN	prep	O
81	CD	compound	O
%	NN	compound	O
specificity	NN	pobj	O
.	.	punct	O

3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Chloromethylthiochromone	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dioxide	NN	nsubjpass	I-Simple_chemical
was	VBD	auxpass	O
observed	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	xcomp	O
of	IN	case	O
Ehrlich	NN	nmod	B-Cancer
ascites	VBZ	acl	I-Cancer
carcinoma	NN	compound	I-Cancer
growth	NN	dobj	O
and	CC	cc	O
a	DT	det	O
moderate	JJ	amod	O
inhibitor	NN	conj	O
of	IN	case	O
P	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
388	CD	nummod	I-Cancer
lymphocytic	JJ	amod	I-Cancer
leukemia	NN	compound	I-Cancer
growth	NN	nmod	O
at	IN	case	O
10	CD	compound	O
mg	NN	nummod	O
/	:	punct	O
kg	NN	compound	O
/	:	punct	O
day	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
strongly	RB	advmod	O
support	VBP	appos	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
PI3K	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Akt	NNP	conj	B-Gene_or_gene_product
/	:	punct	O
mTOR	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
in	IN	case	O
PET	NN	nmod	B-Cancer
,	,	punct	O
which	WDT	nsubj	O
ties	VBZ	acl:relcl	O
in	IN	case	O
with	IN	case	O
the	DT	det	O
fact	NN	nmod	O
that	IN	mark	O
mTOR	NN	compound	B-Gene_or_gene_product
inhibitors	NNS	nsubj	O
have	VBP	aux	O
reached	VBN	ccomp	O
phase	NN	compound	O
III	CD	nummod	O
trials	NNS	dobj	O
in	IN	case	O
neuroendocrine	JJ	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
relative	JJ	amod	O
resistance	NN	nsubjpass	O
of	IN	case	O
PC	NN	compound	B-Cell
-	:	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
drug	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
constitutive	JJ	amod	O
Akt	JJ	compound	B-Gene_or_gene_product
activation	NN	nmod	O
,	,	punct	O
higher	JJR	amod	O
levels	NNS	conj	O
of	IN	case	O
cFLIP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
L	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
Bcl	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
lower	JJR	amod	O
levels	NNS	conj	O
of	IN	case	O
Bax	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

[	-LRB-	punct	O
Inhibitory	JJ	amod	O
effect	NN	ROOT	O
of	IN	case	O
adenovirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
endostatin	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
transfer	NN	nmod	O
on	IN	case	O
transplanted	VBN	amod	O
lung	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
]	-RRB-	punct	O

Expressions	NNS	nsubj	O
of	IN	case	O
KISS1	NN	compound	B-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
low	JJ	amod	O
TNM	NN	compound	O
stages	NNS	nmod	O
of	IN	case	O
NSCLC	NNP	nmod	B-Cancer
(	-LRB-	punct	O
I	CD	compound	O
-	SYM	punct	O
II	CD	appos	O
)	-RRB-	punct	O
compared	VBN	case	O
to	TO	case	O
more	RBR	advmod	O
advanced	JJ	amod	O
stages	NNS	advcl	O
(	-LRB-	punct	O
III	CD	compound	O
-	SYM	punct	O
IV	CD	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
p	NN	dep	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Tip30	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	ROOT	O
that	WDT	nsubj	O
can	MD	aux	O
inhibit	VB	acl:relcl	O
estrogen	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
transcription	NN	dobj	O
in	IN	case	O
MECs	NNS	nmod	B-Cell
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
MEC	NN	compound	B-Cell
proliferation	NN	nmod	O
remains	VBZ	conj	O
unknown	JJ	xcomp	O
.	.	punct	O

TIMP2	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
TIMP3	NN	conj	B-Gene_or_gene_product
play	VBP	ROOT	O
functional	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
LPA	NN	compound	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
invasion	NN	nmod	O
as	IN	case	O
negative	JJ	amod	O
regulators	NNS	nmod	O
.	.	punct	O

Topotecan	NNP	nsubj	B-Simple_chemical
-	HYPH	punct	O
and	CC	cc	O
gimatecan	NN	conj	B-Simple_chemical
induced	VBN	ROOT	O
moderate	JJ	amod	O
up	RP	prt	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
TRAIL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R1	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
-	:	punct	B-Gene_or_gene_product
R2	NN	conj	I-Gene_or_gene_product
which	WDT	nsubj	O
resulted	VBD	acl:relcl	O
in	IN	case	O
a	DT	det	O
different	JJ	amod	O
cell	NN	compound	B-Cell
response	NN	nmod	O
to	TO	case	O
the	DT	det	O
combination	NN	nmod	O
in	IN	case	O
androgen	NN	compound	B-Simple_chemical
-	HYPH	punct	O
independent	JJ	amod	O
cells	NNS	nmod	B-Cell
(	-LRB-	punct	O
DU	NN	compound	B-Cell
-	:	punct	I-Cell
145	CD	nummod	I-Cell
and	CC	cc	O
PC	NN	conj	B-Cell
-	:	punct	I-Cell
3	CD	appos	I-Cell
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
15d	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
PGJ	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
suppressed	VBD	ROOT	O
tumour	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
-	HYPH	punct	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
confirming	VBG	advcl	O
the	DT	det	O
reciprocal	JJ	amod	O
correlation	NN	dobj	O
between	IN	case	O
COX	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
PPARgamma	NN	conj	B-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
analyzed	VBD	ROOT	O
their	PRP$	nmod:poss	O
ability	NN	dobj	O
to	TO	mark	O
block	VB	acl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
chemotaxis	NN	dobj	O
and	CC	cc	O
induce	VBP	conj	O
apoptosis	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
antiangiogenic	JJ	amod	O
activity	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

For	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
adenocarcinomas	NNS	nmod	B-Cancer
in	IN	case	O
the	DT	det	O
lung	NN	nmod	B-Organ
,	,	punct	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
staining	NN	dep	O
is	VBZ	auxpass	O
now	RB	advmod	O
routinely	RB	advmod	O
used	VBN	ROOT	O
to	TO	mark	O
distinguish	VB	xcomp	O
a	DT	det	O
primary	JJ	amod	O
lung	NN	compound	B-Cancer
cancer	NN	dobj	I-Cancer
from	IN	case	O
a	DT	det	O
lung	NN	compound	B-Organ
metastasis	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Fifty	CD	compound	O
-	HYPH	punct	O
one	CD	nummod	O
percent	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
RDEB	NN	nmod	O
had	VBD	appos	O
elevated	JJ	amod	O
levels	NNS	dobj	O
(	-LRB-	punct	O
greater	JJR	dep	O
than	IN	dep	O
5000	CD	nummod	O
pg	NN	compound	O
/	SYM	punct	O
g	NN	dep	O
)	-RRB-	punct	O
of	IN	case	O
urinary	JJ	amod	B-Organism_substance
bFGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Careful	JJ	amod	O
selection	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
may	MD	aux	O
be	VB	cop	O
necessary	JJ	ROOT	O
before	IN	mark	O
designing	VBG	advcl	O
therapeutic	JJ	amod	O
strategies	NNS	dobj	O
using	VBG	acl	O
either	CC	cc:preconj	O
p53	NN	dobj	B-Gene_or_gene_product
or	CC	cc	O
E2F	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
therapeutic	JJ	amod	O
tools	NNS	nmod	O
for	IN	case	O
glioma	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

Statistical	JJ	amod	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
explore	VB	xcomp	O
the	DT	det	O
links	NNS	dobj	O
between	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
CCN	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
and	CC	cc	O
pathological	JJ	conj	O
parameters	NNS	conj	O
.	.	punct	O

Repetitive	JJ	amod	O
cycles	NNS	nsubjpass	O
of	IN	case	O
hypoxia	NN	nmod	O
and	CC	cc	O
reoxygenation	NN	conj	O
associated	VBN	acl	O
with	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
synovial	JJ	amod	B-Multi-tissue_structure
perfusion	NN	nmod	O
are	VBP	auxpass	O
postulated	VBN	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
nuclear	JJ	amod	B-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
kappaB	NN	conj	I-Gene_or_gene_product
,	,	punct	O
two	CD	nummod	O
key	JJ	amod	O
transcription	NN	compound	O
factors	NNS	appos	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
cellular	JJ	amod	B-Cell
oxygenation	NN	nmod	O
and	CC	cc	O
cytokine	NN	compound	O
stimulation	NN	conj	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
in	IN	case	O
turn	NN	nmod	O
orchestrate	VBP	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
spectrum	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
critical	JJ	amod	O
to	TO	case	O
the	DT	det	O
persistence	NN	nmod	O
of	IN	case	O
synovitis	NN	nmod	O
.	.	punct	O

High	NNP	amod	O
-	HYPH	punct	O
risk	NN	compound	O
human	JJ	amod	B-Organism
papillomaviruses	NNS	nsubjpass	I-Organism
(	-LRB-	punct	O
HPVs	NNS	appos	B-Organism
)	-RRB-	punct	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
carcinomas	NNS	nmod	B-Cancer
of	IN	case	O
the	DT	det	O
cervix	NNS	nmod	B-Multi-tissue_structure
and	CC	cc	O
other	JJ	amod	O
genital	JJ	amod	B-Cancer
tumors	NNS	conj	I-Cancer
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
mast	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
have	VBP	ROOT	O
no	DT	neg	O
mitogenic	JJ	amod	O
activity	NN	dobj	O
for	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

This	DT	det	O
observation	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
VCSA	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
is	VBZ	cop	O
likely	JJ	ccomp	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
result	NN	xcomp	O
of	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
between	IN	case	O
the	DT	det	O
viral	JJ	amod	B-Organism
src	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
product	NN	nmod	O
pp60src	NN	dep	B-Gene_or_gene_product
with	IN	case	O
host	NN	compound	O
cell	NN	compound	B-Cell
gene	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
or	CC	cc	O
gene	NN	compound	O
product	NN	compound	O
(	-LRB-	punct	O
s	NNS	conj	O
)	-RRB-	punct	O
,	,	punct	O
rather	RB	cc	O
than	IN	mwe	O
the	DT	det	O
simple	JJ	amod	O
expression	NN	conj	O
of	IN	case	O
this	DT	det	O
molecule	NN	nmod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
evaluated	VBD	ROOT	O
the	DT	det	O
usefulness	NN	dobj	O
of	IN	mark	O
measuring	VBG	acl	O
serum	NN	dobj	B-Organism_substance
and	CC	cc	O
urine	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
levels	NNS	conj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
NHL	NN	nmod	B-Cancer
.	.	punct	O

Tissue	NN	compound	B-Tissue
blocks	NNS	nsubjpass	I-Tissue
were	VBD	auxpass	O
obtained	VBN	ROOT	O
and	CC	cc	O
immunoperoxidase	NN	conj	O
staining	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	conj	O
using	VBG	xcomp	O
the	DT	det	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
antibody	NN	dobj	O
.	.	punct	O

Although	IN	mark	O
one	CD	nummod	O
mutant	JJ	amod	O
allele	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	advcl	O
in	IN	case	O
revertant	JJ	amod	B-Cell
EMS	NN	nmod	I-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
-	SYM	punct	I-Cell
19	CD	dep	I-Cell
,	,	punct	O
overexpression	NN	appos	O
of	IN	case	O
this	DT	det	O
mutant	JJ	amod	O
allele	NN	nmod	O
failed	VBD	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	nmod:npmod	I-Gene_or_gene_product
induced	VBD	amod	O
cell	NN	compound	B-Cell
transformation	NN	dobj	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
thrombospondin	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
by	IN	case	O
natural	JJ	amod	O
and	CC	cc	O
synthetic	JJ	conj	O
progestins	NNS	nmod	B-Simple_chemical
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
combined	JJ	amod	O
action	NN	nsubj	O
of	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nmod	I-Simple_chemical
on	IN	case	O
succinate	JJ	amod	B-Gene_or_gene_product
dehydrogenase	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
on	IN	case	O
glycolysis	NN	conj	O
,	,	punct	O
inhibiting	VBG	acl	O
steps	NNS	dobj	O
downstream	RB	amod	O
of	IN	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
,	,	punct	O
play	VBP	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
HepG2	NN	compound	B-Cell
cell	NN	compound	I-Cell
death	NN	nmod	O
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
this	DT	det	O
hypothesis	NN	dobj	O
,	,	punct	O
the	DT	det	O
frequency	NN	nsubjpass	O
of	IN	case	O
metastasis	NN	nmod	O
to	TO	case	O
the	DT	det	O
lung	NN	nmod	B-Organ
as	IN	case	O
a	DT	det	O
function	NN	nmod	O
of	IN	case	O
allergic	JJ	amod	O
pulmonary	JJ	amod	B-Organ
inflammation	NN	nmod	O
was	VBD	auxpass	O
assessed	VBN	ROOT	O
following	VBG	case	O
the	DT	det	O
i	NN	nmod	B-Immaterial_anatomical_entity
.	.	punct	I-Immaterial_anatomical_entity
v	LS	ROOT	I-Immaterial_anatomical_entity
.	.	punct	I-Immaterial_anatomical_entity
injection	NN	ROOT	O
of	IN	case	O
B16	NN	compound	B-Cell
-	:	punct	I-Cell
F10	NN	compound	I-Cell
melanoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
adenovirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
endostatin	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
transfer	NN	nmod	O
on	IN	case	O
transplanted	VBN	amod	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
and	CC	cc	O
its	PRP$	nmod:poss	O
mechanism	NN	conj	O
of	IN	case	O
action	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
normally	RB	advmod	O
produced	VBN	ROOT	O
in	IN	case	O
bone	NN	nmod	B-Tissue
,	,	punct	O
teeth	NNS	conj	B-Organ
,	,	punct	O
kidney	NN	conj	B-Organ
and	CC	cc	O
epithelial	JJ	amod	B-Tissue
lining	JJ	compound	I-Tissue
tissues	NNS	conj	I-Tissue
and	CC	cc	O
is	VBZ	auxpass	O
found	VBN	conj	O
in	IN	case	O
plasma	NN	nmod	B-Organism_substance
and	CC	cc	O
breast	NN	compound	B-Organism_substance
milk	NN	conj	I-Organism_substance
.	.	punct	O

Perlecan	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
anti	JJ	amod	O
-	HYPH	punct	O
adhesive	JJ	xcomp	O
for	IN	prep	O
platelets	NNS	pobj	B-Cell
,	,	punct	O
however	RB	advmod	O
after	IN	case	O
removal	NN	nmod	O
of	IN	case	O
the	DT	det	O
HS	NN	compound	O
chains	NNS	nmod	O
attached	VBN	acl	O
to	TO	case	O
perlecan	VB	nmod	B-Gene_or_gene_product
,	,	punct	O
platelet	NN	compound	B-Cell
adhesion	NN	nsubjpass	O
and	CC	cc	O
aggregation	NN	conj	O
were	VBD	auxpass	O
supported	VBN	advcl	O
.	.	punct	O

Effect	NN	nsubjpass	O
of	IN	case	O
ROS	NN	nmod	B-Simple_chemical
on	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
expressing	VBG	acl	O
hot	JJ	amod	O
-	HYPH	punct	O
spot	NN	compound	O
p53	NN	compound	B-Gene_or_gene_product
mutants	NNS	dobj	O
was	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
increase	VB	acl	O
a	DT	det	O
content	NN	dobj	O
of	IN	case	O
HIF1	NN	compound	B-Gene_or_gene_product
transcriptional	JJ	amod	O
factor	NN	nmod	O
responsible	JJ	amod	O
for	IN	case	O
up	RB	amod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	DT	compound	I-Gene_or_gene_product
mRNAs	NNS	nmod	O
.	.	punct	O

KISS1	NN	compound	B-Gene_or_gene_product
hypermethylation	NN	nsubjpass	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
bladder	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
providing	VBG	advcl	O
a	DT	det	O
potential	JJ	amod	O
mechanistic	JJ	amod	O
explanation	NN	dobj	O
(	-LRB-	punct	O
epigenetic	JJ	amod	O
silencing	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
the	DT	det	O
observed	VBN	amod	O
loss	NN	nmod	O
of	IN	case	O
KISS1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
uroepithelial	JJ	amod	B-Cancer
malignancies	NNS	nmod	I-Cancer
.	.	punct	O

In	IN	prep	O
intestinal	JJ	amod	B-Pathological_formation
metaplasia	NN	pobj	I-Pathological_formation
,	,	punct	O
dysplasia	NN	conj	B-Pathological_formation
,	,	punct	O
and	CC	cc	O
GC	NN	conj	B-Cancer
of	IN	case	O
the	DT	det	O
intestinal	JJ	amod	B-Multi-tissue_structure
and	CC	cc	O
atypical	JJ	conj	O
subtypes	NNS	nmod	O
,	,	punct	O
C	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	appos	I-Gene_or_gene_product
was	VBD	ROOT	O
over	RB	advmod	O
-	HYPH	punct	O
expressed	VBN	amod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	attr	O
0	CD	nummod	O
.	.	punct	O
0001	CD	ROOT	O
,	,	punct	O
for	IN	case	O
the	DT	det	O
association	NN	nmod	O
with	IN	case	O
histological	JJ	amod	O
type	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
reduction	NN	nsubj	O
in	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
overexpression	NN	conj	O
correlated	VBD	ROOT	O
to	TO	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
studies	NNS	nsubj	O
define	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
survivin	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	dobj	O
activated	VBN	acl	O
by	IN	case	O
DNA	NN	compound	B-Cellular_component
damage	NN	nmod	O
that	WDT	nsubj	O
results	VBZ	acl:relcl	O
in	IN	case	O
down	RB	amod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
survivin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
the	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
clearly	RB	advmod	O
demonstrates	VBZ	ROOT	O
the	DT	det	O
potential	NN	dobj	O
of	IN	case	O
vector	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
antiangiogenic	JJ	amod	O
gene	NN	compound	O
therapy	NN	nmod	O
as	IN	case	O
a	DT	det	O
component	NN	nmod	O
in	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
autocrine	NN	compound	O
angiotensin	NN	compound	B-Gene_or_gene_product
system	NN	nmod	O
,	,	punct	O
with	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
angiotensin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
converting	NN	compound	I-Gene_or_gene_product
enzyme	NN	compound	I-Gene_or_gene_product
inhibitor	NN	compound	O
lisinopril	NN	nmod	B-Simple_chemical
or	CC	cc	O
the	DT	det	O
angiotensin	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
antagonist	NN	compound	O
sar1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
ile8	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
angiotensin	NN	appos	I-Simple_chemical
II	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
leads	VBZ	ROOT	O
to	TO	case	O
increased	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
and	CC	cc	O
urokinase	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
plasminogen	NN	compound	I-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
u	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PA	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
activity	NN	conj	O
(	-LRB-	punct	O
Bell	NNP	dep	O
,	,	punct	O
L	NNP	appos	O
.	.	punct	O
,	,	punct	O
and	CC	cc	O
J	NN	conj	O
.	.	punct	O
A	DT	ROOT	O
.	.	punct	O
Madri	NNP	ROOT	O
.	.	punct	O
1990	CD	nummod	O
.	.	punct	O
Am	VBP	ROOT	O
.	.	punct	O
J	NNP	ROOT	O
.	.	punct	O
Pathol	NNP	ROOT	O
.	.	punct	O
137	CD	ROOT	O
:	:	punct	O
7	CD	nummod	O
-	SYM	punct	O
12	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

With	IN	case	O
a	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
null	NN	amod	O
cell	NN	compound	O
line	NN	nmod	O
(	-LRB-	punct	O
EU	NN	dep	B-Cell
-	SYM	punct	I-Cell
4	CD	nummod	I-Cell
)	-RRB-	punct	I-Cell
,	,	punct	O
although	IN	mark	O
doxorubicin	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
arrested	VBD	advcl	O
cells	NNS	dobj	B-Cell
in	IN	case	O
G	NN	nmod	O
(	-LRB-	punct	O
2	CD	dep	O
)	-RRB-	punct	O
/	:	punct	O
M	NN	conj	O
,	,	punct	O
survivin	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
was	VBD	cop	O
unchanged	JJ	ROOT	O
,	,	punct	O
and	CC	cc	O
cells	NNS	nsubj	B-Cell
underwent	VBD	conj	O
only	RB	advmod	O
limited	JJ	amod	O
apoptosis	NN	dobj	O
.	.	punct	O

Transcutaneous	JJ	amod	O
measurements	NNS	nsubj	O
of	IN	case	O
tissue	NN	compound	B-Tissue
pO2	NN	nmod	O
showed	VBD	ROOT	O
elevation	NN	dobj	O
from	IN	case	O
20	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
10	CD	dep	O
mm	NN	dep	O
Hg	NN	nmod	O
during	IN	case	O
air	NN	compound	O
breathing	NN	pobj	O
to	IN	case	O
643	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
242	CD	nummod	O
mm	NN	compound	O
Hg	NNP	dobj	O
while	IN	mark	O
breathing	VBG	advcl	O
pure	JJ	amod	O
oxygen	NN	dobj	B-Simple_chemical
at	IN	case	O
2	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
ATA	NN	ROOT	O
.	.	punct	O

LPA	NN	nsubj	B-Simple_chemical
downregulates	VBZ	ROOT	O
TIMP3	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
have	VB	aux	O
targets	NNS	acl:relcl	O
other	JJ	xcomp	O
than	IN	prep	O
metalloproteinases	NNS	pobj	O
.	.	punct	O

Antisera	NN	nsubj	O
to	TO	case	O
bovine	JJ	amod	B-Organism
u	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PA	NN	nmod	I-Gene_or_gene_product
blocked	VBD	ROOT	O
the	DT	det	O
increase	NN	dobj	O
in	IN	case	O
migration	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
increased	VBN	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

Application	NN	ROOT	O
of	IN	case	O
clonal	JJ	amod	B-Organism
analysis	NN	nmod	O
.	.	punct	O

Convenience	NN	nsubj	O
of	IN	prep	O
administration	NN	pobj	O
,	,	punct	O
tolerability	NN	conj	O
,	,	punct	O
and	CC	cc	O
patient	NN	compound	B-Organism
factors	NNS	conj	O
not	RB	neg	O
necessarily	RB	advmod	O
age	NN	conj	O
may	MD	aux	O
be	VB	ROOT	O
considerations	NNS	attr	O
in	IN	case	O
decisions	NNS	nmod	O
about	IN	case	O
adjuvant	JJ	amod	O
therapy	NN	nmod	O
after	IN	case	O
resection	NN	nmod	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2A	NN	nmod	I-Gene_or_gene_product
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
decreased	VBN	amod	O
proliferation	NN	compound	O
rate	NN	nmod	O
and	CC	cc	O
inhibitin	NN	conj	O
of	IN	case	O
colony	NN	compound	B-Cell
formation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
biological	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
estrogen	NN	compound	B-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
ERs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
NIH3T3	NN	compound	B-Cell
cell	NN	compound	I-Cell
transformation	NN	nmod	O
by	IN	case	O
the	DT	det	O
[	-LRB-	punct	O
12Val	NN	nummod	B-Amino_acid
]	-RRB-	punct	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ras	NN	compound	I-Gene_or_gene_product
mutant	NN	nmod	O
.	.	punct	O

These	DT	det	O
antivascular	JJ	amod	B-Multi-tissue_structure
actions	NNS	nsubj	O
are	VBP	cop	O
due	JJ	ROOT	O
in	IN	case	O
part	NN	nmod	O
to	TO	case	O
direct	VB	amod	O
effects	NNS	nmod	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
all	DT	det	O
MBDs	NNS	nsubj	B-Simple_chemical
(	-LRB-	punct	O
both	CC	cc:preconj	O
microtubule	JJ	compound	B-Cellular_component
-	HYPH	punct	O
stabilizing	NN	nsubj	O
and	CC	cc	O
microtubule	JJ	compound	B-Cellular_component
-	HYPH	punct	O
destabilizing	VBG	conj	O
)	-RRB-	punct	O
inhibit	VBP	conj	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
tube	NN	compound	B-Tissue
formation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
actions	NNS	dep	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
thought	VBN	acl:relcl	O
to	TO	mark	O
correspond	VB	xcomp	O
to	TO	case	O
therapeutic	JJ	amod	O
antiangiogenic	JJ	amod	O
actions	NNS	nmod	O
.	.	punct	O

In	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
resectable	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
the	DT	det	O
grade	NN	nsubj	O
of	IN	case	O
infiltrating	VBG	amod	O
dendritic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
suitable	JJ	amod	O
predictor	NN	ROOT	O
of	IN	case	O
prognosis	NN	nmod	O
.	.	punct	O

Based	VBN	advcl	O
on	IN	prep	O
the	DT	det	O
models	NNS	pobj	O
assessed	VBN	acl	O
herein	RB	advmod	B-Simple_chemical
,	,	punct	O
we	PRP	nsubj	O
infer	VBP	ROOT	O
that	IN	mark	O
that	IN	mark	O
FH	NN	compound	B-Gene_or_gene_product
deficiency	NN	compound	O
compels	NNS	compound	O
cells	NNS	nsubj	B-Cell
to	TO	mark	O
adopt	VB	csubj	O
an	DT	det	O
early	JJ	amod	O
,	,	punct	O
reversible	JJ	conj	O
,	,	punct	O
and	CC	cc	O
progressive	JJ	amod	O
protumorigenic	JJ	compound	O
metabolic	JJ	amod	O
milieu	NN	dobj	O
that	WDT	nsubj	O
is	VBZ	cop	O
reminiscent	NN	ccomp	O
of	IN	case	O
that	DT	nmod	O
driving	VBG	acl	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	dobj	O
.	.	punct	O

The	DT	det	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cell	NN	compound	I-Cell
fate	NN	compound	O
determinant	NN	nsubj	O
TLX	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ROOT	O
a	DT	det	O
pivotal	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
neurogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
adult	JJ	amod	O
brain	NN	nmod	B-Organ
by	IN	mark	O
maintaining	VBG	advcl	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Microarray	NN	compound	O
analysis	NN	nsubj	O
indicated	VBD	ROOT	O
significant	JJ	amod	O
alterations	NNS	dobj	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
related	JJ	amod	O
to	TO	case	O
the	DT	det	O
TGFbeta	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
genes	NNS	conj	O
involved	VBN	acl	O
in	IN	case	O
infertility	NN	nmod	O
and	CC	cc	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
production	NN	conj	O
.	.	punct	O

The	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
inactivated	VBN	ROOT	O
in	IN	case	O
about	RB	advmod	O
50	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
and	CC	cc	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
component	NN	conj	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
response	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
genotoxic	JJ	amod	O
stresses	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
those	DT	nmod	O
generated	VBN	acl	O
by	IN	case	O
radiotherapy	NN	nmod	O
or	CC	cc	O
chemotherapy	NN	conj	O
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
as	IN	mark	O
measured	VBN	acl	O
by	IN	case	O
annexin	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
to	TO	case	O
exposed	VBN	amod	O
phosphatidylserine	NN	compound	B-Amino_acid
moieties	NNS	nmod	O
,	,	punct	O
increased	VBD	ROOT	O
significantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
treated	VBN	amod	O
cells	NNS	nmod	B-Cell
at	IN	case	O
concentrations	NNS	nmod	O
higher	JJR	amod	O
than	IN	case	O
50	CD	nummod	O
microM	NN	nmod	O
for	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
003	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Newly	RB	advmod	O
formed	VBN	amod	O
bone	NN	compound	B-Organ
densities	NNS	nsubjpass	O
were	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
higher	JJR	xcomp	O
in	IN	case	O
these	DT	det	O
2	CD	nummod	O
groups	NNS	nmod	O
.	.	punct	O

14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	compound	I-Gene_or_gene_product
Overexpression	NN	nsubjpass	O
and	CC	cc	O
abnormal	JJ	amod	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
poor	JJ	amod	O
differentiation	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
in	IN	case	O
stage	NN	compound	B-Cancer
I	CD	nummod	I-Cancer
non	JJ	advmod	I-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Targeting	VBG	csubj	O
tumour	NN	compound	B-Cell
pericytes	NNS	dobj	I-Cell
is	VBZ	ROOT	O
a	DT	det	O
promising	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
therapy	NN	attr	O
but	CC	cc	O
requires	VBZ	conj	O
identifying	VBG	xcomp	O
the	DT	det	O
mechanisms	NNS	dobj	O
of	IN	case	O
their	PRP$	nmod:poss	O
recruitment	NN	nmod	O
in	IN	case	O
tumour	NN	nmod	B-Cancer
and	CC	cc	O
addressing	VBG	conj	O
whether	IN	mark	O
these	DT	det	O
mechanisms	NNS	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
selectively	RB	advmod	O
harnessed	VBN	ccomp	O
.	.	punct	O

Pharmacological	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
autophagic	JJ	amod	O
flux	NN	nmod	O
by	IN	case	O
chloroquine	NN	nmod	B-Simple_chemical
increased	VBD	ROOT	O
apoptosis	NN	dobj	O
and	CC	cc	O
decreased	VBN	amod	O
cell	NN	compound	B-Cell
viability	NN	conj	O
in	IN	case	O
hepatoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

[	-LRB-	punct	O
mRNA	NN	compound	O
expression	NN	ROOT	O
of	IN	case	O
metastasis	NN	compound	O
-	HYPH	punct	O
suppressor	NN	compound	O
gene	NN	compound	O
nm23	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
carcinoma	NN	nmod	B-Cancer
of	IN	case	O
buccal	JJ	amod	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
.	.	punct	O
II	CD	ROOT	O
.	.	punct	O
Quantitative	JJ	amod	O
reverse	JJ	amod	O
transcription	NN	compound	O
PCR	NN	compound	O
amplification	NN	ROOT	O
]	-RRB-	punct	O
.	.	punct	O

However	RB	ROOT	O
,	,	punct	O
the	DT	det	O
frequency	NN	intj	O
of	IN	case	O
the	DT	det	O
p	NN	nmod	O
.	.	punct	O
Val600Lys	NN	compound	B-Amino_acid
mutation	NN	nsubj	O
was	VBD	cop	O
higher	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
most	JJS	amod	O
other	JJ	amod	O
studies	NNS	nmod	O
and	CC	cc	O
comprised	VBD	conj	O
almost	RB	advmod	O
one	CD	nummod	O
-	HYPH	punct	O
third	NN	dobj	O
of	IN	case	O
all	DT	det	O
BRAF	NN	compound	B-Gene_or_gene_product
mutations	NNS	nmod	O
in	IN	case	O
our	PRP$	nmod:poss	O
cohort	NN	nmod	O
(	-LRB-	punct	O
27	CD	nummod	O
/	SYM	punct	O
89	CD	nummod	O
,	,	punct	O
30	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

At	IN	prep	O
later	JJ	amod	O
stages	NNS	pobj	O
,	,	punct	O
branches	NNS	nsubj	B-Multi-tissue_structure
of	IN	prep	O
radial	JJ	amod	B-Multi-tissue_structure
arteries	NNS	pobj	I-Multi-tissue_structure
penetrated	VBD	ROOT	O
the	DT	det	O
periphery	NN	dobj	O
forming	VBG	acl	O
an	DT	det	O
extensive	JJ	amod	O
mesh	NN	dobj	O
of	IN	prep	O
capillaries	NNS	pobj	B-Tissue
on	IN	prep	O
the	DT	det	O
concave	NN	compound	O
surface	NN	pobj	O
.	.	punct	O

They	PRP	nsubj	O
also	RB	advmod	O
serve	VBP	ROOT	O
as	IN	case	O
important	JJ	amod	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
signaling	VBG	compound	O
molecules	NNS	nmod	O
that	WDT	nsubj	O
amplify	VBP	acl:relcl	O
the	DT	det	O
synovial	JJ	amod	B-Multi-tissue_structure
inflammatory	JJ	amod	O
-	HYPH	punct	O
proliferative	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

Anti	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IL	NNP	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
therapy	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
new	JJ	amod	O
strategy	NN	ROOT	O
in	IN	case	O
the	DT	det	O
inflammatory	JJ	amod	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
and	CC	cc	O
cancer	NN	conj	B-Cancer
.	.	punct	O

The	DT	det	O
malate	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
citrate	JJ	amod	B-Simple_chemical
cycle	NN	nsubjpass	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
during	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
and	CC	cc	O
glutaminolysis	NN	conj	O
in	IN	case	O
a	DT	det	O
strain	NN	nmod	O
of	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	conj	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
which	WDT	nsubj	O
showed	VBD	acl:relcl	O
a	DT	det	O
very	RB	advmod	O
low	JJ	amod	O
malate	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
aspartate	NN	compound	B-Simple_chemical
shuttle	JJ	amod	O
system	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
as	IN	case	O
only	RB	advmod	O
a	DT	det	O
fraction	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
in	IN	case	O
advanced	JJ	amod	B-Cancer
Kaposi	NN	nmod:poss	I-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	compound	I-Cancer
lesions	NNS	nmod	I-Cancer
express	VBP	advcl	O
vGPCR	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	ROOT	O
whether	IN	mark	O
this	DT	det	O
unique	JJ	amod	O
viral	JJ	amod	O
oncogene	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
Kaposi	NN	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

The	DT	det	O
fibrinolytic	JJ	amod	O
(	-LRB-	punct	O
plasminogen	NN	compound	B-Gene_or_gene_product
/	:	punct	O
plasmin	NN	nsubj	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
MMP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
systems	NNS	nsubj	O
cooperate	VBP	ROOT	O
in	IN	case	O
these	DT	det	O
processes	NNS	nmod	O
.	.	punct	O

Antivascular	JJ	amod	B-Multi-tissue_structure
actions	NNS	ROOT	O
of	IN	case	O
microtubule	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
binding	VBG	compound	I-Simple_chemical
drugs	NNS	nmod	I-Simple_chemical
.	.	punct	O

Addition	NN	ROOT	O
of	IN	case	O
the	DT	det	O
caspase	NN	compound	B-Gene_or_gene_product
inhibitor	NN	compound	O
Z	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
VAD	NNP	nmod	I-Simple_chemical
.	.	punct	I-Simple_chemical
fmk	NN	advmod	I-Simple_chemical
inhibited	VBD	ROOT	O
caspase	NN	dobj	B-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
3	CD	conj	B-Gene_or_gene_product
significantly	RB	advmod	O
but	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	conj	O
caspase	NN	dobj	B-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
ARD1	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
augmented	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
synthetic	JJ	amod	O
androgen	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
R1881	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
unless	IN	mark	O
AR	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
deficient	JJ	advcl	O
or	CC	cc	O
is	VBZ	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
AR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
specific	JJ	amod	O
siRNA	NN	nmod	O
or	CC	cc	O
androgen	NN	compound	B-Simple_chemical
inhibitor	NN	compound	O
bicalutamide	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
Casodex	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

BACKGROUND	NN	dep	O
:	:	punct	O
Impaired	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	conj	I-Gene_or_gene_product
is	VBZ	auxpass	O
frequently	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
several	JJ	amod	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
stimulatory	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
mast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
on	IN	case	O
migration	NN	nmod	O
is	VBZ	cop	O
specific	JJ	ROOT	O
for	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
modulation	NN	ROOT	O
of	IN	case	O
platelet	NN	nmod	B-Cell
and	CC	cc	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
adhesion	NN	conj	O
to	TO	case	O
vascular	JJ	amod	B-Multi-tissue_structure
graft	NN	compound	I-Multi-tissue_structure
materials	NNS	nmod	O
by	IN	prep	O
perlecan	NN	pobj	B-Gene_or_gene_product
.	.	punct	O

Calretinin	NNP	ROOT	B-Gene_or_gene_product
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
significant	JJ	amod	O
associations	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
CYR61	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
versus	CC	cc	O
tumor	NN	compound	B-Cancer
grade	NN	conj	O
,	,	punct	O
pathology	NN	conj	O
,	,	punct	O
gender	NN	conj	O
,	,	punct	O
and	CC	cc	O
age	NN	conj	O
at	IN	case	O
diagnosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
compound	NN	nmod	O
on	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
development	NN	nmod	O
lend	VBP	ROOT	O
credibility	NN	dobj	O
to	TO	case	O
its	PRP$	nmod:poss	O
potential	NN	nmod	O
as	IN	case	O
an	DT	det	O
anticancer	NN	compound	B-Cancer
agent	NN	nmod	O
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
newly	RB	advmod	O
demonstrate	VBP	ROOT	O
the	DT	det	O
antiangiogenic	JJ	amod	O
action	NN	dobj	O
of	IN	case	O
p75	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
and	CC	cc	O
open	VB	amod	O
new	JJ	amod	O
avenues	NNS	conj	O
for	IN	case	O
the	DT	det	O
therapeutic	JJ	amod	O
use	NN	nmod	O
of	IN	case	O
p75	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
inhibition	NN	nmod	O
to	TO	case	O
combat	NN	compound	O
diabetes	NNS	nmod	O
-	:	punct	O
induced	VBN	amod	O
microvascular	JJ	amod	B-Tissue
liabilities	NNS	conj	O
.	.	punct	O

All	DT	det	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	JJ	amod	I-Simple_chemical
retinoic	JJ	amod	I-Simple_chemical
acid	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
ATRA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
could	MD	aux	O
potently	RB	advmod	O
inhibit	VB	ROOT	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
combination	NN	nsubj	O
with	IN	case	O
various	JJ	amod	O
anticancer	NN	compound	B-Cancer
agents	NNS	nmod	O
results	VBZ	conj	O
in	IN	case	O
increased	VBN	amod	O
cytotoxicity	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
mutant	JJ	amod	O
WT1	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
R394W	NN	appos	B-Amino_acid
)	-RRB-	punct	O
which	WDT	nsubj	O
has	VBZ	acl:relcl	O
a	DT	det	O
mutation	NN	dobj	O
in	IN	case	O
the	DT	det	O
DNA	NN	compound	B-Cellular_component
binding	NN	compound	O
domain	NN	nmod	O
could	MD	aux	O
not	RB	neg	O
repress	VB	ROOT	O
the	DT	det	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
promoter	NN	dobj	O
.	.	punct	O

Survivin	NN	compound	B-Gene_or_gene_product
expression	NN	ROOT	O
in	IN	case	O
breast	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
:	:	punct	O
correlation	NN	dep	O
with	IN	case	O
apoptosis	NN	nmod	O
and	CC	cc	O
prognosis	NN	conj	O
.	.	punct	O

The	DT	det	O
objective	NN	nsubj	O
of	IN	prep	O
this	DT	det	O
article	NN	pobj	O
is	VBZ	ROOT	O
to	TO	mark	O
explain	VB	xcomp	O
radiologic	JJ	amod	O
patterns	NNS	dobj	O
of	IN	case	O
benign	JJ	amod	B-Pathological_formation
and	CC	cc	O
malignant	JJ	conj	B-Pathological_formation
breast	NN	compound	I-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
(	-LRB-	punct	O
masses	NNS	dep	B-Pathological_formation
,	,	punct	O
microcalcifications	NNS	appos	B-Pathological_formation
)	-RRB-	punct	O
based	VBN	case	O
on	IN	case	O
histological	JJ	amod	O
correlations	NNS	nmod	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
second	JJ	amod	O
step	NN	nmod	O
,	,	punct	O
these	DT	det	O
parameters	NNS	nsubjpass	O
were	VBD	auxpass	O
further	RB	advmod	O
analyzed	VBN	ROOT	O
by	IN	case	O
hierarchical	JJ	amod	O
cluster	NN	compound	O
analyses	NNS	nmod	O
.	.	punct	O

Phospholipase	NN	compound	B-Gene_or_gene_product
D	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
PLD	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
functions	NNS	nmod	O
.	.	punct	O

This	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
transformation	NN	compound	O
process	NN	nsubj	O
involves	VBZ	ROOT	O
multiple	JJ	amod	O
steps	NNS	dobj	O
:	:	punct	O
slow	JJ	amod	O
-	HYPH	punct	O
growing	VBG	nmod:poss	O
'	''	case	O
pre	JJ	npadvmod	O
-	HYPH	punct	O
neoplastic	JJ	amod	O
'	POS	punct	O
epithelial	JJ	amod	B-Cell
foci	NNS	nsubjpass	I-Cell
are	VBP	auxpass	O
induced	VBN	conj	O
70	CD	compound	O
-	SYM	punct	O
100	CD	nummod	O
days	NNS	nmod	O
after	IN	case	O
MNU	NN	compound	B-Simple_chemical
treatment	NN	dep	O
and	CC	cc	O
from	IN	case	O
such	JJ	amod	O
foci	NNS	amod	B-Cell
rapidly	RB	advmod	O
proliferating	VBG	amod	O
immortal	JJ	amod	O
cell	NN	compound	B-Cell
lines	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
established	VBN	conj	O
,	,	punct	O
some	DT	nsubj	O
of	IN	case	O
which	WDT	nmod	O
became	VBD	parataxis	O
tumorigenic	JJ	xcomp	O
after	IN	prep	O
a	DT	det	O
further	JJ	amod	O
latent	JJ	amod	O
period	NN	pobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
SFLLR	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
agonist	NN	appos	O
of	IN	case	O
the	DT	det	O
activated	VBN	amod	O
thrombin	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
thrombin	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
peptide	NN	conj	O
and	CC	cc	O
non	JJ	amod	O
peptide	NN	compound	O
antagonists	NNS	conj	O
on	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
chick	NN	compound	B-Organism
chorioallantoic	JJ	amod	B-Multi-tissue_structure
membrane	NN	compound	I-Multi-tissue_structure
(	-LRB-	punct	O
CAM	NN	appos	B-Multi-tissue_structure
)	-RRB-	punct	O
system	NN	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
sorafenib	NN	nsubj	B-Simple_chemical
induced	VBD	ROOT	O
autophagy	NN	dobj	O
in	IN	case	O
Huh7	NN	compound	B-Cancer
xenograft	NN	compound	I-Cancer
tumors	NNS	nmod	I-Cancer
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
and	CC	cc	O
coadministration	NN	conj	O
with	IN	case	O
chloroquine	NN	nmod	B-Simple_chemical
significantly	RB	advmod	O
suppressed	VBD	advcl	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
compared	VBN	case	O
with	IN	case	O
sorafenib	NN	nmod	B-Simple_chemical
alone	RB	advmod	O
.	.	punct	O

Hepatitis	NN	compound	B-Organism
B	NN	compound	I-Organism
virus	NN	compound	I-Organism
integration	NN	compound	O
event	NN	nsubj	O
in	IN	case	O
human	JJ	amod	B-Organism
chromosome	NN	compound	B-Cellular_component
17p	NN	nmod	I-Cellular_component
near	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
identifies	VBZ	ROOT	O
the	DT	det	O
region	NN	dobj	O
of	IN	case	O
the	DT	det	O
chromosome	NN	nmod	B-Cellular_component
commonly	RB	advmod	O
deleted	VBN	acl	O
in	IN	case	O
virus	NN	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
positive	JJ	amod	I-Cancer
hepatocellular	JJ	amod	I-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
P18	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
and	CC	cc	O
potent	JJ	conj	O
antiangiogenic	JJ	amod	O
biotherapeutic	JJ	amod	O
agent	NN	appos	O
that	WDT	nsubj	O
has	VBZ	acl:relcl	O
potential	JJ	dobj	O
to	TO	mark	O
be	VB	auxpass	O
developed	VBN	acl	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
prostate	NN	nmod	B-Cancer
and	CC	cc	O
renal	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
.	.	punct	O

Under	IN	case	O
physiological	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
local	JJ	amod	O
balance	NN	nmod	O
between	IN	case	O
endogenous	JJ	amod	O
stimulators	NNS	nmod	O
and	CC	cc	O
inhibitors	NNS	conj	O
of	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
MybER	NN	nmod	B-Gene_or_gene_product
both	CC	nmod	O
prevented	VBD	ROOT	O
the	DT	det	O
growth	NN	compound	O
arrest	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
interleukin	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
rapidly	RB	advmod	O
restored	VBD	conj	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
nearly	RB	advmod	O
terminal	JJ	amod	O
differentiated	VBN	amod	O
cells	NNS	nmod	B-Cell
that	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
exposed	VBN	acl:relcl	O
to	TO	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
for	IN	case	O
3	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O

Interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
6	CD	nsubjpass	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
associated	VBN	xcomp	O
with	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
including	VBG	case	O
inhibition	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
apoptosis	NN	dep	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Osteotomy	JJ	amod	O
fracture	NN	compound	O
healing	VBG	nsubj	O
without	IN	case	O
the	DT	det	O
traction	NN	compound	O
stimulus	NN	nmod	O
failed	VBD	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
a	DT	det	O
corresponding	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
these	DT	det	O
factors	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
showed	VBD	dep	O
that	IN	mark	O
:	:	punct	O
tuberous	JJ	amod	B-Gene_or_gene_product
sclerosis	NN	nsubjpass	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
TSC2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
phosphatase	NN	conj	B-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
tensin	NN	compound	I-Gene_or_gene_product
homolog	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
PTEN	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
were	VBD	auxpass	O
downregulated	VBN	ccomp	O
in	IN	case	O
most	JJS	nmod	O
of	IN	case	O
the	DT	det	O
primary	JJ	amod	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
low	JJ	amod	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
associated	VBN	conj	O
with	IN	case	O
shorter	JJR	amod	O
disease	NN	compound	O
-	HYPH	punct	O
free	JJ	amod	O
and	CC	cc	O
overall	JJ	conj	O
survival	NN	nmod	O
;	:	punct	O
somatostatin	NN	compound	B-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
SSTR2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	cop	O
absent	JJ	parataxis	O
or	CC	cc	O
very	RB	advmod	O
low	JJ	conj	O
in	IN	case	O
insulinomas	NNS	nmod	B-Cancer
compared	VBN	case	O
with	IN	case	O
nonfunctioning	JJ	amod	O
tumors	NNS	nmod	B-Cancer
;	:	punct	O
and	CC	cc	O
expression	NN	nsubjpass	O
of	IN	case	O
fibroblast	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
13	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
FGF13	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	nmod	O
was	VBD	auxpass	O
significantly	RB	advmod	O
associated	VBN	conj	O
with	IN	case	O
the	DT	det	O
occurrence	NN	nmod	O
of	IN	case	O
liver	NN	compound	B-Organ
metastasis	NN	nmod	O
and	CC	cc	O
shorter	JJR	amod	O
disease	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	conj	O
.	.	punct	O

Clear	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
renal	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nsubj	I-Cancer
(	-LRB-	punct	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	appos	I-Cancer
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
highly	RB	advmod	O
vascularised	VBN	amod	O
tumour	NN	ROOT	B-Cancer
and	CC	cc	O
is	VBZ	cop	O
therefore	RB	advmod	O
an	DT	det	O
attractive	JJ	amod	O
disease	NN	conj	O
to	TO	mark	O
study	VB	acl	O
angiogenesis	NN	dobj	O
and	CC	cc	O
to	TO	mark	O
test	VB	conj	O
novel	JJ	amod	O
angiogenesis	NN	compound	O
inhibitors	NNS	dobj	O
in	IN	case	O
early	JJ	amod	O
clinical	JJ	amod	O
development	NN	nmod	O
.	.	punct	O

Stimulation	NN	nsubjpass	O
of	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
was	VBD	auxpass	O
connected	VBN	ROOT	O
with	IN	case	O
about	RB	advmod	O
2	CD	nummod	O
-	HYPH	punct	O
fold	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
level	NN	nmod	O
of	IN	case	O
reactive	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
species	NNS	nmod	I-Simple_chemical
(	-LRB-	punct	O
ROS	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

Inhibition	NN	nsubj	O
by	IN	case	O
N	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
phosphonacetyl	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
L	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aspartate	NN	nmod	I-Simple_chemical
of	IN	case	O
Ehrlich	NN	nmod	B-Cancer
ascites	VBZ	ROOT	I-Cancer
tumour	NN	compound	I-Cancer
growth	NN	dobj	O
and	CC	cc	O
glucose	NN	compound	B-Simple_chemical
transport	NN	conj	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
secondary	JJ	amod	O
by	IN	case	O
-	HYPH	punct	O
product	NN	advcl	O
of	IN	prep	O
the	DT	det	O
transformed	VBN	amod	O
state	NN	pobj	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
equally	RB	advmod	O
possible	JJ	ROOT	O
that	IN	mark	O
p53	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
actively	RB	advmod	O
involved	VBN	ccomp	O
in	IN	mark	O
altering	VBG	advcl	O
cellular	JJ	amod	B-Cell
growth	NN	compound	O
properties	NNS	dobj	O
,	,	punct	O
especially	RB	advmod	O
as	IN	mark	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	advcl	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
normal	JJ	amod	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
.	.	punct	O

Seventy	CD	compound	O
-	HYPH	punct	O
five	CD	nummod	O
patients	NNS	nsubj	B-Organism
underwent	VBD	ROOT	O
biopsies	NNS	dobj	O
of	IN	case	O
carcinomas	NNS	nmod	B-Cancer
metastatic	JJ	amod	O
to	TO	case	O
the	DT	det	O
brain	NN	nmod	B-Organ
.	.	punct	O

Immunohistochemical	JJ	amod	O
staining	NN	ROOT	O
for	IN	case	O
thyroid	NN	compound	B-Gene_or_gene_product
transcription	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
helpful	JJ	amod	O
aid	NN	conj	O
in	IN	mark	O
discerning	VBG	acl	O
primary	JJ	amod	O
site	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
origin	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
brain	NN	compound	B-Organ
metastases	NNS	nmod	O
.	.	punct	O

Combined	JJ	amod	O
topical	JJ	amod	O
fluconazole	NN	ROOT	B-Simple_chemical
and	CC	cc	O
corticosteroid	NN	compound	B-Simple_chemical
treatment	NN	conj	O
for	IN	prep	O
experimental	JJ	amod	O
Candida	NN	compound	B-Organism
albicans	NNS	compound	I-Organism
keratomycosis	NN	pobj	O
.	.	punct	O

TS	NN	nsubj	B-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
new	JJ	amod	O
,	,	punct	O
oral	JJ	amod	B-Organism_subdivision
anticancer	NN	compound	B-Cancer
agent	NN	nsubjpass	O
composed	VBN	acl	O
of	IN	case	O
two	CD	nummod	O
modulators	NNS	nmod	O
,	,	punct	O
gimeracil	NN	appos	B-Simple_chemical
(	-LRB-	punct	O
CDHP	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
oteracil	NN	compound	B-Simple_chemical
potassium	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
Oxo	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
are	VBP	auxpass	O
mixed	VBN	ROOT	O
with	IN	case	O
tegafur	NN	nmod	B-Simple_chemical
in	IN	case	O
a	DT	det	O
ratio	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
:	:	punct	O
0	CD	nummod	O
.	.	punct	O
4	CD	nummod	O
:	:	punct	O
1	CD	nmod	O
.	.	punct	O

Whereas	IN	mark	O
agents	NNS	nsubj	O
seem	VBP	advcl	O
promising	NN	xcomp	O
in	IN	case	O
the	DT	det	O
test	NN	compound	O
tube	NN	nmod	O
,	,	punct	O
clinical	JJ	amod	O
trials	NNS	nsubj	O
often	RB	advmod	O
fail	VBP	ROOT	O
due	JJ	advmod	O
to	TO	mwe	O
unfavorable	JJ	amod	O
pharmacokinetics	NNS	pobj	O
,	,	punct	O
poor	JJ	amod	O
delivery	NN	conj	O
,	,	punct	O
low	JJ	amod	O
local	JJ	amod	O
concentrations	NNS	conj	O
,	,	punct	O
and	CC	cc	O
limited	JJ	amod	O
accumulation	NN	conj	O
in	IN	case	O
the	DT	det	O
target	NN	compound	O
cell	NN	nmod	B-Cell
.	.	punct	O

Disabling	JJ	amod	O
mutations	NNS	nsubj	O
and	CC	cc	O
deletions	NNS	conj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
occur	VBP	ROOT	O
in	IN	case	O
50	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
tumours	NNS	nmod	B-Cancer
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
most	RBS	advmod	O
efficient	JJ	amod	O
time	NN	compound	O
point	NN	dobj	O
and	CC	cc	O
concentration	NN	conj	O
of	IN	prep	O
topical	JJ	amod	O
corticosteroids	NNS	pobj	B-Simple_chemical
in	IN	case	O
Candida	NN	compound	B-Organism
albicans	NNS	compound	I-Organism
keratitis	NN	nmod	O
treated	VBN	acl	O
with	IN	prep	O
fluconazole	NN	pobj	B-Simple_chemical
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
subclinical	JJ	amod	O
cumulative	JJ	amod	O
dose	NN	nsubj	O
of	IN	case	O
900	CD	nummod	O
cGy	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
threshold	NN	ccomp	O
for	IN	case	O
impaired	JJ	amod	O
tissue	NN	compound	B-Tissue
revascularization	NN	nmod	O
provided	VBD	ccomp	O
that	IN	mark	O
treatment	NN	nsubjpass	O
is	VBZ	auxpass	O
delivered	VBN	ccomp	O
immediately	RB	advmod	O
after	IN	case	O
implantation	NN	nmod	O
over	IN	case	O
a	DT	det	O
48	CD	nummod	O
-	HYPH	punct	O
hour	NN	compound	O
interval	NN	nmod	O
.	.	punct	O

At	IN	prep	O
6	CD	nummod	O
weeks	NNS	pobj	O
,	,	punct	O
animals	NNS	nsubjpass	O
were	VBD	auxpass	O
killed	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
flaps	NNS	nsubjpass	B-Multi-tissue_structure
were	VBD	auxpass	O
analyzed	VBN	conj	O
for	IN	prep	O
length	NN	pobj	O
,	,	punct	O
width	NN	conj	O
,	,	punct	O
and	CC	cc	O
weight	NN	conj	O
;	:	punct	O
perfused	VBN	dep	O
with	IN	case	O
fluorescein	NN	nmod	B-Simple_chemical
or	CC	cc	O
lead	VB	amod	B-Simple_chemical
oxide	NN	conj	I-Simple_chemical
;	:	punct	O
and	CC	cc	O
examined	VBN	conj	O
histologically	RB	advmod	O
.	.	punct	O

A	DT	det	O
71	CD	nummod	O
-	HYPH	punct	O
year	NN	npadvmod	O
-	HYPH	punct	O
old	JJ	amod	O
woman	NN	nsubjpass	B-Organism
was	VBD	auxpass	O
admitted	VBN	ROOT	O
to	IN	prep	O
our	PRP$	poss	O
hospital	NN	pobj	O
because	IN	prep	O
of	IN	pcomp	O
breathlessness	NN	pobj	O
.	.	punct	O

Survivin	NN	nsubj	B-Gene_or_gene_product
is	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
member	NN	attr	O
of	IN	case	O
the	DT	det	O
inhibitor	NN	nmod	B-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
apoptosis	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
(	-LRB-	punct	O
IAP	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
family	NN	nmod	O
.	.	punct	O

Animals	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
sacrificed	VBN	ROOT	O
at	IN	prep	O
3	CD	nummod	O
-	HYPH	punct	O
week	NN	compound	O
intervals	NNS	pobj	O
from	IN	prep	O
0	CD	quantmod	O
to	TO	quantmod	O
39	CD	nummod	O
weeks	NNS	npadvmod	O
after	IN	mark	O
treatments	NNS	nsubj	O
began	VBD	advcl	O
.	.	punct	O

Eight	CD	nummod	O
founder	NN	nsubjpass	O
and	CC	cc	O
progeny	NN	compound	O
mice	NNS	conj	B-Organism
of	IN	case	O
5	CD	nummod	O
different	JJ	amod	O
lines	NNS	nmod	O
were	VBD	auxpass	O
monitored	VBN	ROOT	O
for	IN	case	O
leukemogenesis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
constructed	VBN	ROOT	O
a	DT	det	O
recombinant	JJ	amod	O
adenovirus	NN	dobj	B-Organism
that	WDT	nsubj	O
expresses	VBZ	acl:relcl	O
murine	JJ	amod	B-Organism
endostatin	NN	dobj	B-Gene_or_gene_product
that	WDT	nsubj	O
is	VBZ	cop	O
biologically	RB	advmod	O
active	JJ	acl:relcl	O
both	CC	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
by	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
165	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
PLGA	NN	compound	B-Simple_chemical
microspheres	VBZ	nsubjpass	O
with	IN	case	O
an	DT	det	O
open	JJ	amod	O
-	HYPH	punct	O
porous	JJ	amod	O
structure	NN	nmod	O
were	VBD	auxpass	O
formed	VBN	appos	O
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
provides	VBZ	ROOT	O
basic	JJ	amod	O
information	NN	dobj	O
for	IN	case	O
the	DT	det	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
biology	NN	nmod	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
aims	VBZ	conj	O
at	IN	case	O
presenting	VBG	amod	O
experimental	JJ	amod	O
data	NNS	nmod	O
illustrating	VBG	acl	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
/	:	punct	O
Rel	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
pancreatic	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
outline	VBP	ROOT	O
the	DT	det	O
known	JJ	amod	O
mechanisms	NNS	dobj	O
that	WDT	nsubj	O
impair	VBP	acl:relcl	O
p53	NN	dobj	B-Gene_or_gene_product
itself	PRP	dep	O
and	CC	cc	O
its	PRP$	nmod:poss	O
immediate	JJ	amod	O
regulators	NNS	conj	O
or	CC	cc	O
target	NN	compound	O
genes	NNS	conj	O
during	IN	case	O
melanomagenesis	NN	nmod	O
.	.	punct	O

To	TO	mark	O
verify	VB	advcl	O
that	IN	mark	O
P18	NN	nsubj	B-Gene_or_gene_product
acts	VBZ	ccomp	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
manner	NN	nmod	O
as	IN	case	O
PEDF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
immunohistochemistry	NN	dobj	O
to	TO	mark	O
measure	VB	xcomp	O
PEDF	NN	compound	B-Gene_or_gene_product
targets	NNS	dobj	I-Gene_or_gene_product
,	,	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	appos	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
CD95	NN	compound	B-Gene_or_gene_product
ligand	NN	compound	I-Gene_or_gene_product
expression	NN	conj	O
in	IN	case	O
P18	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
treated	VBN	amod	O
vasculature	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

During	IN	case	O
8	CD	nummod	O
days	NNS	nmod	O
of	IN	case	O
culture	NN	nmod	O
under	IN	case	O
5	CD	compound	O
%	NN	compound	O
O	NN	nmod	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
room	NN	compound	O
air	NN	conj	O
,	,	punct	O
the	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
FGF2	NN	nmod	B-Gene_or_gene_product
to	TO	case	O
explants	NNS	nmod	O
stimulated	VBD	ROOT	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
Gs	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IB	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
positive	JJ	dep	O
,	,	punct	O
CD31	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	conj	O
,	,	punct	O
and	CC	cc	O
Flk	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
microvessels	NNS	dobj	O
in	IN	case	O
a	DT	det	O
concentration	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
possible	JJ	ROOT	O
that	IN	mark	O
loss	NN	nsubj	O
of	IN	case	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
contributes	VBZ	ccomp	O
to	TO	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
by	IN	mark	O
impairing	VBG	advcl	O
the	DT	det	O
G	NN	compound	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
checkpoint	NN	compound	O
function	NN	dobj	O
,	,	punct	O
thus	RB	advmod	O
allowing	VBG	advcl	O
an	DT	det	O
accumulation	NN	dobj	O
of	IN	case	O
genetic	JJ	amod	O
defects	NNS	nmod	O
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
will	MD	aux	O
focus	VB	ROOT	O
on	IN	case	O
recent	JJ	amod	O
studies	NNS	nmod	O
to	TO	mark	O
define	VB	acl	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
for	IN	case	O
the	DT	det	O
antivascular	JJ	amod	B-Multi-tissue_structure
actions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
MBDs	NNS	nmod	B-Simple_chemical
,	,	punct	O
information	NN	dobj	O
that	WDT	nsubj	O
could	MD	aux	O
be	VB	cop	O
useful	JJ	acl:relcl	O
in	IN	case	O
the	DT	dep	O
identification	NN	nmod	O
or	CC	cc	O
design	NN	conj	O
of	IN	case	O
agents	NNS	nmod	O
whose	WP$	nmod:poss	O
actions	NNS	nsubj	O
more	RBR	advmod	O
selectively	RB	advmod	O
target	VBP	acl:relcl	O
the	DT	det	O
tumor	NN	compound	B-Multi-tissue_structure
vasculature	NN	dobj	I-Multi-tissue_structure
.	.	punct	O

Migration	NN	nsubj	O
of	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
component	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

In	IN	case	O
1997	CD	nmod	O
,	,	punct	O
the	DT	det	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nsubjpass	O
(	-LRB-	punct	O
phosphatase	NN	dep	B-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
tensin	NN	compound	I-Gene_or_gene_product
homolog	NN	conj	I-Gene_or_gene_product
deleted	VBN	acl	I-Gene_or_gene_product
on	IN	case	I-Gene_or_gene_product
chromosome	NN	nmod	I-Gene_or_gene_product
10	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	nmod	O
on	IN	case	O
the	DT	det	O
long	JJ	amod	O
arm	NN	compound	O
of	IN	case	O
chromosome	NN	nmod	B-Cellular_component
10	CD	nummod	I-Cellular_component
.	.	punct	O

Genetic	JJ	amod	O
alterations	NNS	nsubj	O
at	IN	case	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	nmod	I-Gene_or_gene_product
such	JJ	case	O
as	IN	mwe	O
loss	NN	nmod	O
of	IN	case	O
heterozygosity	NN	nmod	O
were	VBD	cop	O
rare	JJ	ROOT	O
(	-LRB-	punct	O
1	CD	nummod	O
/	SYM	punct	O
20	CD	nummod	O
informative	JJ	amod	O
cases	NNS	dep	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
no	DT	neg	O
mutations	NNS	nsubjpass	O
were	VBD	auxpass	O
detected	VBN	conj	O
(	-LRB-	punct	O
0	CD	nummod	O
/	SYM	punct	O
34	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
action	NN	nsubjpass	O
of	IN	case	O
thrombin	NN	nmod	B-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
thrombin	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Transfection	NN	nsubj	O
with	IN	case	O
TSP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
purified	VBN	amod	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
added	VBD	nsubj	O
to	TO	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
did	VBD	aux	O
not	RB	neg	O
alter	VB	ROOT	O
the	DT	det	O
protein	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
SMA	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
desmin	NN	conj	B-Gene_or_gene_product
but	CC	cc	O
significantly	RB	advmod	O
inhibited	VBD	conj	O
matrix	NN	compound	B-Gene_or_gene_product
metalloprotease	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

c	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Met	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
Mitf	NNP	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
melanocyte	NN	compound	B-Cell
lineage	NN	nmod	I-Cell
.	.	punct	O

These	DT	det	O
patients	NNS	nsubj	B-Organism
included	VBD	ROOT	O
many	JJ	dobj	O
who	WP	nsubjpass	O
were	VBD	auxpass	O
enrolled	VBN	acl:relcl	O
in	IN	prep	O
the	DT	det	O
Epidermolysis	NNP	compound	O
Bullosa	NNP	compound	O
Registry	NNP	pobj	O
and	CC	cc	O
others	NNS	conj	O
who	WP	nsubjpass	O
were	VBD	auxpass	O
referred	VBN	relcl	O
by	IN	agent	O
their	PRP$	poss	O
physicians	NNS	pobj	O
.	.	punct	O

The	DT	det	O
distinction	NN	nsubjpass	O
between	IN	prep	O
these	DT	det	O
two	CD	nummod	O
possibilities	NNS	pobj	O
is	VBZ	auxpass	O
made	VBN	ROOT	O
based	VBN	xcomp	O
on	IN	prep	O
clinicopathologic	JJ	amod	O
observations	NNS	pobj	O
,	,	punct	O
and	CC	cc	O
therefore	RB	advmod	O
may	MD	aux	O
not	RB	neg	O
be	VB	cop	O
definitive	JJ	conj	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
HGF	NN	compound	B-Gene_or_gene_product
stimulation	NN	nsubjpass	O
of	IN	case	O
melanocytes	NNS	nmod	B-Cell
was	VBD	auxpass	O
seen	VBN	ROOT	O
to	IN	case	O
up	RB	advmod	O
-	HYPH	punct	O
regulate	VB	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Met	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

Differential	JJ	amod	O
proteomic	JJ	amod	O
analysis	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
metastasis	NN	compound	O
-	:	punct	O
associated	VBN	amod	O
proteins	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
Y705F	NN	preconj	B-Amino_acid
/	:	punct	O
S727E	NN	nsubj	B-Amino_acid
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
Y705F	NN	conj	B-Amino_acid
/	:	punct	O
S727A	NN	dep	B-Amino_acid
mutant	NN	dep	O
induced	VBD	ROOT	O
anchorage	NN	nmod:npmod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	dobj	O
of	IN	case	O
noncancerous	JJ	amod	B-Cell
prostate	NN	compound	I-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
RWPE	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
)	-RRB-	punct	O
.	.	punct	O

Angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
inhibited	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
DMBA	NNP	compound	B-Simple_chemical
-	HYPH	punct	O
vitamin	NN	compound	B-Simple_chemical
E	NN	compound	I-Simple_chemical
group	NN	nmod	O
and	CC	cc	O
TGF	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
inhibited	VBN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HL	NN	nsubj	I-Simple_chemical
significantly	RB	advmod	O
inhibited	VBD	dep	O
adhesion	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
vitronectin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
tubular	JJ	amod	B-Tissue
structures	NNS	conj	I-Tissue
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

ERK1	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
JNK	NN	conj	B-Gene_or_gene_product
inactivation	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
Ets	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
transcription	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
ELK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	LS	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
dephosphorylation	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
TLX	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
glioma	NN	compound	B-Cell
stem	NN	compound	I-Cell
cell	NN	compound	I-Cell
genesis	NN	nmod	O
and	CC	cc	O
represents	VBZ	conj	O
a	DT	det	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
target	NN	dobj	O
for	IN	case	O
this	DT	det	O
type	NN	nmod	O
of	IN	case	O
malignancy	NN	nmod	B-Cancer
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
leukemogenic	JJ	amod	O
phenotype	NN	nmod	O
is	VBZ	auxpass	O
generally	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
inappropriate	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
this	DT	det	O
transcriptional	JJ	amod	O
regulator	NN	nmod	O
.	.	punct	O

INTRODUCTION	NN	ROOT	O
:	:	punct	O
Increased	VBN	amod	O
angiogenesis	NN	nsubj	O
in	IN	case	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
is	VBZ	cop	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
characteristics	NNS	nmod	O
of	IN	case	O
chronic	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukaemia	NN	nmod	I-Cancer
(	-LRB-	punct	O
CML	NN	appos	B-Cancer
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
clonal	JJ	amod	O
myeloproliferative	JJ	amod	O
disorder	NN	appos	O
that	WDT	nsubj	O
expresses	VBZ	acl:relcl	O
a	DT	det	O
chimeric	JJ	amod	O
bcr	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
abl	NN	compound	I-Gene_or_gene_product
protein	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
Hes	NN	compound	B-Gene_or_gene_product
genes	NNS	nsubj	O
cooperatively	RB	advmod	O
regulate	VBP	ccomp	O
intestinal	JJ	amod	B-Multi-tissue_structure
development	NN	dobj	O
and	CC	cc	O
homeostasis	NN	conj	O
and	CC	cc	O
raised	VBD	conj	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
Hes1	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
promising	JJ	amod	O
target	NN	ccomp	O
to	TO	mark	O
induce	VB	acl	O
the	DT	det	O
differentiation	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Patterns	NNS	nsubj	O
of	IN	case	O
X	NN	compound	B-Cellular_component
-	HYPH	punct	I-Cellular_component
chromosome	NN	compound	I-Cellular_component
inactivation	NN	nmod	O
,	,	punct	O
mutations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
,	,	punct	O
mutations	NNS	conj	O
or	CC	cc	O
allelic	JJ	amod	O
loss	NN	conj	O
of	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
,	,	punct	O
or	CC	cc	O
human	JJ	amod	B-Organism
papillomavirus	NN	compound	I-Organism
detection	NN	conj	O
were	VBD	cop	O
identical	JJ	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
endometrial	JJ	amod	B-Pathological_formation
and	CC	cc	O
ovarian	JJ	conj	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
in	IN	case	O
three	CD	nmod	O
of	IN	case	O
the	DT	det	O
cases	NNS	nmod	O
suggesting	VBG	xcomp	O
that	IN	mark	O
those	DT	det	O
three	CD	nummod	O
cases	NNS	nsubj	O
represented	VBD	ccomp	O
single	JJ	amod	O
primary	JJ	amod	B-Cancer
tumors	NNS	dobj	I-Cancer
with	IN	case	O
metastases	NNS	nmod	O
.	.	punct	O

As	IN	mark	O
coronary	JJ	amod	B-Multi-tissue_structure
artery	NN	compound	I-Multi-tissue_structure
disease	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
major	JJ	amod	O
cause	NN	nsubj	O
of	IN	case	O
death	NN	nmod	O
in	IN	case	O
the	DT	det	O
developed	VBN	amod	O
societies	NNS	nmod	O
and	CC	cc	O
also	RB	advmod	O
an	DT	det	O
emerging	VBG	amod	O
health	NN	compound	O
problem	NN	conj	O
in	IN	prep	O
developing	VBG	pcomp	O
countries	NNS	dobj	O
like	IN	prep	O
Bangladesh	NN	amod	O
therapeutic	JJ	amod	O
angiogenesis	NN	pobj	O
may	MD	aux	O
provide	VB	ROOT	O
hope	NN	dobj	O
as	IN	case	O
a	DT	det	O
new	JJ	amod	O
treatment	NN	compound	O
modality	NN	nmod	O
for	IN	case	O
ischemic	JJ	amod	O
heart	NN	compound	B-Organ
disease	NN	nmod	O
with	IN	dep	O
or	CC	cc	O
in	IN	conj	O
place	NN	pobj	O
of	IN	prep	O
current	JJ	amod	O
therapies	NNS	pobj	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
also	RB	advmod	O
suggest	VBP	ROOT	O
progesterone	NN	nsubj	B-Simple_chemical
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
modulating	VBG	advcl	O
inflammation	NN	dobj	O
.	.	punct	O

The	DT	det	O
deregulated	VBN	amod	O
Bcr	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
Abl	NN	compound	I-Gene_or_gene_product
tyrosine	NN	compound	B-Amino_acid
kinase	NN	nsubj	O
is	VBZ	cop	O
responsible	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
Philadelphia	NNP	compound	O
(	-LRB-	punct	O
Ph	NNP	appos	O
)	-RRB-	punct	O
-	:	punct	O
positive	JJ	amod	O
leukemia	NN	nmod	B-Cancer
in	IN	case	O
humans	NNS	nmod	B-Organism
.	.	punct	O

This	DT	nsubj	O
prompted	VBD	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
examine	VB	xcomp	O
a	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
insulin	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
hexokinase	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	nsubjpass	I-Gene_or_gene_product
might	MD	aux	O
be	VB	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
prognostic	JJ	amod	O
biomarkers	NNS	nmod	O
for	IN	case	O
NSCLC	NNP	nmod	B-Cancer
.	.	punct	O

Multikinase	NN	compound	O
inhibitor	NN	compound	O
sorafenib	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
proliferation	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
by	IN	mark	O
suppressing	VBG	advcl	O
the	DT	det	O
Raf	NNP	compound	B-Gene_or_gene_product
/	:	punct	O
MEK	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ERK	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	dobj	O
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
tyrosine	NN	compound	B-Amino_acid
kinase	NN	conj	O
.	.	punct	O

Accordingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
rate	NN	nsubj	O
of	IN	case	O
elimination	NN	nmod	O
of	IN	case	O
abnormal	JJ	amod	O
proteins	NNS	nmod	O
was	VBD	cop	O
lower	JJR	ROOT	O
in	IN	case	O
cells	NNS	nmod	B-Cell
lacking	VBG	acl	O
a	DT	det	O
functional	JJ	amod	O
VHL	NN	compound	B-Gene_or_gene_product
gene	NN	dobj	O
than	IN	case	O
in	IN	case	O
wtVHL	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
cell	NN	compound	B-Cell
autonomous	JJ	amod	O
function	NN	nsubjpass	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
melanocytes	NNS	nmod	B-Cell
is	VBZ	auxpass	O
not	RB	neg	O
well	RB	advmod	O
described	VBN	advcl	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
balance	NN	nsubj	O
of	IN	case	O
the	DT	det	O
evidence	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
an	DT	det	O
effective	JJ	amod	O
tumor	NN	compound	B-Cancer
suppressor	NN	ccomp	O
and	CC	cc	O
the	DT	det	O
myriad	NN	nsubj	O
of	IN	case	O
mechanisms	NNS	nmod	O
by	IN	case	O
which	WDT	nmod	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
pathway	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
dysregulated	VBN	acl:relcl	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
attests	VBZ	conj	O
to	IN	mark	O
it	PRP	nsubj	O
importance	VB	nmod	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
syndecans	NNS	nsubj	B-Gene_or_gene_product
bind	VBP	ROOT	O
to	TO	case	O
obesity	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
factors	NNS	nmod	O
and	CC	cc	O
regulate	VBP	conj	O
their	PRP$	nmod:poss	O
signaling	NN	dobj	O
,	,	punct	O
in	IN	case	O
turn	NN	nmod	O
modulating	NN	advcl	O
food	NN	compound	O
consumption	NN	dobj	O
and	CC	cc	O
weight	NN	compound	O
balance	NN	conj	O
.	.	punct	O

Although	IN	mark	O
AID	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
focused	VBN	advcl	O
at	IN	case	O
Immunoglobulin	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
Ig	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	compound	O
loci	NNS	nmod	O
,	,	punct	O
it	PRP	nsubj	O
also	RB	advmod	O
targets	VBZ	ROOT	O
a	DT	det	O
wide	JJ	amod	O
array	NN	dobj	O
of	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
Ig	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
including	VBG	case	O
oncogenes	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
lymphomas	NNS	nmod	B-Cancer
.	.	punct	O

N	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
coexpressed	VBN	ROOT	O
with	IN	case	O
WT1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
developing	VBG	amod	O
kidney	NN	nmod	B-Organ
and	CC	cc	O
is	VBZ	auxpass	O
overexpressed	VBN	conj	O
in	IN	prep	O
many	JJ	amod	O
Wilms	NN	poss	B-Cancer
'	POS	case	I-Cancer
tumors	NNS	pobj	I-Cancer
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
p24	NN	compound	B-Gene_or_gene_product
proteins	NNS	nmod	I-Gene_or_gene_product
in	IN	case	O
insulin	NN	compound	B-Gene_or_gene_product
transport	NN	nmod	O
.	.	punct	O

The	DT	det	O
importance	NN	nsubjpass	O
of	IN	case	O
NO	NN	nmod	B-Simple_chemical
in	IN	case	O
the	DT	det	O
vasculature	NN	nmod	B-Anatomical_system
is	VBZ	auxpass	O
demonstrated	VBN	ROOT	O
by	IN	case	O
several	JJ	amod	O
experimental	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
induced	VBN	amod	O
angiogenesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
immunohistochemical	JJ	amod	O
analysis	NN	nmod	O
of	IN	case	O
EGFR	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
Ki67	NN	conj	B-Gene_or_gene_product
index	NN	conj	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
Ca	NNP	compound	B-Cancer
ex	FW	case	I-Cancer
-	HYPH	punct	I-Cancer
PA	NNP	nmod	I-Cancer
,	,	punct	O
especially	RB	advmod	O
with	IN	case	O
adenocarcinoma	NN	nmod	B-Cancer
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
PA	NN	nmod	B-Pathological_formation
and	CC	cc	O
sialadenitis	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
strategy	NN	dobj	O
to	TO	case	O
engineer	NN	nmod	O
and	CC	cc	O
express	VBP	conj	O
stable	JJ	amod	O
and	CC	cc	O
soluble	JJ	conj	O
human	JJ	amod	B-Organism
recombinant	JJ	amod	O
polyvalent	JJ	dep	O
/	SYM	punct	O
polyspecific	JJ	dep	O
fusion	NN	compound	O
proteins	NNS	dobj	O
.	.	punct	O

Insulin	NNP	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	prep	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
enhances	VBZ	ROOT	O
invasion	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
resistance	NN	dobj	O
to	TO	case	O
apoptosis	NN	nmod	O
of	IN	case	O
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
the	DT	det	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
Bcl	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
L	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

Cell	NN	nmod:npmod	B-Cell
type	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
angiogenic	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
nonischemic	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
by	IN	case	O
a	DT	det	O
constitutively	RB	advmod	O
active	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

AID	NN	nsubj	B-Gene_or_gene_product
deaminates	NNS	ROOT	O
cytidines	NNS	dobj	B-Simple_chemical
in	IN	case	O
DNA	NN	nmod	B-Cellular_component
resulting	VBG	acl	O
in	IN	case	O
U	NN	nmod	O
:	:	punct	O
G	NN	nsubj	O
mismatches	NNS	parataxis	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
processed	VBN	ccomp	O
into	IN	case	O
point	NN	compound	O
mutations	NNS	nmod	O
in	IN	case	O
SHM	NN	nmod	O
or	CC	cc	O
double	JJ	amod	O
-	HYPH	punct	O
strand	NN	compound	O
breaks	NNS	conj	O
in	IN	case	O
CSR	NN	nmod	O
.	.	punct	O

Insulin	NN	compound	B-Gene_or_gene_product
concentrations	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
at	IN	case	O
baseline	NN	nmod	O
and	CC	cc	O
at	IN	conj	O
the	DT	det	O
5	CD	pobj	O
-	HYPH	punct	O
,	,	punct	O
45	CD	conj	O
-	:	punct	O
,	,	punct	O
60	CD	conj	O
-	HYPH	punct	O
,	,	punct	O
and	CC	cc	O
90	CD	nummod	O
-	HYPH	punct	O
minute	NN	amod	O
time	NN	compound	O
periods	NNS	dobj	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
tolerance	NN	compound	O
test	NN	nmod	O
in	IN	case	O
dogs	NNS	nmod	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
.	.	punct	O

Loss	NN	nsubjpass	O
of	IN	case	O
heterozygosity	NN	nmod	O
at	IN	case	O
the	DT	det	O
E	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Cadherin	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
uvo	NN	appos	O
)	-RRB-	punct	O
locus	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
mutations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
seem	VBP	conj	O
to	TO	mark	O
be	VB	cop	O
rare	JJ	xcomp	O
.	.	punct	O

Infection	NN	nsubj	O
with	IN	case	O
retroviruses	NNS	nmod	B-Organism
containing	VBG	acl	O
transforming	VBG	amod	O
genes	NNS	dobj	O
of	IN	case	O
the	DT	dep	O
src	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
ras	NN	conj	B-Gene_or_gene_product
oncogene	NN	compound	O
families	NNS	dep	O
led	VBD	ROOT	O
to	TO	case	O
rapid	JJ	amod	O
loss	NN	nmod	O
of	IN	case	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
dependence	NN	nmod	O
,	,	punct	O
in	IN	case	O
some	DT	det	O
cases	NNS	nmod	O
,	,	punct	O
accompanied	VBN	advcl	O
by	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
cellular	JJ	amod	B-Cell
morphology	NN	nmod	O
.	.	punct	O

c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	NN	nsubj	I-Gene_or_gene_product
is	VBZ	ROOT	O
a	DT	det	O
frequent	JJ	amod	O
target	NN	attr	O
of	IN	case	O
retroviral	JJ	amod	B-Organism
insertional	JJ	amod	O
mutagenesis	NN	nmod	O
in	IN	case	O
murine	JJ	amod	B-Organism
leukemia	NN	compound	I-Organism
virus	NN	nmod:npmod	I-Organism
-	:	punct	O
induced	VBN	amod	O
myeloid	JJ	amod	B-Cancer
leukemia	NN	nmod	I-Cancer
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
these	DT	det	O
data	NNS	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
aim	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
the	DT	det	O
synergistic	JJ	amod	O
/	SYM	punct	O
additive	JJ	dep	O
cytotoxic	JJ	amod	O
and	CC	cc	O
apoptotic	JJ	conj	O
effects	NNS	dobj	O
of	IN	case	O
combination	NN	nmod	O
of	IN	case	O
docetaxel	NN	nmod	B-Simple_chemical
and	CC	cc	O
ATRA	NN	conj	B-Simple_chemical
,	,	punct	O
in	IN	case	O
hormone	NN	compound	O
-	HYPH	punct	O
and	CC	cc	O
drug	NN	conj	O
refractory	JJ	amod	O
human	JJ	amod	B-Organism
DU	NN	compound	B-Cell
-	:	punct	I-Cell
145	CD	nummod	I-Cell
prostate	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
early	JJ	amod	O
steps	NNS	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
local	JJ	amod	O
dissolution	NN	nmod	O
of	IN	case	O
basement	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
collagen	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
the	DT	det	O
activated	VBN	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Serum	NN	compound	B-Organism_substance
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
measured	VBN	ROOT	O
using	VBG	xcomp	O
the	DT	det	O
enzyme	NN	nmod:npmod	O
-	HYPH	punct	O
linked	VBN	amod	O
immunosorbent	JJ	amod	O
assay	NN	compound	O
(	-LRB-	punct	O
ELISA	NN	appos	O
)	-RRB-	punct	O
kit	NN	dobj	O
.	.	punct	O

After	IN	prep	O
a	DT	det	O
48	CD	nummod	O
-	HYPH	punct	O
hour	NN	compound	O
incubation	NN	compound	O
period	NN	pobj	O
,	,	punct	O
seven	CD	nummod	O
groups	NNS	nsubjpass	O
of	IN	case	O
animals	NNS	nmod	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
for	IN	prep	O
21	CD	nummod	O
days	NNS	pobj	O
with	IN	prep	O
fluconazole	NN	pobj	B-Simple_chemical
,	,	punct	O
with	IN	prep	O
group	NN	pobj	O
I	CD	nsubj	O
acting	VBG	acl	O
as	IN	prep	O
a	DT	det	O
control	NN	pobj	O
,	,	punct	O
and	CC	cc	O
groups	NNS	conj	O
II	CD	nummod	O
to	TO	case	O
VII	NN	nmod	O
receiving	VBG	acl	O
adjunct	JJ	compound	O
therapy	NN	dobj	O
with	IN	case	O
the	DT	det	O
corticosteroid	NN	compound	B-Simple_chemical
prednisolone	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
5	CD	nummod	O
or	CC	cc	O
10	CD	conj	O
times	NNS	dep	O
daily	RB	advmod	O
;	:	punct	O
3	CD	nummod	O
,	,	punct	O
9	CD	conj	O
,	,	punct	O
or	CC	cc	O
15	CD	conj	O
days	NNS	dep	O
after	IN	case	O
infection	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
document	VB	dep	O
that	IN	mark	O
a	DT	det	O
polyclonal	JJ	amod	O
antiserum	NN	nsubj	B-Organism_substance
to	TO	case	O
calretinin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
29	CD	nummod	O
-	HYPH	punct	O
kd	NN	amod	O
calcium	NN	compound	B-Simple_chemical
-	HYPH	punct	O
binding	NN	compound	O
protein	NN	appos	O
,	,	punct	O
consistently	RB	advmod	O
decorates	VBZ	ccomp	O
normal	JJ	dobj	O
and	CC	cc	O
tumor	NN	compound	B-Cell
mesothelial	JJ	amod	I-Cell
cells	NNS	dep	I-Cell
in	IN	case	O
cytologic	JJ	amod	B-Tissue
preparations	NNS	nmod	I-Tissue
.	.	punct	O

Maintained	VBN	amod	O
utilization	NN	nsubj	O
of	IN	case	O
these	DT	det	O
substrates	NNS	nmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
substrate	NN	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
environment	NN	nmod	O
,	,	punct	O
suggests	VBZ	ROOT	O
increased	VBN	amod	O
sensitivities	NNS	dobj	O
to	TO	case	O
metabolic	JJ	amod	O
signals	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
play	VB	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
metabolic	JJ	amod	O
diseases	NNS	nmod	O
in	IN	case	O
later	JJ	amod	O
adult	JJ	amod	O
life	NN	nmod	O
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
migration	NN	nsubj	O
and	CC	cc	O
invasion	NN	conj	O
resulted	VBD	ROOT	O
from	IN	case	O
up	RB	amod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
expression	NN	nmod	O
and	CC	cc	O
activities	NNS	conj	O
of	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Targets	NNS	nsubj	O
identified	VBN	ROOT	O
in	IN	case	O
these	DT	det	O
novel	JJ	amod	O
and	CC	cc	O
diverse	JJ	conj	O
FH	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	dep	O
models	NNS	nmod	O
represent	VBP	conj	O
excellent	JJ	amod	O
potential	JJ	amod	O
candidates	NNS	dobj	O
for	IN	case	O
further	JJ	advmod	O
mechanistic	JJ	amod	O
investigation	NN	nmod	O
and	CC	cc	O
therapeutic	JJ	amod	O
metabolic	JJ	amod	O
manipulation	NN	conj	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Group	NN	compound	B-Organism
2	CD	nummod	I-Organism
animals	NNS	nsubj	I-Organism
had	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
procedure	NN	dobj	O
of	IN	case	O
DMBA	JJ	compound	B-Simple_chemical
applications	NNS	nmod	O
but	CC	cc	O
also	RB	advmod	O
received	VBD	conj	O
alpha	NN	compound	B-Simple_chemical
tocopherol	NN	dobj	I-Simple_chemical
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
mean	NN	amod	O
Rentrop	NNP	compound	O
collateral	JJ	amod	O
score	NN	nsubj	O
was	VBD	cop	O
higher	JJR	appos	O
in	IN	case	O
Group	NN	nmod	O
1	CD	nummod	O
than	IN	prep	O
in	IN	prep	O
Group	NN	pobj	O
2	CD	nummod	O
(	-LRB-	punct	O
2	CD	nummod	O
.	.	punct	O
39	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
1	CD	dep	O
.	.	punct	O
07	CD	nmod	O
vs	CC	cc	O
.	.	punct	O
1	LS	nummod	O
.	.	punct	O
76	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
76	CD	dep	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	nummod	O
.	.	punct	O
001	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Glucocorticoid	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
MAPK	NN	compound	B-Gene_or_gene_product
phosphatase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
MPK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	LS	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	nsubj	O
inhibits	VBZ	ROOT	O
paclitaxel	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
associated	VBN	amod	O
MAPK	NN	compound	B-Gene_or_gene_product
activation	NN	dobj	O
and	CC	cc	O
contributes	VBZ	conj	O
to	TO	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
survival	NN	nmod	O
.	.	punct	O

Invasion	NN	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
hallmark	NN	attr	O
of	IN	prep	O
tumor	NN	compound	B-Cancer
malignancy	NN	pobj	O
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
microvascular	JJ	amod	B-Tissue
proliferation	NN	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
histological	JJ	amod	O
diagnosis	NN	nmod	O
of	IN	case	O
glioblastoma	NN	compound	B-Cancer
multiforme	NN	nmod	I-Cancer
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
association	NN	nsubj	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2beta	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
level	NN	conj	O
of	IN	case	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
between	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2gamma	NN	conj	I-Gene_or_gene_product
double	JJ	amod	O
positivity	NN	dep	O
and	CC	cc	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
expression	NN	conj	O
.	.	punct	O

Microscopic	JJ	amod	O
technique	NN	ROOT	O
for	IN	case	O
the	DT	det	O
detection	NN	nmod	O
of	IN	case	O
nitric	JJ	amod	B-Simple_chemical
oxide	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
dependent	JJ	amod	O
angiogenesis	NN	nmod	O
in	IN	case	O
an	DT	det	O
animal	NN	compound	O
model	NN	nmod	O
.	.	punct	O

UV	NN	compound	O
radiation	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cutaneous	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
to	TO	case	O
the	DT	det	O
metastatic	JJ	amod	O
state	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
very	RB	advmod	O
well	RB	advmod	O
defined	VBN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
loss	NN	nsubj	O
of	IN	case	O
wt	RB	nummod	O
-	HYPH	punct	O
p53	NN	compound	B-Gene_or_gene_product
function	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
up	RB	advmod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
survivin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
resistance	NN	conj	O
to	TO	prep	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
damaging	JJ	amod	O
agents	NNS	pobj	O
.	.	punct	O

Integrin	NN	compound	B-Gene_or_gene_product
alphavbeta3	NN	compound	I-Gene_or_gene_product
requirement	NN	ROOT	O
for	IN	case	O
sustained	JJ	amod	O
mitogen	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
activity	NN	nmod	O
during	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
quantified	VBD	ROOT	O
CYR61	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
CTGF	NN	conj	B-Gene_or_gene_product
,	,	punct	O
WISP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
NOV	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	compound	O
levels	NNS	conj	O
in	IN	case	O
samples	NNS	nmod	B-Cancer
from	IN	case	O
sixty	CD	compound	O
-	HYPH	punct	O
six	CD	nummod	O
primary	JJ	amod	O
gliomas	NNS	nmod	B-Cancer
and	CC	cc	O
five	CD	nummod	O
normal	JJ	amod	O
brain	NN	compound	B-Multi-tissue_structure
samples	NNS	conj	I-Multi-tissue_structure
using	VBG	xcomp	O
quantitative	JJ	amod	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
PCR	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

The	DT	det	O
initial	JJ	amod	O
wave	NN	nsubj	O
of	IN	case	O
ERK	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
(	-LRB-	punct	O
5	CD	compound	O
-	SYM	punct	O
120	CD	nummod	O
min	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
refractory	JJ	ROOT	O
to	TO	case	O
integrin	NN	compound	B-Simple_chemical
antagonists	NNS	nmod	I-Simple_chemical
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
sustained	JJ	amod	O
activity	NN	nsubj	O
(	-LRB-	punct	O
4	CD	compound	O
-	SYM	punct	O
20	CD	nummod	O
h	NN	appos	O
)	-RRB-	punct	O
depended	VBD	parataxis	O
on	IN	case	O
integrin	NN	nmod	B-Gene_or_gene_product
alphavbeta3	NN	nummod	I-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
beta1	NN	compound	B-Gene_or_gene_product
integrins	NNS	conj	I-Gene_or_gene_product
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
SPARC	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
secreted	VBN	amod	B-Gene_or_gene_product
protein	NN	dep	I-Gene_or_gene_product
,	,	punct	I-Gene_or_gene_product
acidic	JJ	appos	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
rich	JJ	conj	I-Gene_or_gene_product
in	IN	case	I-Gene_or_gene_product
cysteine	NN	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
closely	RB	advmod	O
related	JJ	appos	O
with	IN	case	O
the	DT	det	O
progress	NN	nmod	O
,	,	punct	O
invasion	NN	conj	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
tumor	NN	nmod	I-Cancer
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Crucial	JJ	amod	O
genetic	JJ	amod	O
events	NNS	nsubjpass	O
underlying	VBG	acl	O
the	DT	det	O
initiation	NN	dobj	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
and	CC	cc	O
pancreatic	JJ	conj	B-Cancer
adenocarcinoma	NN	nmod	I-Cancer
with	IN	case	O
a	DT	det	O
particular	JJ	amod	O
focus	NN	nmod	O
on	IN	case	O
the	DT	det	O
modulation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
antiangiogenic	JJ	amod	O
therapies	NNS	conj	O
are	VBP	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
functions	VBZ	ROOT	O
to	TO	mark	O
prevent	VB	xcomp	O
tumour	NN	compound	B-Cancer
development	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
the	DT	det	O
outgrowth	NN	dobj	O
of	IN	case	O
stressed	JJ	amod	O
or	CC	cc	O
damaged	VBN	conj	O
cells	NNS	nmod	B-Cell
.	.	punct	O

HBO	NNP	nsubj	O
is	VBZ	cop	O
useful	JJ	ROOT	O
in	IN	case	O
chronic	JJ	amod	B-Pathological_formation
nonhealing	NN	amod	I-Pathological_formation
wounds	NNS	nmod	I-Pathological_formation
of	IN	case	O
the	DT	det	O
diabetic	JJ	amod	O
foot	NN	nmod	B-Organism_subdivision
and	CC	cc	O
of	IN	case	O
the	DT	det	O
diabetic	JJ	amod	O
foot	NN	conj	B-Organism_subdivision
with	IN	prep	O
impending	VBG	pcomp	O
amputation	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
ARD1	NN	nsubj	B-Gene_or_gene_product
interacted	VBD	ROOT	O
physically	RB	advmod	O
with	IN	advmod	O
and	CC	cc	O
acetylated	VBD	conj	O
the	DT	det	O
AR	NN	compound	B-Gene_or_gene_product
protein	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
this	DT	det	O
strain	NN	nmod	B-Cell
,	,	punct	O
the	DT	det	O
malate	JJ	npadvmod	B-Simple_chemical
-	HYPH	punct	O
citrate	NN	compound	B-Simple_chemical
shuttle	NN	nsubj	O
is	VBZ	ccomp	O
not	RB	neg	O
an	DT	det	O
effective	JJ	amod	O
pathway	NN	attr	O
for	IN	prep	O
transferring	VBG	pcomp	O
glycolytic	JJ	amod	O
reducing	NN	compound	O
equivalents	NNS	dobj	O
from	IN	case	O
cytosol	NN	nmod	B-Organism_substance
to	TO	case	O
mitochondria	VB	nmod	B-Cellular_component
.	.	punct	O

Neoplastic	JJ	amod	O
transformation	NN	ROOT	O
and	CC	cc	O
tumorigenesis	NN	conj	O
associated	VBN	acl	O
with	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
phospholipase	NN	compound	B-Gene_or_gene_product
D	NN	compound	I-Gene_or_gene_product
isozymes	NNS	nmod	O
in	IN	case	O
cultured	VBN	amod	O
murine	JJ	amod	B-Organism
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

Despite	IN	case	O
several	JJ	amod	O
advances	NNS	nmod	O
in	IN	case	O
therapeutic	JJ	amod	O
options	NNS	nmod	O
,	,	punct	O
the	DT	det	O
disease	NN	nsubj	O
remains	VBZ	ROOT	O
incurable	JJ	xcomp	O
.	.	punct	O

Also	RB	advmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
existed	VBD	ROOT	O
between	IN	case	O
CTGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	nmod	O
versus	CC	cc	O
tumor	NN	compound	B-Cancer
grade	NN	conj	O
,	,	punct	O
gender	NN	conj	O
,	,	punct	O
and	CC	cc	O
pathology	NN	conj	O
.	.	punct	O

p53	NN	nsubj	B-Gene_or_gene_product
has	VBZ	ccomp	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
skin	NN	compound	B-Organ
pigmentation	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
impact	VB	conj	O
on	IN	case	O
melanoma	NN	nmod	B-Cancer
at	IN	case	O
all	DT	det	O
stages	NNS	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
as	IN	mark	O
it	PRP	nsubj	O
'	''	punct	O
s	VBZ	compound	O
mutation	NN	compound	O
frequency	NN	dobj	O
in	IN	case	O
melanoma	NN	nmod	B-Cancer
is	VBZ	cop	O
low	JJ	conj	O
,	,	punct	O
it	PRP	nmod:poss	O
'	''	punct	O
s	VBZ	compound	O
role	NN	nsubj	O
has	VBZ	aux	O
been	VBN	ROOT	O
somewhat	RB	advmod	O
under	IN	advmod	O
-	HYPH	punct	O
appreciated	VBN	acomp	O
.	.	punct	O

The	DT	det	O
selected	VBN	amod	O
peptide	NN	nsubjpass	O
was	VBD	auxpass	O
tested	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
antitumor	NN	compound	B-Cancer
activity	NN	nmod	O
against	IN	case	O
mildly	RB	advmod	O
aggressive	JJ	amod	O
xenografted	JJ	amod	O
prostate	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
highly	RB	advmod	O
aggressive	JJ	amod	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	conj	I-Cancer
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
correlated	VBD	ROOT	O
inversely	RB	advmod	O
with	IN	case	O
the	DT	det	O
degree	NN	nmod	O
of	IN	case	O
splenomegaly	NN	nmod	B-Pathological_formation
(	-LRB-	punct	O
Pearson	NN	dep	O
,	,	punct	O
r	NN	nsubj	O
=	JJ	conj	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
400	CD	dep	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
011	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
staging	NN	nsubjpass	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
therapeutic	JJ	amod	O
decision	NN	appos	O
making	VBG	acl	O
in	IN	prep	O
the	DT	det	O
management	NN	pobj	O
of	IN	prep	O
early	JJ	amod	O
and	CC	cc	O
advanced	JJ	conj	O
colorectal	JJ	amod	B-Cancer
cancer	NN	pobj	I-Cancer
,	,	punct	O
and	CC	cc	O
dilemmas	NNS	conj	O
posed	VBN	acl	O
by	IN	case	O
drug	NN	npadvmod	O
-	HYPH	punct	O
related	JJ	amod	O
toxicity	NN	nmod	O
are	VBP	auxpass	O
discussed	VBN	dep	O
.	.	punct	O

Treatment	NN	ROOT	O
with	IN	case	O
anti	JJ	compound	O
-	HYPH	punct	O
Fas	NN	nmod	B-Gene_or_gene_product
for	IN	case	O
48	CD	nummod	O
h	NN	compound	O
induced	VBD	amod	O
apoptosis	NN	nmod	O
with	IN	case	O
cells	NNS	nmod	B-Cell
exhibiting	VBG	acl	O
typical	JJ	amod	O
apoptotic	JJ	amod	O
features	NNS	dobj	O
including	VBG	case	O
loss	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
contact	NN	nmod	O
,	,	punct	O
condensation	NN	appos	O
of	IN	case	O
chromatin	NN	nmod	B-Cellular_component
,	,	punct	O
and	CC	cc	O
increased	VBN	amod	O
staining	NN	conj	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
NRP1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
angiogenesis	NN	dobj	O
by	IN	mark	O
analyzing	VBG	advcl	O
the	DT	det	O
association	NN	dobj	O
of	IN	case	O
NRP1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
KDR	NN	conj	B-Gene_or_gene_product
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
physiologic	JJ	amod	O
and	CC	cc	O
pathologic	JJ	conj	O
events	NNS	nmod	O
including	VBG	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
inflammation	NN	conj	O
,	,	punct	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
metastasis	NN	conj	O
.	.	punct	O

Netrin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
up	RP	dep	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
in	IN	case	O
inflammatory	JJ	amod	O
bowel	NN	compound	B-Organ
diseases	NNS	nmod	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

Monitoring	VBG	csubj	O
peroxide	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
changes	NNS	nsubj	O
in	IN	case	O
GSH	NN	nmod	B-Simple_chemical
and	CC	cc	O
GSSG	NN	conj	B-Simple_chemical
gave	VBD	ROOT	O
consistent	JJ	amod	O
results	NNS	dobj	O
;	:	punct	O
e	NN	dep	O
.	.	punct	O
g	NN	ROOT	O
.	.	punct	O
,	,	punct	O
glucose	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
depleted	VBN	amod	O
L	NN	conj	O
.	.	punct	O
Se	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
+	CC	cc	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nsubj	I-Cell
exhibited	VBD	ROOT	O
a	DT	det	O
first	JJ	amod	O
order	NN	compound	O
loss	NN	dobj	O
of	IN	case	O
GSH	NN	nmod	B-Simple_chemical
that	WDT	nsubj	O
was	VBD	cop	O
substantially	RB	advmod	O
faster	JJR	acl:relcl	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
glucose	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
depleted	VBN	amod	O
L	NN	nmod	B-Cell
.	.	punct	I-Cell
Se	NNP	compound	I-Cell
(	-LRB-	punct	I-Cell
-	:	punct	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	ROOT	I-Cell
.	.	punct	O

Endothelialisation	NN	nsubjpass	O
and	CC	cc	O
platelet	NN	compound	B-Cell
adhesion	NN	conj	O
to	TO	case	O
purified	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	,	punct	O
derived	VBN	amod	O
perlecan	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
major	JJ	amod	O
heparan	NN	compound	B-Gene_or_gene_product
sulfate	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
HS	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
proteoglycan	JJ	appos	I-Gene_or_gene_product
in	IN	case	O
basement	NN	compound	B-Cellular_component
membranes	NNS	nmod	I-Cellular_component
,	,	punct	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
using	VBG	xcomp	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vitro	FW	dep	O
assays	NNS	conj	O
.	.	punct	O

For	IN	prep	O
this	DT	det	O
reason	NN	pobj	O
,	,	punct	O
formalin	NN	compound	B-Simple_chemical
-	HYPH	punct	O
fixed	VBN	amod	O
,	,	punct	O
paraffin	NN	amod	B-Simple_chemical
-	HYPH	punct	O
embedded	JJ	amod	O
specimens	NNS	nsubjpass	B-Tissue
from	IN	case	O
130	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
to	TO	mark	O
generate	VB	acl	O
monospecific	JJ	amod	O
divalent	NN	dobj	O
and	CC	cc	O
tetravalent	JJ	conj	O
antibodies	NNS	dep	O
,	,	punct	O
immunocytokines	NNS	conj	O
,	,	punct	O
and	CC	cc	O
dual	JJ	amod	O
specificity	NN	compound	O
tetravalent	JJ	amod	O
antibodies	NNS	conj	O
.	.	punct	O

We	PRP	nsubj	O
verified	VBD	ROOT	O
this	DT	det	O
finding	NN	dobj	O
by	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
clusterin	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
PNT1a	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
subjected	VBN	acl	O
to	TO	case	O
serum	NN	compound	B-Organism_substance
-	HYPH	punct	O
starvation	NN	nmod	O
with	IN	case	O
the	DT	det	O
aim	NN	nmod	O
of	IN	mark	O
defining	VBG	acl	O
clusterin	NN	compound	B-Gene_or_gene_product
early	JJ	amod	O
molecular	JJ	amod	O
changes	NNS	dobj	O
following	VBG	case	O
apoptosis	NN	compound	O
induction	NN	nmod	O
.	.	punct	O

Serum	NN	compound	B-Organism_substance
endostatin	NN	compound	B-Gene_or_gene_product
concentration	NN	nsubj	O
was	VBD	cop	O
1540	CD	nmod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
560	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	dep	O
at	IN	prep	O
the	DT	det	O
second	JJ	amod	O
week	NN	pobj	O
of	IN	prep	O
administration	NN	pobj	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
endostatin	NN	nmod	B-Gene_or_gene_product
diminished	VBD	ROOT	O
a	DT	det	O
month	NN	npadvmod	O
later	RB	advmod	O
.	.	punct	O

In	IN	case	O
an	DT	det	O
effort	NN	nmod	O
to	TO	mark	O
dissect	VB	acl	O
the	DT	det	O
mechanisms	NNS	dobj	O
of	IN	case	O
GR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
breast	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
survival	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
now	RB	advmod	O
examine	VBP	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
events	NNS	dobj	O
downstream	RB	amod	O
of	IN	case	O
GR	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
.	.	punct	O

Injection	NN	nsubj	O
of	IN	case	O
AdCA5	NN	nmod	B-Organism
into	IN	case	O
mouse	NN	compound	B-Organism
eyes	NNS	nmod	B-Organ
induced	VBD	ROOT	O
neovascularization	NN	dobj	O
in	IN	case	O
multiple	JJ	amod	O
capillary	JJ	amod	B-Multi-tissue_structure
beds	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
including	VBG	case	O
those	DT	nmod	O
not	RB	neg	O
responsive	JJ	amod	O
to	TO	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
alone	RB	advmod	O
.	.	punct	O

Abnormal	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
poor	JJ	amod	O
differentiation	NN	nmod	O
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
difference	NN	nsubj	O
in	IN	case	O
fat	NN	compound	B-Tissue
encapsulation	NN	nmod	O
,	,	punct	O
necrosis	NN	conj	O
,	,	punct	O
hemorrhage	NN	conj	O
,	,	punct	O
or	CC	cc	O
exudate	VB	conj	B-Organism_substance
between	IN	prep	O
prostheses	NNS	pobj	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
crossing	NN	nsubj	O
of	IN	case	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	compound	I-Gene_or_gene_product
transgenic	JJ	amod	O
mice	NNS	nmod	O
with	IN	case	O
E	NN	compound	B-Gene_or_gene_product
mu	NN	compound	I-Gene_or_gene_product
L	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
transgenics	NNS	nmod	O
that	WDT	nsubj	O
express	VBP	acl:relcl	O
their	PRP$	nmod:poss	O
transgene	NN	dobj	O
in	IN	case	O
both	DT	cc:preconj	O
B	NN	compound	B-Cell
-	:	punct	I-Cell
and	CC	cc	O
T	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cells	NNS	nmod	I-Cell
but	CC	cc	O
predominantly	RB	advmod	O
develop	VBP	conj	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
tumours	NNS	nsubj	I-Cancer
leads	VBZ	ROOT	O
in	IN	prep	O
double	JJ	amod	O
transgenics	NNS	pobj	B-Organism
exclusively	RB	advmod	O
to	IN	prep	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
neoplasia	NN	pobj	I-Cell
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
tumors	NNS	nsubj	B-Cancer
behave	VBP	ROOT	O
like	IN	prep	O
wounds	NNS	pobj	B-Pathological_formation
that	WDT	nsubj	O
fail	VBP	relcl	O
to	TO	aux	O
heal	VB	xcomp	O
.	.	punct	O

CONCLUSIONS	NNS	dep	O
:	:	punct	O
Fluconazole	NN	amod	B-Simple_chemical
plus	CC	cc	O
adjunct	JJ	conj	O
high	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
prednisolone	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
was	VBD	cop	O
most	RBS	advmod	O
effective	JJ	ROOT	O
when	WRB	advmod	O
administered	VBN	advcl	O
9	CD	nummod	O
days	NNS	nmod	O
after	IN	case	O
infection	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
cell	NN	compound	B-Cell
type	NN	compound	O
specificity	NN	nsubj	O
for	IN	case	O
oncogene	NN	compound	O
activation	NN	nmod	O
during	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
rat	NN	compound	B-Organism
bladder	NN	compound	B-Organ
transformation	NN	nmod	O
initiated	VBN	acl	O
by	IN	case	O
a	DT	det	O
single	JJ	amod	O
carcinogen	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
ras	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
activation	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
a	DT	det	O
necessary	JJ	amod	O
step	NN	conj	O
in	IN	case	O
urothelial	JJ	amod	B-Cell
transformation	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
p75	NN	compound	B-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
neurotrophins	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
p75	NN	dep	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
scarcely	RB	advmod	O
present	JJ	acl:relcl	O
in	IN	case	O
healthy	JJ	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
ECs	NNS	appos	B-Cell
)	-RRB-	punct	O
,	,	punct	O
becomes	VBZ	ROOT	O
strongly	RB	advmod	O
expressed	VBN	xcomp	O
by	IN	case	O
capillary	JJ	amod	B-Cell
ECs	NNS	nmod	I-Cell
after	IN	case	O
induction	NN	nmod	O
of	IN	case	O
peripheral	JJ	amod	B-Tissue
ischemia	NN	nmod	O
in	IN	case	O
type	NN	compound	O
-	CD	punct	O
1	CD	nummod	O
diabetic	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Heating	VBG	amod	O
and	CC	cc	O
protease	NN	conj	O
treatment	NN	nsubj	O
of	IN	case	O
the	DT	det	O
stimulants	NNS	nmod	O
reduced	VBD	ROOT	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
enhancing	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
Ve	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
OMP	NN	conj	B-Gene_or_gene_product
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Ex	FW	amod	O
vivo	FW	dep	O
cultures	NNS	nsubj	B-Cell
from	IN	case	O
invasive	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
or	CC	cc	O
metastases	NNS	conj	O
produced	VBD	ROOT	O
cells	NNS	dobj	B-Cell
that	WDT	nsubj	O
were	VBD	cop	O
homogeneously	RB	advmod	O
E	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	acl:relcl	O
and	CC	cc	O
noninvasive	JJ	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
'	``	punct	O
angiostatic	JJ	amod	O
'	''	punct	O
steroids	NNS	nsubjpass	O
17	CD	nummod	B-Simple_chemical
hydroxyprogesterone	NN	dep	I-Simple_chemical
and	CC	cc	O
epicortisol	NN	conj	B-Simple_chemical
were	VBD	auxpass	O
tested	VBN	ROOT	O
because	IN	case	O
of	IN	mwe	O
their	PRP$	nmod:poss	O
lack	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-Simple_chemical
and	CC	cc	O
mineralocorticoid	NN	conj	B-Simple_chemical
effects	NNS	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
structural	JJ	amod	O
similarity	NN	conj	O
to	TO	case	O
glucocorticoids	NNS	nmod	B-Simple_chemical
.	.	punct	O

Under	IN	case	O
normal	JJ	amod	O
conditions	NNS	nmod	O
insulin	NN	nsubj	B-Gene_or_gene_product
regulates	VBZ	ROOT	O
expression	NN	dobj	O
of	IN	case	O
hexokinase	NN	compound	B-Gene_or_gene_product
Type	NN	compound	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
isoenzyme	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
predominantly	RB	advmod	O
expressed	VBN	acl:relcl	O
in	IN	case	O
muscle	NN	nmod	B-Organ
.	.	punct	O

To	TO	mark	O
clarify	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
Ang	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
for	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
growth	NN	conj	O
in	IN	case	O
a	DT	det	O
definite	JJ	amod	O
genetic	JJ	amod	O
experimental	JJ	amod	O
setting	NN	nmod	O
,	,	punct	O
the	DT	det	O
present	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
aimed	VBN	ROOT	O
at	IN	mark	O
comparatively	RB	advmod	O
studying	VBG	advcl	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
different	JJ	amod	O
tumors	NNS	nmod	B-Cancer
in	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	nmod	O
and	CC	cc	O
Ang	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	conj	O
.	.	punct	O

HYPOTHESIS	NN	dep	O
:	:	punct	O
This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
compare	VB	xcomp	O
coronary	JJ	amod	B-Multi-tissue_structure
collateral	JJ	amod	I-Multi-tissue_structure
circulation	NN	dobj	O
(	-LRB-	punct	O
CCC	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
proliferative	JJ	amod	O
diabetic	JJ	amod	O
retinopathy	NN	nmod	O
(	-LRB-	punct	O
PDR	NN	appos	O
)	-RRB-	punct	O
with	IN	case	O
that	DT	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
without	IN	case	O
DR	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
expression	NN	compound	O
level	NN	nsubj	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
had	VBD	ROOT	O
an	DT	det	O
inverse	JJ	amod	O
relationship	NN	dobj	O
with	IN	case	O
both	CC	det	O
differentiation	NN	compound	O
level	NN	nmod	O
of	IN	case	O
the	DT	dep	O
tumor	NN	nmod	B-Cancer
and	CC	cc	O
lymphatic	JJ	amod	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
invasion	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
0430	CD	ROOT	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
0320	CD	dep	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

Ba	NN	compound	B-Cell
/	:	punct	I-Cell
F3	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
transformed	VBN	acl	O
to	TO	case	O
growth	NN	compound	O
factor	NN	compound	O
independence	NN	nmod	O
by	IN	case	O
various	JJ	amod	O
oncogenic	JJ	amod	O
PTKs	NN	nmod	O
(	-LRB-	punct	O
TEL	NN	compound	B-Gene_or_gene_product
/	:	punct	O
JAK2	NN	dep	B-Gene_or_gene_product
,	,	punct	O
TEL	NN	appos	B-Gene_or_gene_product
/	:	punct	O
TRKC	NN	conj	B-Gene_or_gene_product
,	,	punct	O
TEL	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ABL	NN	conj	B-Gene_or_gene_product
,	,	punct	O
BCR	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ABL	NN	conj	B-Gene_or_gene_product
,	,	punct	O
FLT3	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
ITD	NNP	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
H4	NN	conj	B-Gene_or_gene_product
/	:	punct	O
PDGFbetaR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
show	VBP	ROOT	O
abundant	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
PIM	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
PIM	NNP	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Kaplan	NNP	compound	O
-	HYPH	punct	O
Meier	NNP	amod	O
survival	NN	compound	O
curves	NNS	nsubj	O
showed	VBD	ROOT	O
a	DT	det	O
statistically	RB	advmod	O
significant	JJ	amod	O
worse	JJR	amod	O
prognosis	NN	dobj	O
for	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
high	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
grade	NN	nmod	O
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
difference	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	conj	O
between	IN	case	O
low	JJ	amod	O
and	CC	cc	O
medium	NN	conj	O
vascular	JJ	conj	B-Multi-tissue_structure
grade	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
that	IN	mark	O
S727	NN	compound	B-Amino_acid
phosphorylation	NN	nsubj	O
is	VBZ	cop	O
sufficient	JJ	acl:relcl	O
to	TO	mark	O
activate	VB	xcomp	O
Stat3	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
thereby	RB	advmod	O
driving	VBG	advcl	O
prostate	NN	compound	B-Organ
tumorigenesis	NN	dobj	O
independent	JJ	amod	O
of	IN	case	O
Y705	NN	compound	B-Amino_acid
phosphorylation	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
the	DT	det	O
metastatic	JJ	amod	O
lung	NN	compound	B-Cancer
carcinomas	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
subtyped	VBN	advcl	O
,	,	punct	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
staining	NN	nsubjpass	O
was	VBD	auxpass	O
noted	VBN	ROOT	O
in	IN	case	O
11	CD	compound	O
of	IN	advmod	O
11	CD	nummod	O
(	-LRB-	punct	O
100	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
adenocarcinomas	NNS	nmod	B-Cancer
,	,	punct	O
in	IN	case	O
6	CD	nmod	O
of	IN	advmod	O
7	CD	nummod	O
(	-LRB-	punct	O
86	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
small	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
in	IN	case	O
15	CD	compound	O
of	IN	advmod	O
19	CD	nummod	O
(	-LRB-	punct	O
79	CD	nummod	O
%	NN	intj	O
)	-RRB-	punct	O
large	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
in	IN	case	O
none	NN	conj	O
of	IN	case	O
3	CD	nummod	O
(	-LRB-	punct	O
0	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

WNT	NN	compound	B-Gene_or_gene_product
/	:	punct	O
TCF	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
through	IN	case	O
LEF1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
HOXB9	NN	conj	B-Gene_or_gene_product
mediates	VBZ	ROOT	O
lung	NN	compound	B-Cancer
adenocarcinoma	NN	compound	I-Cancer
metastasis	NN	dobj	O
.	.	punct	O

The	DT	det	O
HPV	NN	compound	B-Organism
oncoprotein	NN	compound	O
E6	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

Cells	NNS	nsubj	B-Cell
treated	VBN	acl	O
with	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
Fas	NN	nmod	B-Gene_or_gene_product
also	RB	advmod	O
exhibited	VBD	ROOT	O
increased	VBN	amod	O
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	dobj	O
of	IN	case	O
the	DT	det	O
c	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
met	VBN	amod	I-Gene_or_gene_product
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	compound	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	nmod	O
.	.	punct	O

Coexpression	NN	ROOT	O
of	IN	prep	O
PIM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1KD	NN	intj	I-Gene_or_gene_product
and	CC	cc	O
PIM	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2KD	NN	conj	I-Gene_or_gene_product
abrogated	VBD	amod	O
growth	NN	compound	O
factor	NN	nmod:npmod	O
-	:	punct	O
independent	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
Ba	NN	compound	B-Cell
/	:	punct	I-Cell
F3	NN	nmod	I-Cell
transformed	VBN	acl	O
by	IN	case	O
several	JJ	amod	O
PTKs	NN	nmod	O
,	,	punct	O
including	VBG	case	O
BCR	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ABL	NN	appos	B-Gene_or_gene_product
.	.	punct	O

This	DT	det	O
negative	JJ	amod	O
regulation	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
cytoskeleton	NN	nmod	B-Cellular_component
as	IN	case	O
the	DT	det	O
disruption	NN	nsubj	O
of	IN	case	O
interactions	NNS	nmod	O
between	IN	case	O
the	DT	det	O
PSMA	NNP	compound	B-Gene_or_gene_product
cytoplasmic	JJ	amod	B-Organism_substance
tail	NN	nmod	O
and	CC	cc	O
the	DT	det	O
anchor	NN	compound	O
protein	NN	compound	O
filamin	NN	compound	B-Gene_or_gene_product
A	NN	conj	I-Gene_or_gene_product
decreases	VBZ	conj	O
PSMA	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
,	,	punct	O
integrin	NN	compound	B-Gene_or_gene_product
function	NN	conj	O
,	,	punct	O
and	CC	cc	O
PAK	NN	compound	B-Gene_or_gene_product
activation	NN	conj	O
.	.	punct	O

Allergic	JJ	amod	O
pulmonary	JJ	amod	B-Organ
inflammation	NN	nsubj	O
promotes	VBZ	ROOT	O
the	DT	det	O
recruitment	NN	dobj	O
of	IN	case	O
circulating	VBG	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
the	DT	det	O
lung	NN	nmod	B-Organ
.	.	punct	O

Therapeutic	JJ	amod	O
angiogenesis	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
biological	JJ	amod	O
agents	NNS	ROOT	O
or	CC	cc	O
bioactive	JJ	amod	O
material	NN	conj	O
to	TO	mark	O
stimulate	VB	acl	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
optimal	JJ	amod	O
duration	NN	nsubj	O
of	IN	case	O
chemotherapy	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
early	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	cop	O
unclear	JJ	ROOT	O
.	.	punct	O

Paclitaxel	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
MAPK	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
of	IN	case	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
both	DT	det	O
processes	NNS	nsubjpass	O
were	VBD	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
Dex	NN	compound	B-Simple_chemical
pretreatment	NN	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
PAK	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
enhances	VBZ	ROOT	O
the	DT	det	O
PSMA	NNP	dobj	B-Gene_or_gene_product
/	:	punct	O
filamin	NN	compound	B-Gene_or_gene_product
A	NN	compound	I-Gene_or_gene_product
interaction	NN	conj	O
and	CC	cc	O
,	,	punct	O
thus	RB	advmod	O
,	,	punct	O
boosts	VBZ	parataxis	O
PSMA	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Immunohistochemically	RB	advmod	O
confirmed	VBN	ROOT	O
significance	NN	nsubj	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
dependence	NN	nmod	O
of	IN	case	O
the	DT	det	O
CML	NN	compound	B-Cancer
stage	NN	nmod	O
could	MD	aux	O
be	VB	cop	O
of	IN	case	O
clinical	JJ	amod	O
importance	NN	dobj	O
in	IN	mark	O
deciding	VBG	advcl	O
on	IN	case	O
the	DT	det	O
timing	NN	amod	O
therapy	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
animal	NN	compound	O
models	NNS	nsubj	O
of	IN	case	O
tissue	NN	compound	B-Tissue
injury	NN	nmod	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
data	NNS	conj	O
also	RB	advmod	O
implicate	VBP	ROOT	O
syndecans	NNS	dobj	B-Gene_or_gene_product
in	IN	case	O
processes	NNS	nmod	O
necessary	JJ	amod	O
for	IN	case	O
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
,	,	punct	O
including	VBG	case	O
fibroblast	NN	nmod	B-Cell
and	CC	cc	O
endothelial	JJ	amod	B-Cell
proliferation	NN	conj	O
,	,	punct	O
cell	NN	compound	B-Cell
motility	NN	conj	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
organization	NN	conj	O
.	.	punct	O

Hypermethylation	NN	nsubj	O
of	IN	prep	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	pobj	I-Gene_or_gene_product
is	VBZ	cop	O
functionally	RB	advmod	O
important	JJ	ROOT	O
,	,	punct	O
because	IN	mark	O
treatment	NN	nsubj	O
of	IN	case	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
non	NNP	dep	O
-	HYPH	punct	O
expressing	VBG	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
with	IN	case	O
the	DT	det	O
drug	NN	nmod	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aza	NNP	compound	I-Simple_chemical
-	SYM	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
'	''	punct	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxycytidine	NN	dep	I-Simple_chemical
resulted	VBD	advcl	O
in	IN	case	O
demethylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
intrinsic	JJ	amod	O
resistance	NN	nsubj	O
of	IN	case	O
prostate	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
likely	RB	advmod	O
reflects	VBZ	advcl	O
a	DT	det	O
low	JJ	amod	O
susceptibility	NN	dobj	O
to	TO	case	O
drug	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
explored	VBD	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
of	IN	mark	O
sensitizing	VBG	acl	O
prostate	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
to	TO	case	O
apoptosis	NN	nmod	O
by	IN	case	O
combination	NN	nmod	O
of	IN	case	O
TRAIL	NN	nmod	B-Gene_or_gene_product
with	IN	case	O
camptothecins	NNS	nmod	B-Simple_chemical
.	.	punct	O

These	DT	nsubj	O
included	VBD	ROOT	O
40	CD	nummod	O
(	-LRB-	punct	O
56	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
metastases	NNS	dobj	O
from	IN	case	O
a	DT	det	O
primary	JJ	amod	O
lung	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
31	CD	nummod	O
(	-LRB-	punct	O
44	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
metastases	NNS	conj	O
from	IN	case	O
some	DT	det	O
nonpulmonary	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

c	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nsubj	I-Gene_or_gene_product
is	VBZ	ROOT	O
a	DT	det	O
major	JJ	amod	O
target	NN	attr	O
that	WDT	nsubj	O
transduces	VBZ	relcl	O
Myb	NN	nmod:poss	B-Gene_or_gene_product
'	POS	punct	O
s	VBZ	compound	O
proliferative	JJ	amod	O
signal	NN	dobj	O
,	,	punct	O
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
a	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
estrogen	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
fusion	NN	compound	O
protein	NN	nmod	O
alone	RB	advmod	O
to	TO	mark	O
also	RB	advmod	O
reverse	VB	acl	O
growth	NN	compound	O
arrest	NN	dobj	O
in	IN	case	O
this	DT	det	O
system	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Prognostic	JJ	amod	O
significance	NN	ROOT	O
of	IN	case	O
cellular	JJ	amod	B-Cell
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	nmod	O
in	IN	case	O
the	DT	det	O
course	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukaemia	NN	nmod	I-Cancer
]	-RRB-	punct	O

The	DT	det	O
integration	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
grading	NN	nmod	O
in	IN	case	O
clinical	JJ	amod	O
trials	NNS	nmod	O
on	IN	case	O
adjuvant	JJ	amod	O
chemotherapy	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
radiotherapy	NN	conj	O
could	MD	aux	O
substantially	RB	advmod	O
contribute	VB	ROOT	O
in	IN	mark	O
defining	VBG	advcl	O
groups	NNS	dobj	O
of	IN	case	O
operable	JJ	amod	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
might	MD	aux	O
benefit	VB	acl:relcl	O
from	IN	case	O
cytotoxic	JJ	amod	O
treatment	NN	nmod	O
.	.	punct	O

The	DT	det	O
Kaposi	NN	poss	B-Organism
'	POS	case	I-Organism
s	NNS	compound	I-Organism
sarcoma	NN	npadvmod	I-Organism
-	HYPH	punct	I-Organism
associated	VBN	amod	I-Organism
herpesvirus	NN	nsubj	I-Organism
(	-LRB-	punct	O
KSHV	NN	appos	B-Organism
)	-RRB-	punct	O
encodes	VBZ	ROOT	O
a	DT	det	O
G	NN	compound	B-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
coupled	VBN	amod	I-Gene_or_gene_product
receptor	NN	dobj	I-Gene_or_gene_product
(	-LRB-	punct	O
vGPCR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
that	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
Kaposi	NN	poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	nmod	I-Cancer
,	,	punct	O
identifying	VBG	advcl	O
vGPCR	NN	dobj	B-Gene_or_gene_product
as	IN	case	O
an	DT	det	O
attractive	JJ	amod	O
target	NN	nmod	O
for	IN	mark	O
preventing	VBG	acl	O
Kaposi	NN	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	dobj	I-Cancer
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
recently	RB	advmod	O
attracted	VBN	ROOT	O
attention	NN	dobj	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
inducer	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Tumor	NN	compound	B-Cancer
angiogenesis	NN	nsubj	O
has	VBZ	aux	O
been	VBN	cop	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
initiation	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
progression	NN	conj	O
toward	IN	case	O
more	RBR	advmod	O
aggressive	JJ	amod	O
behavior	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Four	CD	nsubj	O
out	IN	prt	O
of	IN	prep	O
seven	CD	nummod	O
control	NN	compound	O
grafts	NNS	pobj	B-Multi-tissue_structure
were	VBD	cop	O
patent	JJ	ROOT	O
with	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
lining	NN	nmod	O
at	IN	case	O
six	CD	nummod	O
months	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
three	CD	nsubjpass	O
were	VBD	auxpass	O
occluded	VBN	conj	O
and	CC	cc	O
one	CD	nsubjpass	O
of	IN	prep	O
the	DT	det	O
four	CD	nummod	O
grafts	NNS	pobj	B-Multi-tissue_structure
was	VBD	auxpass	O
still	RB	advmod	O
covered	VBN	conj	O
with	IN	prep	O
a	DT	det	O
thrombus	JJ	compound	B-Pathological_formation
layer	NN	pobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
microtubule	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
destabilizing	VBG	amod	I-Simple_chemical
agents	NNS	nsubj	I-Simple_chemical
cause	VBP	ROOT	O
prominent	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
morphology	NN	nmod	O
,	,	punct	O
an	DT	det	O
action	NN	appos	O
associated	VBN	acl	O
with	IN	case	O
rapid	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
collapse	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
T140	NN	compound	B-Simple_chemical
analogs	NNS	nsubj	I-Simple_chemical
have	VBP	ccomp	O
potential	JJ	amod	O
use	NN	dobj	O
for	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
small	JJ	amod	O
molecular	JJ	amod	O
CXCR4	NN	compound	B-Gene_or_gene_product
antagonists	NNS	nsubj	O
could	MD	aux	O
potentially	RB	advmod	O
replace	VB	conj	O
neutralizing	VBG	amod	O
antibodies	NNS	dobj	O
as	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
metastatic	JJ	dep	O
agents	NNS	nmod	O
for	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Cancer	NN	compound	B-Cancer
progression	NN	ROOT	O
and	CC	cc	O
p53	NN	conj	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
Hedgehog	JJ	compound	B-Gene_or_gene_product
intercellular	JJ	amod	O
signaling	NN	compound	O
pathway	NN	nsubj	O
regulates	VBZ	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
impaired	JJ	amod	O
placental	JJ	amod	B-Organ
angiogenesis	NN	nsubj	O
and	CC	cc	O
uteroplacental	JJ	amod	B-Organism_substance
blood	NN	compound	I-Organism_substance
flow	NN	conj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
early	JJ	amod	O
defect	NN	xcomp	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
hyperthermic	JJ	amod	O
and	CC	cc	O
adolescent	JJ	conj	O
paradigms	NNS	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
vGPCR	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
Kaposi	NN	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	compound	I-Cancer
progression	NN	nmod	O
and	CC	cc	O
provide	VB	conj	O
experimental	JJ	amod	O
justification	NN	dobj	O
for	IN	mark	O
developing	VBG	acl	O
molecular	JJ	amod	O
-	HYPH	punct	O
based	VBN	amod	O
therapies	NNS	dobj	O
specifically	RB	advmod	O
targeting	VBG	acl	O
vGPCR	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
effectors	NNS	conj	O
for	IN	prep	O
the	DT	det	O
treatment	NN	pobj	O
of	IN	prep	O
Kaposi	NN	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	compound	I-Cancer
patients	NNS	pobj	B-Organism
.	.	punct	O

After	IN	case	O
successive	JJ	amod	O
growth	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
for	IN	case	O
longer	JJR	advmod	O
than	IN	quantmod	O
one	CD	nummod	O
month	NN	nmod	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
scarcely	RB	advmod	O
observed	VBN	acl:relcl	O
with	IN	case	O
the	DT	det	O
erythrophores	NNS	nmod	B-Cell
,	,	punct	O
the	DT	det	O
vast	JJ	amod	O
majority	NN	nsubj	O
of	IN	prep	O
such	JJ	amod	O
transformants	NNS	pobj	B-Cell
began	VBD	ROOT	O
to	TO	mark	O
differentiate	VB	xcomp	O
into	IN	case	O
erythrophores	NNS	nmod	B-Cell
and	CC	cc	O
ceased	VBN	conj	O
proliferation	NN	dobj	O
spontaneously	RB	advmod	O
.	.	punct	O

Disruption	NN	nsubj	O
of	IN	case	O
AR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
ARD1	NN	compound	B-Gene_or_gene_product
interactions	NNS	nmod	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
potent	JJ	amod	O
intervention	NN	ROOT	O
for	IN	case	O
androgen	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
PCa	NNS	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
correlation	NN	nsubj	O
of	IN	prep	O
survivin	NN	pobj	B-Gene_or_gene_product
with	IN	prep	O
bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
or	CC	cc	O
bax	NN	conj	B-Gene_or_gene_product
expression	NN	pobj	O
,	,	punct	O
or	CC	cc	O
with	IN	case	O
other	JJ	amod	O
prognostic	JJ	amod	O
parameters	NNS	conj	O
(	-LRB-	punct	O
age	NN	dep	O
,	,	punct	O
tumor	NN	compound	B-Cancer
size	NN	conj	O
,	,	punct	O
histologic	JJ	amod	O
type	NN	appos	O
,	,	punct	O
histologic	JJ	amod	O
grade	NN	appos	O
,	,	punct	O
nodal	JJ	amod	B-Multi-tissue_structure
status	NN	conj	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
stage	NN	conj	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	dep	O
>	NN	amod	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Coexpression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
progesterone	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
with	IN	case	O
mutant	JJ	amod	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ras	NN	nmod	I-Gene_or_gene_product
led	VBD	ROOT	O
to	TO	case	O
suppression	NN	nmod	O
of	IN	case	O
tumorigenicity	NN	nmod	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
ER	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Concentrations	NNS	nsubj	O
achieved	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
lead	VBP	acl	O
to	TO	case	O
single	JJ	amod	O
-	HYPH	punct	O
agent	NN	compound	O
anti	RB	compound	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
activity	NN	nmod	O
at	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
toxic	JJ	amod	O
doses	NNS	nmod	O
.	.	punct	O

Specimens	NNS	nsubjpass	O
of	IN	case	O
NSCLC	NN	nmod	B-Cancer
and	CC	cc	O
adjacent	JJ	amod	O
normal	JJ	amod	B-Tissue
lung	NN	compound	I-Tissue
tissues	NNS	conj	I-Tissue
were	VBD	auxpass	O
collected	VBN	ROOT	O
from	IN	case	O
110	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Co	NN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
of	IN	case	O
NRP1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
(	-LRB-	punct	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
KDR	NN	conj	B-Gene_or_gene_product
on	IN	case	O
the	DT	det	O
surface	NN	nmod	B-Cellular_component
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
EC	NN	appos	B-Cell
)	-RRB-	punct	O
enhances	VBZ	ROOT	O
VEGF165	NN	compound	B-Gene_or_gene_product
binding	NN	dobj	O
to	TO	case	O
KDR	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
EC	NN	conj	B-Cell
chemotaxis	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
VEGF165	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

A	DT	det	O
considerable	JJ	amod	O
number	NN	nsubj	O
of	IN	case	O
mutant	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
proteins	NNS	nmod	O
probably	RB	advmod	O
have	VBP	ROOT	O
an	DT	det	O
oncogenic	JJ	amod	O
activity	NN	dobj	O
per	FW	compound	O
se	FW	nmod	O
and	CC	cc	O
therefore	RB	advmod	O
actively	RB	advmod	O
participate	VBP	conj	O
in	IN	case	O
cell	NN	compound	B-Cell
transformation	NN	nmod	O
.	.	punct	O

The	DT	det	O
greatest	JJS	amod	O
potential	NN	nsubj	O
for	IN	case	O
angiogenesis	NN	compound	O
inhibitors	NNS	nmod	O
may	MD	aux	O
lie	VB	ROOT	O
in	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
combine	VB	acl	O
safely	RB	advmod	O
with	IN	case	O
chemotherapy	NN	nmod	O
and	CC	cc	O
radiotherapy	NN	conj	O
.	.	punct	O

After	IN	prep	O
cytocentrifugation	NN	pobj	O
the	DT	det	O
specimens	NNS	nsubjpass	B-Multi-tissue_structure
were	VBD	auxpass	O
stained	VBN	ROOT	O
in	IN	case	O
accordance	NN	nmod	O
with	IN	case	O
the	DT	det	O
alkaline	NN	compound	B-Gene_or_gene_product
phosphatase	NN	compound	I-Gene_or_gene_product
anti	NN	compound	O
-	HYPH	punct	O
alkaline	NN	compound	B-Gene_or_gene_product
phosphatase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
APAAP	NN	appos	O
)	-RRB-	punct	O
method	NN	nmod	O
.	.	punct	O

The	DT	det	O
average	JJ	amod	O
IMVD	NN	nsubj	O
in	IN	case	O
positive	JJ	amod	O
and	CC	cc	O
negative	JJ	conj	O
cervical	JJ	amod	B-Multi-tissue_structure
lymphatic	JJ	amod	I-Multi-tissue_structure
metastasis	NN	nmod	O
was	VBD	ROOT	O
(	-LRB-	punct	O
26	CD	nummod	O
.	.	punct	O
33	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
9	CD	attr	O
.	.	punct	O
70	CD	attr	O
)	-RRB-	punct	O
and	CC	cc	O
(	-LRB-	punct	O
17	CD	nummod	O
.	.	punct	O
68	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
6	CD	nummod	O
.	.	punct	O
06	CD	conj	O
)	-RRB-	punct	O
respectively	RB	advmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
IMVD	NN	nsubj	O
with	IN	case	O
positive	JJ	amod	O
lymphatic	JJ	amod	B-Cancer
metastasis	NN	compound	I-Cancer
tumors	NNS	nmod	I-Cancer
was	VBD	cop	O
statistical	JJ	conj	O
significantly	RB	advmod	O
higher	JJR	amod	O
than	IN	case	O
those	DT	nmod	O
with	IN	case	O
negative	JJ	amod	O
cervical	JJ	amod	B-Cancer
lymphatic	JJ	amod	I-Cancer
metastasis	NN	compound	I-Cancer
tumors	NNS	nmod	I-Cancer
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
bone	NN	compound	B-Cell
marrow	NN	nmod:npmod	I-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
haematopoietic	JJ	amod	I-Cell
progenitor	NN	compound	I-Cell
cells	NNS	ccomp	I-Cell
that	WDT	nsubj	O
express	VBP	acl:relcl	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	dobj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGFR1	NN	appos	B-Gene_or_gene_product
;	:	punct	O
also	RB	advmod	O
known	VBN	acl	O
as	IN	case	O
Flt1	NN	nmod	B-Gene_or_gene_product
)	-RRB-	punct	O
home	RB	advmod	O
to	IN	case	O
tumour	NN	compound	B-Cancer
-	HYPH	punct	O
specific	JJ	amod	O
pre	JJ	nmod:npmod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
sites	NNS	nmod	B-Multi-tissue_structure
and	CC	cc	O
form	VB	conj	O
cellular	JJ	amod	B-Cell
clusters	NNS	dobj	I-Cell
before	IN	case	O
the	DT	det	O
arrival	NN	nmod	O
of	IN	case	O
tumour	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
thiol	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
containing	VBG	amod	O
antioxidants	NNS	nsubj	O
completely	RB	advmod	O
blocked	VBD	ccomp	O
MOG	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
mitochondrial	JJ	amod	B-Cellular_component
DeltaPsim	NNP	compound	O
loss	NN	dobj	O
and	CC	cc	O
subsequent	JJ	amod	O
cell	NN	compound	B-Cell
apoptosis	NN	conj	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
apoptosis	NN	nmod	O
by	IN	case	O
benzyloxy	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
carbonyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Val	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Ala	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Asp	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
fluoromethylketone	NN	nmod	I-Simple_chemical
only	RB	advmod	O
partially	RB	advmod	O
attenuated	VBN	advcl	O
mitochondrial	JJ	amod	B-Cellular_component
DeltaPsim	NNP	compound	O
loss	NN	dobj	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
MOG	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
redox	NN	compound	O
imbalance	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
early	JJ	amod	O
event	NN	ccomp	O
upstream	JJ	advmod	O
to	TO	case	O
mitochondrial	JJ	amod	B-Cellular_component
DeltaPsim	NNP	compound	O
loss	NN	nmod	O
and	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
activation	NN	conj	O
.	.	punct	O

Highly	RB	advmod	O
specialized	VBN	amod	O
cells	NNS	nsubj	B-Cell
,	,	punct	O
the	DT	det	O
thyrocytes	NNS	appos	B-Cell
,	,	punct	O
express	VBP	ROOT	O
a	DT	det	O
thyroid	NN	nmod:npmod	B-Organ
-	HYPH	punct	O
specific	JJ	amod	O
set	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
for	IN	case	O
thyroglobulin	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Tg	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
thyroperoxidase	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
transcription	NN	compound	O
factors	NNS	conj	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
TTF	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
Pax	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	conj	I-Gene_or_gene_product
.	.	punct	O

To	TO	mark	O
understand	VB	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
compound	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
hemangiosarcomas	NNS	dobj	B-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
,	,	punct	O
and	CC	cc	O
therefore	RB	advmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
human	JJ	amod	B-Organism
relevance	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
systems	NNS	compound	O
biology	NN	compound	O
approach	NN	nsubjpass	O
was	VBD	auxpass	O
undertaken	VBN	conj	O
using	VBG	xcomp	O
transcriptomics	NNS	dobj	O
and	CC	cc	O
Causal	NNP	compound	O
Network	NNP	compound	O
Modeling	VBG	conj	O
from	IN	case	O
mice	NNS	nmod	B-Organism
treated	VBN	acl	O
with	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butoxyethanol	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BE	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

Saline	NN	ROOT	B-Simple_chemical
,	,	punct	O
thrombin	NN	compound	B-Gene_or_gene_product
solution	NN	conj	O
,	,	punct	O
PPP	NN	conj	B-Organism_substance
,	,	punct	O
and	CC	cc	O
PRP	NN	nsubjpass	B-Organism_substance
were	VBD	auxpass	O
applied	VBN	conj	O
to	TO	case	O
the	DT	det	O
created	VBN	amod	O
defects	NNS	nmod	O
before	IN	case	O
closure	NN	nmod	O
.	.	punct	O

Angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
with	IN	case	O
factor	NN	nmod	B-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
antigen	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
F8	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
RA	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
which	WDT	nsubj	O
identifies	VBZ	acl:relcl	O
endothelial	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

A	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	compound	O
enhancement	NN	compound	O
(	-LRB-	punct	O
VPE	NN	appos	O
)	-RRB-	punct	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
using	VBG	xcomp	O
guinea	NN	compound	B-Organism
pigs	NNS	dobj	I-Organism
to	TO	mark	O
ascertain	VB	xcomp	O
whether	IN	mark	O
supernatant	JJ	nsubj	B-Organism_substance
from	IN	case	O
cultures	NNS	nmod	O
of	IN	case	O
Ve	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
and	CC	cc	O
OMP	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
stimulated	VBN	amod	O
HGF	NN	conj	B-Cell
enhance	VBP	ccomp	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Correspondingly	RB	advmod	O
,	,	punct	O
Fh1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
benign	JJ	amod	O
murine	JJ	amod	O
renal	JJ	amod	O
cysts	NNS	nsubj	O
and	CC	cc	O
an	DT	det	O
advanced	JJ	amod	O
human	JJ	amod	B-Organism
HLRCC	NN	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
related	JJ	amod	I-Cancer
renal	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	conj	I-Cancer
manifested	VBD	ROOT	O
a	DT	det	O
prominent	JJ	amod	O
and	CC	cc	O
progressive	JJ	conj	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
target	NN	compound	O
genes	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
genes	NNS	conj	O
known	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
relevant	JJ	xcomp	O
to	TO	case	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

The	DT	det	O
expression	NN	compound	O
level	NN	nsubj	O
of	IN	case	O
EphA2	NN	nmod	B-Gene_or_gene_product
had	VBD	ROOT	O
a	DT	det	O
statistically	RB	advmod	O
significant	JJ	amod	O
relationship	NN	dobj	O
with	IN	case	O
liver	NN	compound	B-Organ
metastasis	NN	nmod	O
,	,	punct	O
lymphatic	JJ	amod	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
invasion	NN	conj	O
and	CC	cc	O
clinical	JJ	amod	O
stage	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
0477	CD	dobj	O
,	,	punct	O
0	CD	dobj	O
.	.	punct	O
0316	CD	dobj	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
0467	CD	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
impact	NN	nsubj	O
of	IN	case	O
elevated	JJ	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
on	IN	case	O
the	DT	det	O
course	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukaemia	NN	nmod	I-Cancer
is	VBZ	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

Cell	NN	compound	B-Cell
lines	NNS	nsubj	I-Cell
established	VBN	acl	O
from	IN	case	O
such	JJ	amod	O
foci	NNS	compound	B-Cell
elicit	NN	compound	O
tumours	NNS	ROOT	B-Cancer
in	IN	prep	O
syngeneic	JJ	amod	O
animals	NNS	pobj	O
.	.	punct	O

A	DT	det	O
chemokine	NN	compound	O
receptor	NN	nsubjpass	O
,	,	punct	O
CXCR4	NN	appos	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
endogenous	JJ	amod	O
ligand	NN	conj	O
,	,	punct	O
stromal	JJ	amod	B-Gene_or_gene_product
cell	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
factor	NN	appos	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
SDF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
recognized	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
the	DT	det	O
metastasis	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
resulting	VBG	amod	O
clusters	NNS	nsubjpass	O
were	VBD	auxpass	O
correlated	VBN	ROOT	O
to	TO	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
or	CC	cc	O
without	IN	conj	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
involvement	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
elevated	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
occur	VB	ccomp	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2gamma	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
panel	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
mammary	JJ	amod	B-Cell
epithelial	JJ	nmod	I-Cell
and	CC	cc	O
fibroblasts	NNS	conj	B-Cell
cell	NN	compound	I-Cell
lines	NNS	dep	I-Cell
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
the	DT	det	O
overexpression	NN	nsubj	O
of	IN	case	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	nmod	I-Gene_or_gene_product
correlated	VBD	ROOT	O
with	IN	case	O
histological	JJ	amod	O
grades	NNS	nmod	O
,	,	punct	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
and	CC	cc	O
poor	JJ	amod	O
clinical	JJ	amod	O
outcome	NN	conj	O
.	.	punct	O

Notably	RB	advmod	O
,	,	punct	O
three	CD	nummod	O
immortalizing	VBG	amod	O
E6	NN	compound	B-Gene_or_gene_product
mutants	NNS	nsubj	O
that	WDT	nsubj	O
do	VBP	aux	O
not	RB	neg	O
induce	VB	acl:relcl	O
direct	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
degradation	NN	dobj	O
but	CC	cc	O
do	VBP	aux	O
interact	VB	conj	O
with	IN	case	O
hADA3	NN	nmod	B-Gene_or_gene_product
induced	VBD	ROOT	O
the	DT	det	O
abrogation	NN	dobj	O
of	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
transactivation	NN	nmod	O
and	CC	cc	O
G	NN	compound	O
(	-LRB-	punct	O
1	LS	nummod	O
)	-RRB-	punct	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	conj	O
after	IN	case	O
DNA	NN	compound	B-Cellular_component
damage	NN	nmod	O
,	,	punct	O
comparable	JJ	advcl	O
to	TO	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
E6	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
CYR61	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
CTGF	NN	conj	B-Gene_or_gene_product
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
gliomas	NNS	nmod	B-Cancer
;	:	punct	O
their	PRP$	nmod:poss	O
levels	NNS	nsubj	O
at	IN	case	O
diagnosis	NN	nmod	O
may	MD	aux	O
have	VB	parataxis	O
prognostic	JJ	amod	O
significance	NN	dobj	O
;	:	punct	O
and	CC	cc	O
these	DT	det	O
proteins	NNS	nsubj	O
might	MD	aux	O
serve	VB	conj	O
as	IN	case	O
valuable	JJ	amod	O
targets	NNS	nmod	O
for	IN	case	O
therapeutic	JJ	amod	O
intervention	NN	nmod	O
.	.	punct	O

Investigating	VBG	ROOT	O
the	DT	det	O
causes	NNS	dobj	O
of	IN	prep	O
low	JJ	amod	O
birth	NN	compound	O
weight	NN	pobj	O
in	IN	prep	O
contrasting	VBG	pcomp	O
ovine	JJ	compound	O
paradigms	NNS	dobj	O
.	.	punct	O

In	IN	case	O
such	JJ	amod	O
cancers	NNS	nmod	B-Cancer
,	,	punct	O
glycolysis	NN	nsubj	O
may	MD	aux	O
contribute	VB	ROOT	O
nearly	RB	advmod	O
half	PDT	nummod	O
the	DT	det	O
ATP	NN	dobj	B-Simple_chemical
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
oxygen	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
"	``	punct	O
Warburg	NN	compound	O
effect	NN	dep	O
"	''	punct	O
)	-RRB-	punct	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
autocrine	JJ	amod	O
angiotensin	NN	compound	B-Gene_or_gene_product
system	NN	nmod	O
with	IN	case	O
the	DT	det	O
converting	NN	compound	O
-	HYPH	punct	O
enzyme	NN	compound	O
inhibitor	NN	nmod	O
or	CC	cc	O
the	DT	det	O
receptor	NN	compound	O
antagonist	NN	conj	O
also	RB	advmod	O
leads	VBZ	ROOT	O
to	TO	case	O
increased	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	compound	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	nmod	I-Gene_or_gene_product
:	:	punct	O
pp60c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
increased	VBD	conj	O
7	CD	nummod	O
-	SYM	punct	O
11	CD	nummod	O
-	HYPH	punct	O
fold	NN	dep	O
,	,	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
3	CD	nummod	O
-	HYPH	punct	O
fold	NN	conj	O
,	,	punct	O
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	O
activity	NN	conj	O
2	CD	nummod	O
-	SYM	punct	O
3	CD	nummod	O
-	HYPH	punct	O
fold	NN	dobj	O
.	.	punct	O

Chronic	JJ	amod	O
inflammation	NN	nsubjpass	O
and	CC	cc	O
cancer	NN	conj	B-Cancer
are	VBP	auxpass	O
intimately	RB	advmod	O
associated	VBN	ROOT	O
.	.	punct	O

One	CD	nummod	O
cell	NN	compound	B-Cell
line	NN	nsubj	I-Cell
(	-LRB-	punct	O
ESM	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	appos	I-Cell
)	-RRB-	punct	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
erythrophores	NNS	nmod	B-Cell
transfected	VBN	acl	O
with	IN	case	O
src	NN	nmod	B-Gene_or_gene_product
/	SYM	punct	O
myc	NN	nsubj	B-Gene_or_gene_product
grew	VBD	ROOT	O
successively	RB	advmod	O
over	IN	prep	O
nine	CD	nummod	O
months	NNS	pobj	O
,	,	punct	O
indicating	VBG	advcl	O
its	PRP$	poss	O
acquisition	NN	dobj	O
of	IN	case	O
immortality	NN	nmod	O
.	.	punct	O

Hepatocyte	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
HGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
/	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Met	NN	compound	I-Gene_or_gene_product
signaling	NN	nsubjpass	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
key	JJ	amod	O
pathway	NN	xcomp	O
in	IN	case	O
both	CC	cc:preconj	O
melanocyte	NN	compound	B-Cell
development	NN	nmod	O
and	CC	cc	O
melanoma	NN	compound	B-Cancer
metastasis	NN	conj	O
.	.	punct	O

This	DT	det	O
pathway	NN	nsubj	O
will	MD	aux	O
continue	VB	ROOT	O
to	TO	aux	O
be	VB	xcomp	O
a	DT	det	O
focus	NN	attr	O
of	IN	prep	O
investigation	NN	pobj	O
,	,	punct	O
particularly	RB	advmod	O
with	IN	case	O
respect	NN	advmod	O
to	TO	case	O
targeted	VBN	amod	O
experimental	JJ	amod	O
chemotherapeutics	NNS	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Retinochoroidopathy	NNS	ROOT	O
after	IN	prep	O
intravitreal	JJ	amod	O
anti	NN	compound	O
-	HYPH	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
treatment	NN	pobj	O
]	-RRB-	punct	O

KISS1	NN	compound	B-Gene_or_gene_product
hypermethylation	NN	nsubj	O
was	VBD	cop	O
frequent	JJ	ROOT	O
in	IN	case	O
bladder	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
analyzed	VBN	acl	O
by	IN	case	O
methylation	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
PCR	NN	nmod	O
and	CC	cc	O
bisulfite	JJ	amod	B-Simple_chemical
sequencing	NN	conj	O
and	CC	cc	O
was	VBD	auxpass	O
associated	VBN	conj	O
with	IN	case	O
low	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
being	VBG	auxpass	O
restored	VBN	advcl	O
in	FW	compound	O
vitro	FW	advmod	O
by	IN	mark	O
demethylating	VBG	advcl	O
azacytidine	NN	dobj	B-Simple_chemical
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
an	DT	det	O
additional	JJ	amod	O
direct	JJ	amod	O
consequence	NN	nsubj	O
of	IN	case	O
FH	NN	compound	B-Gene_or_gene_product
deficiency	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
establishment	NN	ccomp	O
of	IN	case	O
a	DT	det	O
biosynthetic	JJ	amod	O
milieu	NN	nmod	O
.	.	punct	O

Thyroid	NN	compound	B-Gene_or_gene_product
transcription	NN	compound	I-Gene_or_gene_product
factor	NN	nsubjpass	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
lung	NN	compound	B-Cancer
adenocarcinomas	NNS	nmod	I-Cancer
and	CC	cc	O
thyroid	NN	compound	B-Cancer
carcinomas	NNS	conj	I-Cancer
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
adenocarcinomas	NNS	conj	B-Cancer
arising	VBG	acl	O
from	IN	case	O
other	JJ	amod	O
sites	NNS	nmod	B-Multi-tissue_structure
.	.	punct	O

These	DT	det	O
mutations	NNS	nsubj	O
may	MD	aux	O
have	VB	ROOT	O
functional	JJ	amod	O
consequences	NNS	dobj	O
since	IN	mark	O
they	PRP	nsubj	O
eliminate	VBP	advcl	O
potential	JJ	amod	O
phosphorylation	NN	compound	O
sites	NNS	dobj	O
and	CC	cc	O
may	MD	aux	O
affect	VB	conj	O
the	DT	det	O
tertiary	JJ	amod	O
structure	NN	dobj	O
of	IN	case	O
mature	JJ	amod	O
protein	NN	compound	O
complexes	NNS	nmod	O
.	.	punct	O

Increased	VBN	amod	O
TLX	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
glioma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
glioma	NN	compound	B-Cell
stem	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
poor	JJ	amod	O
survival	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
gliomas	NNS	nmod	B-Cancer
.	.	punct	O

C	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	nsubjpass	I-Gene_or_gene_product
and	CC	cc	O
Ki67	NN	conj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
marker	NN	appos	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
co	NN	advmod	O
-	HYPH	punct	O
expressed	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
GC	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
presented	VBN	acl	O
here	RB	advmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
transcriptional	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	nmod	I-Gene_or_gene_product
can	MD	aux	O
oncogenically	RB	advmod	O
transform	VB	ccomp	O
B	NN	compound	B-Cell
-	:	punct	I-Cell
cells	NNS	dobj	I-Cell
in	IN	case	O
concert	NN	dep	O
with	IN	case	O
a	DT	det	O
myc	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

PP	NN	compound	B-Simple_chemical
mesh	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
more	RBR	advmod	O
fibrous	JJ	amod	B-Tissue
encapsulation	NN	nmod	O
and	CC	cc	O
stiffness	RB	conj	O
than	IN	case	O
PF	NN	compound	O
and	CC	cc	O
PS	NN	conj	O
prostheses	NNS	nmod	O
.	.	punct	O

Understanding	VBG	csubj	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
regulating	VBG	acl	O
angiogenesis	NN	dobj	O
may	MD	aux	O
lead	VB	ROOT	O
to	TO	case	O
novel	JJ	amod	O
therapies	NNS	nmod	O
for	IN	case	O
ischemic	JJ	amod	O
disorders	NNS	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
signal	NN	compound	B-Gene_or_gene_product
transducer	NN	nmod	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
transcription	NN	conj	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
through	IN	case	O
a	DT	det	O
phosphomimetic	JJ	amod	O
serine	NN	nmod	B-Amino_acid
727	CD	nummod	I-Amino_acid
promotes	VBZ	ROOT	O
prostate	NN	compound	B-Organ
tumorigenesis	NN	dobj	O
independent	JJ	amod	O
of	IN	case	O
tyrosine	NN	compound	B-Amino_acid
705	CD	nummod	I-Amino_acid
phosphorylation	NN	nmod	O
.	.	punct	O

The	DT	det	O
interaction	NN	nsubj	O
of	IN	case	O
virally	RB	advmod	O
derived	VBN	intj	O
and	CC	cc	O
endogenous	JJ	amod	O
cellular	JJ	amod	B-Cell
proteins	NNS	nmod	O
converges	NNS	ROOT	O
in	IN	case	O
deregulation	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	nmod	O
and	CC	cc	O
appears	VBZ	conj	O
to	TO	mark	O
be	VB	cop	O
critical	JJ	xcomp	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
enhanced	VBN	amod	O
proliferation	NN	nsubjpass	O
is	VBZ	auxpass	O
precipitated	VBN	ccomp	O
by	IN	case	O
an	DT	det	O
accelerated	VBN	amod	O
cell	NN	compound	B-Cell
cycle	NN	nmod	O
,	,	punct	O
and	CC	cc	O
decreased	VBD	conj	O
migration	NN	dobj	O
by	IN	case	O
an	DT	det	O
inability	NN	nmod	O
to	TO	mark	O
activate	VB	acl	O
CDC42	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
knockdown	NN	nsubj	O
of	IN	case	O
Pbx1	NN	nmod	B-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
impair	VB	ROOT	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	compound	I-Multi-tissue_structure
transformation	NN	dobj	O
by	IN	case	O
E2A	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
HLF	NN	conj	B-Gene_or_gene_product
or	CC	cc	O
AML1	NN	conj	B-Gene_or_gene_product
/	:	punct	O
ETO	NN	conj	B-Gene_or_gene_product
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
Pbx1	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
specifically	RB	advmod	O
required	VBN	ccomp	O
for	IN	case	O
the	DT	det	O
maintenance	NN	nmod	O
of	IN	case	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	compound	I-Multi-tissue_structure
transformation	NN	nmod	O
mediated	VBN	acl	O
by	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
largely	RB	advmod	O
restricted	JJ	amod	O
CCL16	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
in	IN	case	O
the	DT	det	O
liver	NN	nmod	B-Organ
suggests	VBZ	ROOT	O
that	IN	mark	O
this	DT	det	O
chemokine	NN	nsubj	O
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
hepatic	JJ	amod	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
formation	NN	nmod	O
during	IN	case	O
development	NN	nmod	O
and	CC	cc	O
in	IN	case	O
angiogenesis	NN	conj	O
associated	VBN	acl	O
to	TO	case	O
hepatic	JJ	amod	B-Organ
diseases	NNS	nmod	O
.	.	punct	O

In	IN	prep	O
11	CD	pobj	O
there	EX	expl	O
was	VBD	ROOT	O
complete	JJ	amod	O
wound	NN	compound	B-Pathological_formation
healing	NN	attr	O
,	,	punct	O
while	IN	mark	O
in	IN	prep	O
1	CD	pobj	O
there	EX	expl	O
was	VBD	advcl	O
partial	JJ	amod	O
response	NN	nsubj	O
,	,	punct	O
in	IN	case	O
1	CD	nummod	O
minimal	JJ	amod	O
response	NN	nmod	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
1	CD	nummod	O
a	DT	det	O
transient	JJ	amod	O
response	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
sought	VBD	ROOT	O
to	TO	mark	O
test	VB	xcomp	O
whether	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
could	MD	aux	O
behave	VB	ccomp	O
in	IN	case	O
a	DT	det	O
manner	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
known	JJ	amod	O
genes	NNS	nmod	O
in	IN	case	O
a	DT	det	O
biological	JJ	amod	O
test	NN	compound	O
system	NN	nmod	O
,	,	punct	O
and	CC	cc	O
we	PRP	nsubj	O
demonstrate	VBP	conj	O
here	RB	advmod	O
that	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
can	MD	aux	O
cooperate	VB	ccomp	O
with	IN	case	O
the	DT	det	O
activated	VBN	amod	O
Ha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
to	TO	mark	O
transform	VB	xcomp	O
normal	JJ	amod	O
embryonic	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
CX3CR1	JJ	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
accumulation	NN	ccomp	O
of	IN	case	O
subretinal	JJ	amod	B-Cell
MCs	NNS	compound	I-Cell
evokes	VBZ	compound	O
cardinal	JJ	amod	O
features	NNS	nmod	O
of	IN	case	O
AMD	NN	nmod	O
.	.	punct	O

The	DT	det	O
antisense	JJ	amod	O
oligomers	NNS	nsubj	O
complementary	JJ	amod	O
to	TO	case	O
the	DT	det	O
ER	NN	nmod	B-Gene_or_gene_product
suppressed	VBD	ROOT	O
proliferation	NN	dobj	O
and	CC	cc	O
transformed	VBN	amod	O
phenotypes	NNS	conj	O
of	IN	case	O
K12V	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Low	JJ	amod	O
-	HYPH	punct	O
level	NN	compound	O
X	NN	compound	O
-	HYPH	punct	O
radiation	NN	compound	O
effects	NNS	ROOT	O
on	IN	case	O
functional	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
changes	NNS	nmod	O
in	IN	case	O
Syrian	JJ	amod	B-Organism
hamster	NN	compound	I-Organism
cheek	NN	compound	B-Tissue
pouch	JJ	amod	I-Tissue
epithelium	NN	nmod	I-Tissue
during	IN	case	O
hydrocarbon	NN	compound	O
carcinogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
resultant	JJ	amod	O
foci	NNS	compound	B-Cell
contain	VBP	amod	O
cells	NNS	ROOT	B-Cell
of	IN	case	O
a	DT	det	O
markedly	RB	advmod	O
altered	JJ	amod	O
morphology	NN	nmod	O
which	WDT	nsubj	O
produce	VBP	acl:relcl	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
HER3	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
family	NN	nmod	O
.	.	punct	O

Promotion	NN	nsubjpass	O
of	IN	case	O
inflammation	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
involved	VBN	ROOT	O
because	IN	mark	O
lower	JJR	amod	O
TSP	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
was	VBD	cop	O
able	JJ	advcl	O
to	TO	nmod	O
up	RB	advmod	O
-	HYPH	punct	O
regulate	VB	advcl	O
the	DT	det	O
adhesion	NN	compound	O
molecules	NNS	dobj	O
intercellular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	dep	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	conj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

They	PRP	nsubj	O
also	RB	advmod	O
antagonised	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
thrombin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
SFLLR	NN	conj	B-Gene_or_gene_product
on	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
activation	NN	nmod	O
.	.	punct	O

CD40	NN	compound	B-Gene_or_gene_product
engagement	NN	nsubj	O
by	IN	case	O
CD154	NN	nmod	B-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
apoptosis	NN	dobj	O
or	CC	cc	O
survival	NN	conj	O
.	.	punct	O

By	IN	mark	O
introducing	VBG	advcl	O
a	DT	det	O
cDNA	NN	compound	O
library	NN	dobj	O
derived	VBN	acl	O
from	IN	case	O
rat	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblast	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
we	PRP	nsubj	O
isolated	VBD	ROOT	O
several	JJ	amod	O
morphologically	RB	advmod	O
flat	JJ	amod	O
revertants	NNS	dobj	O
of	IN	case	O
rat	NN	compound	B-Organism
3Y1	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
transformed	VBN	acl	O
by	IN	case	O
the	DT	dep	O
E6	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
E7	NN	conj	B-Gene_or_gene_product
genes	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
papillomavirus	NN	compound	I-Organism
type	NN	nmod	I-Organism
18	CD	nummod	I-Organism
(	-LRB-	punct	O
HPV18	NN	appos	B-Organism
)	-RRB-	punct	O
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
MKP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
the	DT	det	O
MCF10A	NN	compound	B-Cell
-	HYPH	punct	I-Cell
Myc	NNP	compound	I-Cell
and	CC	cc	O
MDA	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
breast	NN	compound	I-Cell
epithelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
was	VBD	auxpass	O
also	RB	advmod	O
seen	VBN	ROOT	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
(	-LRB-	punct	O
wt	NN	appos	O
)	-RRB-	punct	O
p53	NN	compound	B-Gene_or_gene_product
ALL	NN	compound	O
cells	NNS	nmod	O
(	-LRB-	punct	O
EU	NN	compound	B-Cell
-	SYM	punct	I-Cell
3	CD	nummod	I-Cell
cell	NN	compound	I-Cell
line	NN	appos	I-Cell
)	-RRB-	punct	O
with	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
caused	VBD	ROOT	O
accumulation	NN	dobj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
dramatic	JJ	amod	O
down	RB	dep	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
survivin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
depletion	NN	appos	O
of	IN	case	O
cells	NNS	nmod	B-Cell
in	IN	case	O
G	NN	compound	O
(	-LRB-	punct	O
2	CD	dep	O
)	-RRB-	punct	O
/	:	punct	O
M	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
(	-LRB-	punct	O
increased	VBN	amod	O
sub	NN	compound	O
-	HYPH	punct	O
G	NN	compound	O
(	-LRB-	punct	O
1	LS	nummod	O
)	-RRB-	punct	O
compartment	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Curcumin	NN	nsubj	B-Simple_chemical
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
immortalized	VBN	amod	O
NIH	NN	compound	B-Cell
3T3	NN	nmod	I-Cell
and	CC	cc	O
malignant	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
.	.	punct	O

Transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
major	JJ	amod	O
factor	NN	appos	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
fibroblasts	NNS	nmod	B-Cell
,	,	punct	O
increased	VBN	amod	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
SMA	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
desmin	NN	conj	B-Gene_or_gene_product
expression	NN	ROOT	O
and	CC	cc	O
the	DT	det	O
ability	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
and	CC	cc	O
invasion	NN	conj	O
in	IN	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Previous	JJ	amod	O
work	NN	nsubj	O
has	VBZ	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
a	DT	det	O
rabbit	NN	compound	B-Organism
anti	JJ	compound	O
-	HYPH	punct	O
VCSA	NN	compound	B-Gene_or_gene_product
serum	NN	compound	B-Organism_substance
lyses	NNS	ccomp	I-Organism_substance
specifically	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
complement	NN	nmod	O
,	,	punct	O
51Cr	NN	appos	B-Simple_chemical
-	:	punct	O
labelled	VBN	amod	O
RSV	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
from	IN	case	O
different	JJ	amod	O
animal	NN	compound	O
species	NNS	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
not	RB	neg	O
only	RB	cc:preconj	O
the	DT	det	O
intratumoral	JJ	amod	B-Cancer
and	CC	cc	O
peritumoral	JJ	conj	B-Multi-tissue_structure
lymphatic	JJ	amod	I-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
density	NN	dobj	O
(	-LRB-	punct	O
ILD	NN	dep	O
and	CC	cc	O
PLD	NN	conj	O
)	-RRB-	punct	O
but	CC	cc	O
also	RB	advmod	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGFs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
to	TO	mark	O
test	VB	conj	O
their	PRP$	nmod:poss	O
correlation	NN	dobj	O
with	IN	case	O
regional	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodal	JJ	amod	I-Multi-tissue_structure
metastases	NNS	nmod	O
in	IN	case	O
papillary	JJ	amod	B-Cancer
thyroid	NN	compound	I-Cancer
microcarcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
PTMC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Binding	NN	nsubjpass	O
of	IN	case	O
anticalretinin	NN	compound	O
antiserum	NN	nmod	B-Organism_substance
to	TO	mark	O
living	VBG	acl	O
mesothelial	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
was	VBD	auxpass	O
consistently	RB	advmod	O
documented	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
four	CD	nummod	O
cases	NNS	nmod	O
investigated	VBD	acl	O
.	.	punct	O

Strong	JJ	amod	O
positive	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
mEndostatin	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
after	IN	case	O
injection	NN	nmod	O
of	IN	case	O
Ad	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
mEndostatin	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
immunhistochemically	RB	advmod	O
ostained	VBN	advcl	O
by	IN	case	O
mouse	NN	compound	B-Organism
endostatin	NN	compound	B-Gene_or_gene_product
monoclonal	JJ	amod	I-Gene_or_gene_product
antibody	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
while	IN	mark	O
the	DT	det	O
control	NN	compound	O
groups	NNS	nsubj	O
showed	VBD	advcl	O
only	RB	advmod	O
very	RB	advmod	O
low	JJ	amod	O
expression	NN	dobj	O
or	CC	cc	O
absence	NN	conj	O
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
anti	JJ	compound	O
-	HYPH	punct	O
Fas	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
significantly	RB	advmod	O
decreased	VBD	ROOT	O
Fas	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NNP	dobj	I-Gene_or_gene_product
and	CC	cc	O
Fas	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
c	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
met	VBN	amod	I-Gene_or_gene_product
association	NN	conj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
Hedgehog	JJ	compound	B-Gene_or_gene_product
signaling	NN	nsubjpass	O
in	IN	case	O
tumor	NN	compound	B-Cancer
related	JJ	amod	O
vasculature	NN	nmod	B-Multi-tissue_structure
and	CC	cc	O
microenvironment	NN	conj	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
using	VBG	xcomp	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	dobj	I-Cell
and	CC	cc	O
B16F0	NN	compound	B-Cell
(	-LRB-	punct	O
murine	JJ	amod	B-Organism
melanoma	NN	appos	B-Cancer
)	-RRB-	punct	O
tumors	NNS	compound	B-Cancer
models	NNS	conj	O
.	.	punct	O

The	DT	det	O
apoptosis	NN	nsubjpass	O
induced	VBN	acl	O
by	IN	case	O
Sim	NN	nmod	B-Simple_chemical
is	VBZ	auxpass	O
probably	RB	advmod	O
initiated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
mitochondrial	JJ	amod	B-Cellular_component
caspase	NN	nmod	B-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
indirectly	RB	advmod	O
leads	VBZ	acl:relcl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
caspase	NN	nmod	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
8	CD	conj	B-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
these	DT	det	O
settings	NNS	nmod	O
TNF	NN	nsubj	B-Gene_or_gene_product
demonstrates	VBZ	ROOT	O
potent	JJ	amod	O
and	CC	cc	O
selective	JJ	conj	O
activity	NN	dobj	O
on	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
bed	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
which	WDT	nsubj	O
strongly	RB	advmod	O
improves	VBZ	acl:relcl	O
tumor	NN	compound	B-Cancer
response	NN	dobj	O
.	.	punct	O

Because	IN	mark	O
AR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
ARD1	NN	compound	B-Gene_or_gene_product
interaction	NN	nsubj	O
facilitated	VBD	advcl	O
the	DT	det	O
AR	NN	compound	B-Gene_or_gene_product
binding	VBG	dobj	O
to	TO	case	O
its	PRP$	nmod:poss	O
targeted	VBN	amod	O
promoters	NNS	nmod	O
for	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
ARD1	NN	nsubj	B-Gene_or_gene_product
functions	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
unique	JJ	amod	O
AR	NN	compound	B-Gene_or_gene_product
regulator	NN	nmod	O
and	CC	cc	O
forms	VBZ	conj	O
a	DT	det	O
positive	JJ	amod	O
feedback	NN	compound	O
loop	NN	dobj	O
for	IN	case	O
AR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
prostate	NN	compound	B-Organ
tumorigenesis	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
25	CD	nummod	O
mg	NN	compound	O
/	:	punct	O
kg	NN	compound	O
cyclopamine	NN	nmod	B-Simple_chemical
significantly	RB	advmod	O
attenuated	VBD	ROOT	O
BrdU	NN	compound	B-Simple_chemical
incorporation	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
threefold	RB	advmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
related	JJ	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
threefold	RB	dep	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
004	CD	ROOT	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
delayed	VBN	conj	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
by	IN	prep	O
4	CD	nummod	O
days	NNS	pobj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
apoptosis	NN	nmod	O
of	IN	case	O
latent	JJ	amod	O
gene	NN	compound	O
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	B-Cell
after	IN	case	O
the	DT	det	O
pharmacologic	JJ	amod	O
deletion	NN	nmod	O
of	IN	case	O
the	DT	det	O
vGPCR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
cyclooxygenase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
non	JJ	amod	O
-	HYPH	punct	O
selective	JJ	amod	O
and	CC	cc	O
selective	JJ	conj	O
inhibitors	NNS	nmod	O
on	IN	case	O
proliferation	NN	compound	O
inhibition	NN	nmod	O
and	CC	cc	O
apoptosis	NN	compound	O
induction	NN	conj	O
of	IN	case	O
esophageal	JJ	amod	B-Cell
squamous	JJ	amod	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
CXCR4	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
gastric	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
strong	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
CXCR4	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
gastric	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	auxpass	O
significantly	RB	advmod	O
associated	VBN	conj	O
with	IN	case	O
lymphatic	JJ	amod	B-Organ
metastasis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
CXCR4	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
during	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Immunohistochemical	JJ	amod	O
staining	NN	nsubjpass	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	conj	I-Gene_or_gene_product
was	VBD	auxpass	O
performed	VBN	dep	O
using	VBG	xcomp	O
specimens	NNS	dobj	B-Multi-tissue_structure
from	IN	case	O
143	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
early	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Intrauterine	JJ	compound	O
growth	NN	compound	O
restriction	NN	nsubj	O
(	-LRB-	punct	O
IUGR	NN	appos	O
)	-RRB-	punct	O
still	RB	advmod	O
accounts	VBZ	ROOT	O
for	IN	case	O
a	DT	det	O
large	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
infant	JJ	amod	B-Organism
mortality	NN	nmod	O
and	CC	cc	O
morbidity	NN	compound	O
worldwide	NN	conj	O
.	.	punct	O

Nitric	JJ	amod	B-Simple_chemical
oxide	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
NO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
maintaining	VBG	advcl	O
vascular	JJ	amod	B-Multi-tissue_structure
homeostasis	NN	dobj	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
serum	NN	nmod	B-Organism_substance
and	CC	cc	O
urine	NN	conj	B-Organism_substance
concentrations	NNS	dep	O
of	IN	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
clinical	JJ	conj	O
variables	NNS	dep	O
,	,	punct	O
the	DT	det	O
only	JJ	amod	O
exception	NN	appos	O
being	VBG	cop	O
the	DT	det	O
international	JJ	amod	O
prognostic	JJ	amod	O
index	NN	nmod	O
(	-LRB-	punct	O
IPI	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
showed	VBD	acl:relcl	O
a	DT	det	O
marginal	JJ	amod	O
correlation	NN	dobj	O
with	IN	case	O
urine	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
Cr	JJ	compound	B-Simple_chemical
levels	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
07	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Lysophosphatidic	NN	amod	B-Simple_chemical
acid	NN	nsubj	I-Simple_chemical
downregulates	VBZ	ROOT	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	dobj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
metalloproteinases	NNS	nmod	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
negatively	RB	advmod	O
involved	VBN	acl:relcl	O
in	IN	case	O
lysophosphatidic	NN	amod	B-Simple_chemical
acid	NN	nmod:npmod	I-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
invasion	NN	nmod	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
properties	NNS	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
gingival	JJ	amod	B-Cell
fibroblasts	NNS	compound	I-Cell
(	-LRB-	punct	O
HGF	NN	appos	B-Cell
)	-RRB-	punct	O
culture	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
compared	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
EGFR	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
index	NN	conj	O
with	IN	case	O
clinical	JJ	amod	O
data	NNS	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
intramuscular	JJ	amod	B-Immaterial_anatomical_entity
p75	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
gene	NN	compound	O
delivery	NN	nsubj	O
impairs	VBZ	ROOT	O
neovascularization	NN	dobj	O
and	CC	cc	O
blood	NN	compound	B-Organism_substance
flow	NN	compound	O
recovery	NN	conj	O
in	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
model	NN	nmod	O
of	IN	case	O
limb	NN	compound	B-Organism_subdivision
ischemia	NN	nmod	O
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
estrogen	NN	nmod	B-Simple_chemical
and	CC	cc	O
progesterone	NN	conj	B-Simple_chemical
on	IN	case	O
macrophage	NN	compound	B-Cell
activation	NN	nmod	O
during	IN	case	O
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
.	.	punct	O

The	DT	det	O
tumor	NN	compound	B-Cancer
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
by	IN	case	O
electron	NN	compound	O
microscopy	NN	nmod	O
.	.	punct	O

N	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitrosourea	NN	npadvmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
transformation	NN	nsubjpass	O
of	IN	case	O
rat	NN	compound	B-Organism
urothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
is	VBZ	auxpass	O
not	RB	neg	O
mediated	VBN	ROOT	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
ras	NN	compound	B-Gene_or_gene_product
oncogenes	NNS	nmod	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
support	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
of	IN	case	O
both	DT	det	O
systems	NNS	nmod	O
in	IN	case	O
adipogenesis	NN	nmod	O
and	CC	cc	O
obesity	NN	conj	O
;	:	punct	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
specific	JJ	amod	O
members	NNS	nmod	O
of	IN	case	O
these	DT	det	O
families	NNS	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
remains	VBZ	parataxis	O
to	TO	mark	O
be	VB	auxpass	O
determined	VBN	xcomp	O
.	.	punct	O

Patients	NNS	nsubj	B-Organism
with	IN	case	O
high	JJ	amod	O
PLD	NN	nmod	O
(	-LRB-	punct	O
>	NN	dep	O
8	CD	dep	O
.	.	punct	O
0	CD	appos	O
)	-RRB-	punct	O
showed	VBD	ROOT	O
higher	JJR	amod	O
rates	NNS	dobj	O
of	IN	case	O
neck	NN	compound	B-Organism_subdivision
metastases	NNS	nmod	O
than	IN	case	O
low	JJ	amod	O
PLD	NN	nmod	O
(	-LRB-	punct	O
<	JJR	dep	O
=	JJ	amod	O
8	CD	dobj	O
.	.	punct	O
0	CD	ROOT	O
)	-RRB-	punct	O
(	-LRB-	punct	O
74	CD	dep	O
.	.	punct	O
0	CD	nummod	O
%	NN	ROOT	O
vs	CC	cc	O
46	CD	conj	O
.	.	punct	O
8	CD	nummod	O
%	NN	npadvmod	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	ROOT	O
.	.	punct	O
03	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

VEGF165	NN	nsubj	B-Gene_or_gene_product
also	RB	advmod	O
mediated	VBD	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
a	DT	det	O
soluble	JJ	amod	O
NRP1	NN	compound	B-Gene_or_gene_product
dimer	NN	nmod	O
to	TO	case	O
cells	NNS	nmod	B-Cell
expressing	VBG	acl	O
KDR	NN	dobj	B-Gene_or_gene_product
only	RB	advmod	O
,	,	punct	O
confirming	VBG	advcl	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
such	JJ	amod	O
complexes	NNS	nmod	O
.	.	punct	O

Cooccurrence	NN	nsubj	O
of	IN	case	O
reduced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
overexpression	NN	conj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
predictor	NN	ROOT	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
in	IN	case	O
early	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
investigation	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
firstly	RB	advmod	O
whether	IN	mark	O
different	JJ	amod	O
protein	NN	compound	O
expression	NN	compound	O
patterns	NNS	nsubj	O
exist	VBP	ccomp	O
in	IN	case	O
primary	JJ	amod	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	nmod	O
and	CC	cc	O
without	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
involvement	NN	nmod	O
and	CC	cc	O
secondly	RB	conj	O
,	,	punct	O
whether	IN	mark	O
or	CC	cc	O
not	RB	neg	O
different	JJ	amod	O
patterns	NNS	nsubj	O
exist	VBP	ccomp	O
in	IN	case	O
tumours	NNS	nmod	B-Cancer
with	IN	case	O
positive	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
FGF13	NN	dobj	B-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
new	JJ	amod	O
prognostic	JJ	amod	O
marker	NN	nmod	O
that	WDT	nsubj	O
predicted	VBD	acl:relcl	O
poorer	NN	compound	O
outcome	NN	dobj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
who	WP	nsubjpass	O
were	VBD	auxpass	O
clinically	RB	advmod	O
considered	VBN	acl:relcl	O
free	JJ	advmod	O
from	IN	case	O
disease	NN	nmod	O
.	.	punct	O

As	IN	mark	O
pregnancy	NN	nsubj	O
advanced	VBD	advcl	O
the	DT	det	O
complexity	NN	dobj	O
of	IN	prep	O
the	DT	det	O
vasculature	NN	pobj	B-Multi-tissue_structure
increased	VBD	ROOT	O
:	:	punct	O
at	IN	prep	O
4	CD	nummod	O
weeks	NNS	pobj	O
the	DT	det	O
surface	NN	nsubj	O
showed	VBD	parataxis	O
a	DT	det	O
pattern	NN	dobj	O
of	IN	case	O
ridges	NNS	nmod	O
separated	VBN	acl	O
by	IN	case	O
troughs	NN	nmod	O
.	.	punct	O

Immunohistochemistry	NN	compound	O
examinations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
surgical	JJ	amod	B-Cancer
specimens	NNS	nmod	I-Cancer
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
a	DT	det	O
downregulation	NN	nsubjpass	O
of	IN	case	O
TSP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
during	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	B-Multi-tissue_structure
carcinogenesis	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	ccomp	O
by	IN	case	O
an	DT	det	O
emergence	NN	nmod	O
in	IN	case	O
the	DT	det	O
upregulation	NN	nmod	O
of	IN	case	O
stroma	NN	compound	B-Gene_or_gene_product
markers	NNS	nmod	I-Gene_or_gene_product
,	,	punct	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
smooth	NN	amod	I-Gene_or_gene_product
muscle	NN	compound	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
SMA	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
desmin	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
allergic	JJ	amod	O
respiratory	JJ	amod	B-Anatomical_system
inflammation	NN	nsubj	O
may	MD	aux	O
represent	VB	ccomp	O
a	DT	det	O
risk	NN	compound	O
factor	NN	dobj	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
lung	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
amelioration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
pulmonary	JJ	amod	B-Organ
inflammation	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
asthma	NN	nmod	O
will	MD	aux	O
have	VB	ccomp	O
a	DT	det	O
direct	JJ	amod	O
and	CC	cc	O
immediate	JJ	conj	O
benefit	NN	dobj	O
to	IN	case	O
the	DT	det	O
7	CD	nummod	O
%	NN	pobj	O
to	TO	case	O
8	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
with	IN	case	O
this	DT	det	O
lung	NN	compound	B-Organ
disease	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
studies	NNS	nsubj	O
highlight	VBP	ROOT	O
the	DT	det	O
plasticity	NN	dobj	O
of	IN	case	O
aggressive	JJ	amod	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
call	VB	conj	O
into	IN	prep	O
question	NN	pobj	O
the	DT	det	O
underlying	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
form	VB	acl	O
VM	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
induced	VBN	acl	O
by	IN	case	O
VEGF	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
a	DT	advmod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
cellular	JJ	amod	B-Cell
and	CC	cc	O
molecular	JJ	conj	O
mechanisms	NNS	nsubj	O
by	IN	case	O
which	WDT	nmod	O
a	DT	det	O
tumour	NN	compound	B-Cell
cell	NN	nsubj	I-Cell
undergoes	VBZ	acl:relcl	O
metastasis	NN	dobj	O
to	TO	case	O
a	DT	det	O
predetermined	JJ	amod	O
location	NN	nmod	O
are	VBP	cop	O
largely	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O

Melissoidesin	NN	compound	B-Simple_chemical
G	NN	nsubj	I-Simple_chemical
,	,	punct	O
a	DT	det	O
diterpenoid	NN	appos	O
purified	VBN	acl	O
from	IN	case	O
Isodon	NN	compound	B-Organism
melissoides	NNS	nmod	I-Organism
,	,	punct	O
induces	VBZ	ROOT	O
leukemic	JJ	amod	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
through	IN	case	O
induction	NN	nmod	O
of	IN	case	O
redox	NN	compound	O
imbalance	NN	nmod	O
and	CC	cc	O
exhibits	VBZ	conj	O
synergy	NN	dobj	O
with	IN	case	O
other	JJ	amod	O
anticancer	NN	compound	B-Cancer
agents	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
accumulating	VBG	amod	O
evidence	NN	nsubj	O
that	IN	mark	O
the	DT	det	O
tissue	NN	compound	B-Tissue
damage	NN	nsubjpass	O
associated	VBN	acl	O
with	IN	case	O
chronic	JJ	amod	O
wounds	NNS	nmod	B-Pathological_formation
is	VBZ	auxpass	O
initiated	VBN	ccomp	O
and	CC	cc	O
propagated	VBN	conj	O
by	IN	case	O
an	DT	det	O
inappropriately	RB	advmod	O
excessive	JJ	amod	O
inflammatory	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

As	IN	case	O
in	IN	case	O
prior	JJ	amod	O
studies	NNS	nmod	O
,	,	punct	O
there	EX	expl	O
were	VBD	ROOT	O
significant	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
volume	NN	compound	O
differences	NNS	nsubj	O
between	IN	case	O
DMBA	NN	nmod	B-Simple_chemical
and	CC	cc	O
DMBA	NN	conj	B-Simple_chemical
+	CC	cc	O
radiation	NN	compound	O
groups	NNS	conj	O
of	IN	case	O
tumor	NN	npadvmod	B-Cancer
-	HYPH	punct	O
bearing	VBG	amod	O
cheek	JJ	compound	B-Organism_subdivision
pouches	NNS	nmod	I-Organism_subdivision
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
relationship	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
EphA2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	conj	I-Gene_or_gene_product
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Knockdown	NN	nsubj	O
of	IN	case	O
PLCbeta3	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
HUVEC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
affects	VBZ	ROOT	O
IP3	NN	compound	B-Gene_or_gene_product
production	NN	dobj	O
,	,	punct	O
actin	NN	compound	B-Gene_or_gene_product
reorganization	NN	conj	O
,	,	punct	O
migration	NN	conj	O
and	CC	cc	O
proliferation	NN	conj	O
;	:	punct	O
whereas	IN	dep	O
migration	NN	nsubjpass	O
is	VBZ	auxpass	O
inhibited	VBN	parataxis	O
,	,	punct	O
proliferation	NN	nsubjpass	O
is	VBZ	auxpass	O
enhanced	VBN	parataxis	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
complexes	NNS	nmod	O
containing	VBG	acl	O
KDR	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
NRP1	NN	conj	B-Gene_or_gene_product
markedly	RB	advmod	O
increased	VBD	ROOT	O
125I	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
VEGF165	NN	compound	I-Gene_or_gene_product
binding	VBG	dobj	O
to	TO	case	O
KDR	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
mRNA	NN	compound	O
and	CC	cc	O
protein	NN	conj	O
expressions	NNS	nsubjpass	O
of	IN	case	O
KISS1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
of	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
protein	NN	conj	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
respectively	RB	advmod	O
in	IN	case	O
85	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
NSCLC	NN	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
matched	VBN	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	conj	O
.	.	punct	O

The	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
also	RB	advmod	O
display	VBP	ROOT	O
enhanced	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
desmosomal	JJ	amod	B-Cellular_component
and	CC	cc	O
tight	JJ	conj	B-Cellular_component
-	HYPH	punct	I-Cellular_component
junction	NN	dep	I-Cellular_component
proteins	NNS	nmod	O
.	.	punct	O

Experiments	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
mutant	JJ	amod	B-Developing_anatomical_structure
embryos	NNS	nsubj	I-Developing_anatomical_structure
and	CC	cc	O
mutant	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
in	IN	case	O
culture	NN	nmod	O
experienced	JJ	ccomp	O
genome	NN	compound	O
instability	NN	dobj	O
,	,	punct	O
as	IN	mark	O
do	VBP	advcl	O
cells	NNS	dobj	B-Cell
in	IN	case	O
FA	NN	compound	O
patients	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
amount	NN	nsubj	O
of	IN	prep	O
conjugated	VBN	amod	O
amine	NN	compound	O
group	NN	pobj	O
onto	IN	prep	O
the	DT	det	O
microspheres	NNS	pobj	O
was	VBD	ROOT	O
1	CD	attr	O
.	.	punct	O
93	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
01	CD	nummod	O
nmol	NN	compound	O
/	:	punct	O
mg	NN	compound	O
-	HYPH	punct	O
microspheres	NNS	ROOT	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
amount	NN	nsubj	O
of	IN	case	O
heparin	NN	nmod	B-Simple_chemical
was	VBD	cop	O
95	CD	dep	O
.	.	punct	O
8	CD	nummod	O
pmol	NN	compound	O
/	:	punct	O
mg	NN	compound	O
-	HYPH	punct	O
microspheres	NNS	ROOT	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
KATO	NN	compound	B-Cell
III	CD	nummod	I-Cell
cells	NNS	nsubj	I-Cell
expressed	VBD	ROOT	O
membrane	NN	compound	B-Cellular_component
CXCR4	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

Age	NN	nsubj	O
alone	RB	advmod	O
should	MD	aux	O
not	RB	neg	O
preclude	VB	ROOT	O
the	DT	det	O
use	NN	dobj	O
of	IN	case	O
chemotherapy	NN	nmod	O
in	IN	case	O
stage	NN	compound	O
IV	CD	nummod	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
although	IN	mark	O
the	DT	det	O
ability	NN	nsubj	O
to	TO	case	O
tolerate	VB	amod	O
drug	NN	npadvmod	O
-	HYPH	punct	O
related	JJ	amod	O
toxicity	NN	nmod	O
may	MD	aux	O
be	VB	advcl	O
a	DT	det	O
consideration	NN	attr	O
.	.	punct	O

The	DT	det	O
biological	JJ	amod	O
properties	NNS	nsubj	O
of	IN	case	O
CCN	NN	compound	B-Gene_or_gene_product
proteins	NNS	nmod	O
include	VBP	ROOT	O
stimulation	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
adhesion	NN	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
angiogenesis	NN	conj	O
and	CC	cc	O
tumorigenesis	NN	conj	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigate	VBP	ROOT	O
S727	NN	compound	B-Amino_acid
phosphorylation	NN	dobj	O
of	IN	case	O
Stat3	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
subsequent	JJ	amod	O
effects	NNS	conj	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
development	NN	nmod	O
,	,	punct	O
independent	JJ	amod	O
of	IN	case	O
Y705	NN	compound	B-Amino_acid
phosphorylation	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
mutated	VBN	amod	O
Stat3	NN	dobj	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
LNCaP	NN	nmod	I-Cell
.	.	punct	O

The	DT	det	O
WNT	NNP	compound	B-Gene_or_gene_product
/	:	punct	O
TCF	NN	compound	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	nsubjpass	O
HOXB9	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
LEF1	NN	conj	B-Gene_or_gene_product
are	VBP	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
mediators	NNS	nmod	O
of	IN	case	O
chemotactic	JJ	amod	O
invasion	NN	nmod	O
and	CC	cc	O
colony	NN	compound	B-Cancer
outgrowth	NN	conj	O
.	.	punct	O

Swainsonine	NNP	nsubj	B-Simple_chemical
caused	VBD	ROOT	O
a	DT	det	O
great	JJ	amod	O
distortion	NN	dobj	O
to	TO	prep	O
the	DT	det	O
vasculature	NN	pobj	B-Multi-tissue_structure
at	IN	prep	O
18	CD	nummod	O
weeks	NNS	pobj	O
.	.	punct	O

MMP2	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
MMP9	NN	conj	B-Gene_or_gene_product
activity	NN	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
zymographic	NN	amod	O
assay	NN	nmod	O
,	,	punct	O
and	CC	cc	O
MAPK	NN	compound	B-Gene_or_gene_product
activation	NN	conj	O
by	IN	case	O
Western	NN	compound	O
blotting	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
transgenic	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
CDKs	NNS	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
embryonic	JJ	amod	B-Developing_anatomical_structure
oral	JJ	amod	I-Developing_anatomical_structure
ectoderm	NN	nmod	I-Developing_anatomical_structure
is	VBZ	auxpass	O
specifically	RB	advmod	O
retained	VBN	ccomp	O
in	IN	case	O
undifferentiated	JJ	amod	O
cells	NNS	nmod	B-Cell
from	IN	case	O
the	DT	det	O
pars	NNS	amod	B-Multi-tissue_structure
intermedia	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
the	DT	det	O
adenohypophysis	NN	nmod	B-Organ
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
demonstrate	VBP	ROOT	O
a	DT	det	O
requirement	NN	dobj	O
for	IN	case	O
VEGFR1	NN	nmod	B-Gene_or_gene_product
+	CC	cc	O
haematopoietic	JJ	conj	O
progenitors	NNS	dep	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
expression	NN	compound	O
patterns	NNS	nsubj	O
of	IN	case	O
fibronectin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
VEGFR1	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
VLA	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
+	CC	cc	O
clusters	NNS	conj	O
dictate	VBP	ccomp	O
organ	NN	nmod:npmod	B-Organ
-	HYPH	punct	O
specific	JJ	amod	O
tumour	NN	compound	B-Cancer
spread	NN	dobj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
Stat3	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
activated	VBN	ccomp	O
through	IN	case	O
novel	JJ	amod	O
and	CC	cc	O
noncanonical	JJ	conj	O
mechanisms	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
phosphorylation	NN	nmod	O
at	IN	case	O
S727	NN	nmod	B-Amino_acid
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
on	IN	case	O
aerobic	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
consumption	NN	nmod	O
,	,	punct	O
lactic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
formation	NN	conj	O
,	,	punct	O
content	NN	appos	O
of	IN	case	O
total	JJ	intj	O
(	-LRB-	punct	O
T	NN	compound	O
-	HYPH	punct	O
SH	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
non	JJ	amod	O
-	HYPH	punct	O
protein	NN	compound	O
thiol	NN	compound	O
groups	NNS	nmod	O
(	-LRB-	punct	O
NP	NN	compound	O
-	HYPH	punct	O
SH	NNP	appos	O
)	-RRB-	punct	O
,	,	punct	O
endogenous	JJ	amod	O
and	CC	cc	O
exogenous	JJ	conj	O
respiration	NN	nmod	O
and	CC	cc	O
the	DT	det	O
level	NN	conj	O
of	IN	case	O
ATP	NN	nmod	B-Simple_chemical
in	IN	case	O
tumour	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
incubated	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

Inhibition	NN	nsubjpass	O
of	IN	case	O
angiogenesis	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
effective	JJ	amod	O
strategy	NN	xcomp	O
in	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
discuss	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
for	IN	case	O
MMPs	NNS	nmod	B-Gene_or_gene_product
to	TO	mark	O
contribute	VB	acl	O
to	TO	case	O
pericyte	NN	compound	B-Cell
recruitment	NN	nmod	O
at	IN	case	O
six	CD	nummod	O
levels	NNS	nmod	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
direct	JJ	amod	O
promotion	NN	dep	O
of	IN	case	O
pericyte	NN	compound	B-Cell
invasion	NN	nmod	O
by	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
degradation	NN	nmod	O
;	:	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
stimulation	NN	dep	O
of	IN	case	O
pericyte	NN	compound	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
protection	NN	conj	O
against	IN	case	O
apoptosis	NN	nmod	O
by	IN	case	O
modification	NN	nmod	O
of	IN	case	O
the	DT	det	O
ECM	NNS	nmod	B-Cellular_component
;	:	punct	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
activation	NN	dep	O
of	IN	case	O
pericytes	NNS	nmod	B-Cell
through	IN	case	O
the	DT	det	O
release	NN	nmod	O
of	IN	case	O
growth	NN	compound	O
factor	NN	nmod	O
bound	VBD	acl	O
to	TO	case	O
the	DT	det	O
ECM	NN	nmod	B-Cellular_component
;	:	punct	O
(	-LRB-	punct	O
4	LS	dep	O
)	-RRB-	punct	O
transactivation	NN	dep	O
of	IN	case	O
angiogenic	JJ	amod	O
cell	NN	compound	B-Cellular_component
surface	NN	compound	I-Cellular_component
receptor	NN	nmod	O
;	:	punct	O
(	-LRB-	punct	O
5	LS	dep	O
)	-RRB-	punct	O
propagation	NN	dep	O
of	IN	case	O
angiogenic	JJ	nmod	O
signalling	NN	dep	O
as	IN	case	O
cofactor	NN	nmod	O
;	:	punct	O
and	CC	cc	O
(	-LRB-	punct	O
6	LS	dep	O
)	-RRB-	punct	O
recruitment	NN	conj	O
of	IN	case	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Receiver	NN	compound	O
operating	NN	amod	O
characteristic	JJ	amod	O
(	-LRB-	punct	O
ROC	NN	dep	O
)	-RRB-	punct	O
analysis	NN	nsubj	O
gave	VBD	ROOT	O
0	CD	dobj	O
.	.	punct	O
83	CD	ROOT	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
43	CD	nummod	O
ROC	NN	compound	O
area	NN	compound	O
values	NNS	ROOT	O
for	IN	case	O
urine	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
Cr	NN	nmod	B-Simple_chemical
and	CC	cc	O
serum	NN	conj	B-Organism_substance
IL	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Metastasis	NN	nsubj	O
from	IN	case	O
lung	NN	compound	B-Cancer
adenocarcinoma	NN	nmod	I-Cancer
can	MD	aux	O
occur	VB	ROOT	O
swiftly	RB	advmod	O
to	TO	case	O
multiple	JJ	amod	O
organs	NNS	nmod	B-Organ
within	IN	case	O
months	NNS	nmod	O
of	IN	case	O
diagnosis	NN	nmod	O
.	.	punct	O

TIMP3	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
affect	VB	ROOT	O
two	CD	nummod	O
independent	JJ	amod	O
downstream	JJ	amod	O
targets	NNS	dobj	O
,	,	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
p38	NN	compound	B-Gene_or_gene_product
MAPK	NN	conj	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
pigmentation	NN	nmod	O
,	,	punct	O
tanning	VBG	conj	O
and	CC	cc	O
melanoma	NN	conj	B-Cancer
.	.	punct	O

Regulation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
resident	JJ	amod	O
chromosomal	JJ	amod	B-Cellular_component
copy	NN	nmod	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myb	NN	nmod	I-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
myeloid	JJ	amod	B-Cell
leukemogenesis	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	nsubj	O
:	:	punct	O
p53	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	dep	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
.	.	punct	O

Antiangiogenic	JJ	amod	O
and	CC	cc	O
antitumor	JJ	conj	B-Cancer
effects	NNS	nsubj	O
of	IN	case	O
a	DT	det	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
Cbeta	NN	compound	I-Gene_or_gene_product
inhibitor	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
ovarian	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
xenografts	NNS	ROOT	I-Cancer
.	.	punct	O

The	DT	det	O
metabolic	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
resist	VBP	ROOT	O
the	DT	det	O
shift	NN	dobj	O
to	TO	case	O
glycolysis	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
characteristically	RB	advmod	O
seen	VBN	acl:relcl	O
in	IN	case	O
cancers	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
also	RB	advmod	O
help	VBP	conj	O
cells	NNS	nsubj	B-Cell
adapt	VB	dobj	O
to	TO	dep	O
and	CC	cc	O
survive	VB	conj	O
limited	JJ	amod	O
periods	NNS	dobj	O
of	IN	prep	O
metabolic	JJ	amod	O
stress	NN	pobj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Corneas	NNS	nsubjpass	B-Multi-tissue_structure
of	IN	case	O
105	CD	nummod	O
rabbits	NNS	nmod	B-Organism
were	VBD	auxpass	O
infected	VBN	dep	O
with	IN	case	O
viable	JJ	amod	O
yeast	NN	compound	B-Organism
cells	NNS	nmod	B-Cell
of	IN	case	O
C	NN	nmod	B-Organism
.	.	punct	I-Organism
albicans	NNS	ROOT	I-Organism
(	-LRB-	punct	O
2	CD	dep	O
.	.	punct	O
5	CD	dep	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
5	CD	dep	O
)	-RRB-	punct	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
clarify	VB	xcomp	O
how	WRB	advmod	O
expression	NN	nsubj	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
participates	VBZ	ccomp	O
in	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
whether	IN	mark	O
the	DT	det	O
coexpression	NN	nsubj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	conj	O
has	VBZ	conj	O
a	DT	det	O
significance	NN	dobj	O
for	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
the	DT	det	O
clinicopathological	JJ	amod	O
features	NNS	conj	O
in	IN	case	O
esophageal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
SCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

As	IN	mark	O
predicted	VBN	advcl	O
,	,	punct	O
these	DT	det	O
MEFs	NNS	nsubj	B-Cell
upregulated	VBD	ROOT	O
Hif	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
HIF	NN	conj	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	dobj	O
directly	RB	advmod	O
as	IN	case	O
a	DT	det	O
result	NN	nmod	O
of	IN	case	O
FH	NN	compound	B-Gene_or_gene_product
deficiency	NN	nmod	O
.	.	punct	O

This	DT	det	O
work	NN	nsubj	O
is	VBZ	ROOT	O
again	RB	advmod	O
extremely	RB	advmod	O
significant	JJ	acomp	O
for	IN	case	O
patients	NNS	nmod	B-Organism
worldwide	VBP	amod	O
,	,	punct	O
as	IN	mark	O
Dvorak	NNP	poss	O
'	POS	case	O
s	VBZ	nsubj	O
scientific	JJ	amod	O
research	NN	dobj	O
is	VBZ	aux	O
leading	VBG	advcl	O
his	PRP$	poss	O
colleagues	NNS	dobj	O
all	RB	advmod	O
over	IN	prep	O
the	DT	det	O
world	NN	pobj	O
to	TO	aux	O
examine	VB	advcl	O
how	WRB	advmod	O
to	TO	aux	O
treat	VB	advcl	O
a	DT	det	O
tumor	NN	dobj	B-Cancer
through	IN	prep	O
its	PRP$	poss	O
blood	NN	compound	B-Organism_substance
supply	NN	pobj	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
CDK4	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
CDK2	NN	conj	B-Gene_or_gene_product
in	IN	case	O
mouse	NN	compound	B-Organism
oral	JJ	amod	B-Immaterial_anatomical_entity
cavity	NN	nmod	I-Immaterial_anatomical_entity
is	VBZ	auxpass	O
retained	VBN	ROOT	O
in	IN	case	O
adult	JJ	amod	O
pituitary	NN	nmod	B-Organ
with	IN	case	O
distinct	JJ	amod	O
effects	NNS	nmod	O
on	IN	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	dep	O
in	IN	case	O
58	CD	nmod	O
.	.	punct	O
3	CD	nummod	O
%	NN	nsubjpass	O
,	,	punct	O
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
61	CD	nmod	O
.	.	punct	O
7	CD	nummod	O
%	NN	ROOT	O
of	IN	case	O
the	DT	det	O
60	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

In	IN	case	O
tumor	NN	compound	B-Cancer
studies	NNS	nmod	O
,	,	punct	O
P18	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
more	RBR	advmod	O
effective	JJ	ROOT	O
in	IN	mark	O
blocking	VBG	advcl	O
the	DT	det	O
angiogenesis	NN	dobj	O
and	CC	cc	O
growth	NN	conj	O
of	IN	case	O
the	DT	det	O
prostate	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
than	IN	case	O
parental	JJ	amod	B-Gene_or_gene_product
34	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
mer	NN	nmod	I-Gene_or_gene_product
;	:	punct	O
in	IN	case	O
the	DT	det	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
P18	NN	nsubj	B-Gene_or_gene_product
strongly	RB	advmod	O
decreased	VBD	parataxis	O
angiogenesis	NN	dobj	O
and	CC	cc	O
halted	VBD	conj	O
the	DT	det	O
progression	NN	dobj	O
of	IN	case	O
established	JJ	amod	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Using	VBG	dep	O
two	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	amod	O
electrophoresis	NN	dobj	O
and	CC	cc	O
liquid	JJ	amod	O
chromatography	NN	conj	O
-	HYPH	punct	O
electrospray	NN	amod	O
ionization	NN	compound	O
-	HYPH	punct	O
tandem	JJ	amod	O
mass	NN	compound	O
spectrometry	NN	dobj	O
(	-LRB-	punct	O
LC	NN	compound	O
-	HYPH	punct	O
ESI	NNP	compound	O
-	HYPH	punct	O
MS	NNP	dep	O
/	:	punct	O
MS	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	parataxis	O
differentially	RB	advmod	O
displayed	VBD	amod	O
proteomics	NNS	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
Hep3B	NN	dep	I-Cell
,	,	punct	O
MHCC97L	NN	conj	B-Cell
,	,	punct	O
MHCC97H	JJ	dobj	B-Cell
with	IN	case	O
different	JJ	amod	O
metastasic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O

Current	JJ	amod	O
therapy	NN	nsubj	O
for	IN	case	O
glioma	NN	nmod	B-Cancer
is	VBZ	cop	O
suboptimal	JJ	ROOT	O
.	.	punct	O

Desensitization	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
induced	VBN	ROOT	O
in	IN	prep	O
NIH	NN	compound	B-Cell
-	HYPH	punct	I-Cell
3T3	NN	compound	I-Cell
cells	NNS	pobj	I-Cell
by	IN	prep	O
culturing	VBG	pcomp	O
under	IN	prep	O
conditions	NNS	pobj	O
where	WRB	advmod	O
the	DT	det	O
cells	NNS	nsubj	B-Cell
were	VBD	cop	O
all	RB	relcl	O
in	IN	case	O
the	DT	det	O
exponential	JJ	amod	O
growth	NN	compound	O
phase	NN	nmod	O
,	,	punct	O
or	CC	cc	O
by	IN	case	O
a	DT	det	O
12	CD	nummod	O
h	NN	compound	O
exposure	NN	conj	O
to	TO	case	O
a	DT	det	O
C	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	intj	I-Gene_or_gene_product
-	HYPH	punct	O
activating	VBG	amod	O
phorbol	NN	compound	B-Simple_chemical
ester	NN	nmod	I-Simple_chemical
.	.	punct	O

As	IN	prep	O
a	DT	det	O
result	NN	pobj	O
,	,	punct	O
he	PRP	nsubj	O
and	CC	cc	O
other	JJ	amod	O
investigators	NNS	conj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
VPF	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
capable	JJ	ccomp	O
of	IN	mark	O
stimulating	VBG	advcl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
work	NN	nsubj	O
supports	VBZ	ROOT	O
and	CC	cc	O
extends	VBZ	conj	O
the	DT	det	O
finding	NN	dobj	O
of	IN	case	O
previous	JJ	amod	O
studies	NNS	nmod	O
,	,	punct	O
since	IN	mark	O
the	DT	det	O
results	NNS	nsubj	O
showed	VBD	advcl	O
that	IN	mark	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nsubj	O
depressed	VBD	ccomp	O
the	DT	det	O
oxidative	JJ	amod	O
processes	NNS	dobj	O
in	IN	case	O
Ehrlich	NN	nmod	B-Cancer
ascites	VBZ	conj	I-Cancer
tumor	NN	compound	I-Cancer
mitochondria	NN	dobj	B-Cellular_component
,	,	punct	O
not	RB	neg	O
only	RB	advmod	O
alone	RB	advmod	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
glutamine	NN	nmod	B-Amino_acid
.	.	punct	O

Malate	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
citrate	JJ	compound	B-Simple_chemical
cycle	NN	nsubj	O
during	IN	case	O
glycolysis	NN	nmod	O
and	CC	cc	O
glutaminolysis	NN	conj	O
in	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	ROOT	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

An	DT	det	O
increase	NN	nsubjpass	O
in	IN	case	O
oligomycin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
independent	JJ	amod	O
respiration	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
HepG2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
treated	VBN	acl	O
with	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nmod	I-Simple_chemical
only	RB	advmod	O
when	WRB	advmod	O
incubated	VBN	advcl	O
in	IN	case	O
glucose	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
supplemented	VBN	amod	O
medium	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nsubj	I-Simple_chemical
induces	VBZ	ccomp	O
mitochondrial	JJ	amod	B-Cellular_component
proton	NN	compound	B-Simple_chemical
leakage	NN	dobj	O
as	RB	advmod	O
well	RB	mwe	O
as	IN	mark	O
blocking	VBG	advcl	O
the	DT	det	O
electron	NN	compound	B-Simple_chemical
transport	NN	compound	O
system	NN	dobj	O
.	.	punct	O

Gene	NN	compound	O
expression	NN	compound	O
signatures	VBZ	nsubjpass	O
denoting	VBG	acl	O
WNT	NN	compound	B-Gene_or_gene_product
/	:	punct	O
TCF	NN	compound	B-Gene_or_gene_product
activation	NN	dobj	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
relapse	NN	nmod	O
to	TO	case	O
multiple	JJ	amod	O
organs	NNS	nmod	B-Organ
in	IN	case	O
primary	JJ	amod	O
lung	NN	compound	B-Cancer
adenocarcinoma	NN	nmod	I-Cancer
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
022	CD	dobj	O
)	-RRB-	punct	O
between	IN	case	O
survivin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	conj	I-Gene_or_gene_product
expression	NN	conj	O
;	:	punct	O
survivin	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
bcl	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	nsubj	I-Gene_or_gene_product
tended	VBD	conj	O
to	TO	aux	O
correlate	VB	xcomp	O
with	IN	case	O
overall	JJ	amod	O
survival	NN	nmod	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
072	CD	dep	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
075	CD	dobj	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
disease	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
19	CD	ROOT	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
18	CD	dep	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

Hypoxic	JJ	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
distant	JJ	nsubjpass	O
from	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
were	VBD	auxpass	O
dramatically	RB	advmod	O
reoxygenated	JJ	ROOT	O
at	IN	case	O
24	CD	nummod	O
h	NN	compound	O
postirradiation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activity	NN	nsubj	O
increased	VBD	conj	O
as	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
accumulated	VBD	acl	O
in	IN	case	O
the	DT	det	O
reoxygenated	JJ	amod	O
regions	NNS	nmod	O
.	.	punct	O

Breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
lacking	VBG	acl	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
showed	VBD	ROOT	O
increased	VBN	amod	O
number	NN	dobj	O
of	IN	case	O
chromosomal	JJ	amod	B-Cellular_component
breaks	NNS	nmod	O
and	CC	cc	O
gaps	NNS	conj	O
when	WRB	advmod	O
exposed	VBN	advcl	O
to	TO	case	O
gamma	NN	compound	O
-	HYPH	punct	O
irradiation	NN	nmod	O
.	.	punct	O

Patients	NNS	nsubj	B-Organism
with	IN	case	O
other	JJ	amod	O
genetic	JJ	amod	O
blistering	NN	compound	O
disorders	NNS	nmod	O
do	VBP	aux	O
not	RB	neg	O
have	VB	ROOT	O
elevated	JJ	amod	O
collagenase	NN	dobj	B-Gene_or_gene_product
or	CC	cc	O
an	DT	det	O
increased	VBN	amod	O
risk	NN	conj	O
of	IN	case	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
despite	IN	case	O
chronic	JJ	amod	O
wounding	NN	nmod	O
.	.	punct	O

No	DT	det	O
tumours	NNS	nsubjpass	B-Cancer
were	VBD	auxpass	O
induced	VBN	ROOT	O
within	IN	prep	O
the	DT	det	O
latent	JJ	amod	O
period	NN	pobj	O
for	IN	case	O
tumour	NN	compound	B-Cancer
production	NN	nmod	O
by	IN	case	O
control	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
transfected	VBN	acl	O
with	IN	case	O
NIH3T3	NN	compound	B-Cell
cell	NN	compound	I-Cell
DNA	NN	nmod	B-Cellular_component
(	-LRB-	punct	O
40	CD	compound	O
-	SYM	punct	O
60	CD	nummod	O
days	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

Age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
impaired	JJ	amod	O
wound	NN	compound	B-Pathological_formation
healing	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
substantial	JJ	amod	O
morbidity	NN	nmod	O
and	CC	cc	O
mortality	NN	conj	O
along	IN	prep	O
with	IN	prep	O
a	DT	det	O
large	JJ	amod	O
financial	JJ	amod	O
burden	NN	pobj	O
to	IN	prep	O
health	NN	compound	O
services	NNS	pobj	O
.	.	punct	O

Interaction	NN	ROOT	O
between	IN	case	O
cellular	JJ	nmod	B-Cell
and	CC	cc	O
viral	JJ	conj	B-Organism
genes	NNS	dep	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
RSV	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
induced	VBN	amod	O
transformation	NN	compound	O
-	HYPH	punct	O
specific	JJ	amod	O
cell	NN	compound	B-Cellular_component
-	HYPH	punct	I-Cellular_component
surface	NN	compound	I-Cellular_component
antigen	NN	compound	O
VCSA	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
CYR61	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
CTGF	NN	conj	B-Gene_or_gene_product
,	,	punct	O
WISP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
NOV	NN	conj	B-Gene_or_gene_product
occurred	VBD	ROOT	O
in	IN	case	O
48	CD	nummod	O
%	NN	nmod	O
(	-LRB-	punct	O
32	CD	dep	O
of	IN	advmod	O
66	CD	nmod	O
)	-RRB-	punct	O
,	,	punct	O
58	CD	nummod	O
%	NN	conj	O
(	-LRB-	punct	O
38	CD	appos	O
of	IN	case	O
66	CD	nmod	O
)	-RRB-	punct	O
,	,	punct	O
36	CD	nummod	O
%	NN	appos	O
(	-LRB-	punct	O
24	CD	appos	O
of	IN	advmod	O
66	CD	nmod	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
15	CD	nummod	O
%	NN	conj	O
(	-LRB-	punct	O
10	CD	compound	O
of	IN	case	O
66	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
primary	JJ	amod	O
gliomas	NNS	nmod	B-Cancer
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
underlying	JJ	amod	O
mechanisms	NNS	nsubjpass	O
were	VBD	auxpass	O
systematically	RB	advmod	O
investigated	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
cyclooxygenase	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
COX	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
plays	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
and	CC	cc	O
peroxisome	NN	compound	B-Gene_or_gene_product
proliferator	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
gamma	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
PPARgamma	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	conj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
some	DT	det	O
tissues	NNS	nmod	B-Tissue
.	.	punct	O

The	DT	det	O
different	JJ	amod	O
expression	NN	nsubj	O
/	:	punct	O
activation	NN	nsubj	O
of	IN	case	O
apoptosis	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
factors	NNS	nmod	O
appears	VBZ	ROOT	O
to	TO	mark	O
influence	VB	xcomp	O
the	DT	det	O
sensitization	NN	dobj	O
of	IN	case	O
prostate	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
TRAIL	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Additional	JJ	amod	O
rats	NNS	nsubj	B-Organism
underwent	VBD	ROOT	O
partial	JJ	amod	O
hepatectomy	NN	dobj	O
,	,	punct	O
an	DT	det	O
immunosuppressive	JJ	amod	O
procedure	NN	appos	O
known	VBN	acl	O
to	TO	mark	O
accelerate	VB	xcomp	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
hepatic	JJ	amod	B-Cancer
tumor	NN	nmod	I-Cancer
,	,	punct	O
following	VBG	case	O
tumor	NN	compound	B-Cancer
challenge	NN	nmod	O
.	.	punct	O

The	DT	det	O
apoptotic	JJ	amod	O
molecule	NN	compound	O
bax	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
bax	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
not	RB	neg	O
induced	VBN	conj	O
in	IN	case	O
E2F	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
in	IN	case	O
glioma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Heparin	NN	nmod:npmod	B-Simple_chemical
immobilized	VBD	amod	O
porous	JJ	amod	O
poly	NN	dobj	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
D	NN	compound	I-Simple_chemical
,	,	punct	I-Simple_chemical
L	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
lactic	JJ	dep	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
co	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glycolic	JJ	amod	I-Simple_chemical
acid	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
(	-LRB-	punct	O
PLGA	NN	dep	B-Simple_chemical
)	-RRB-	punct	O
microspheres	NNS	nsubjpass	O
were	VBD	auxpass	O
prepared	VBN	appos	O
for	IN	case	O
sustained	JJ	amod	O
release	NN	nmod	O
of	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
bFGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
to	TO	mark	O
induce	VB	xcomp	O
angiogenesis	NN	dobj	O
.	.	punct	O

Growth	NN	compound	O
factor	NN	compound	O
mRNA	NN	compound	O
expression	NN	compound	O
analyses	NNS	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
higher	JJR	amod	O
expression	NN	dobj	O
of	IN	case	O
angiopoietin	NN	nmod	B-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
low	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	nmod	I-Cancer
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
The	DT	det	O
low	JJ	amod	O
expression	NN	nsubj	O
or	CC	cc	O
absence	NN	conj	O
of	IN	case	O
stromal	JJ	amod	B-Cell
SPARC	NN	nmod	B-Gene_or_gene_product
was	VBD	cop	O
an	DT	det	O
independent	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	appos	O
for	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
of	IN	case	O
colon	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
DCE	NN	compound	O
-	:	punct	O
MRI	NN	nsubj	O
revealed	VBD	ROOT	O
greater	JJR	amod	O
enhancement	NN	dobj	O
in	IN	case	O
the	DT	det	O
peripheral	JJ	amod	B-Organism_subdivision
area	NN	nmod	I-Organism_subdivision
than	IN	case	O
in	IN	case	O
the	DT	det	O
central	JJ	amod	B-Organism_subdivision
area	NN	nmod	I-Organism_subdivision
in	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
examined	VBN	amod	O
animal	NN	compound	O
models	NNS	nmod	O
.	.	punct	O

The	DT	det	O
direct	JJ	amod	O
angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
CCL16	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
further	RB	advmod	O
amplified	VBN	ROOT	O
by	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
prime	JJ	acl	O
endothelium	NN	dobj	B-Tissue
to	TO	case	O
a	DT	det	O
mitogen	NN	compound	O
signal	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
A	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
to	TO	mark	O
raise	VB	conj	O
their	PRP$	nmod:poss	O
basal	JJ	amod	O
production	NN	dobj	O
of	IN	case	O
CXCL8	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
CCL2	NN	conj	B-Gene_or_gene_product
,	,	punct	O
2	CD	nummod	O
other	JJ	amod	O
angiogenic	JJ	amod	O
chemokines	NNS	appos	O
.	.	punct	O

A	DT	det	O
receptor	NN	nsubjpass	O
for	IN	case	O
angiostatin	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
identified	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
as	IN	case	O
F	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
F	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
0	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
ATP	NN	compound	I-Gene_or_gene_product
synthase	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
Moser	NNP	dep	O
et	FW	dep	O
al	FW	dep	O
.	NNP	punct	O
,	,	punct	O
1999	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
natural	JJ	amod	O
and	CC	cc	O
synthetic	JJ	conj	O
progestins	NNS	nsubj	B-Simple_chemical
also	RB	advmod	O
induce	VBP	ccomp	O
thrombospondin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
mRNA	NN	dep	O
and	CC	cc	O
protein	NN	conj	O
in	IN	case	O
T47	NN	compound	B-Cell
-	HYPH	punct	I-Cell
D	NN	nmod	I-Cell
and	CC	cc	O
BT	NNP	conj	B-Cell
-	HYPH	punct	I-Cell
474	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

The	DT	det	O
main	JJ	amod	O
purpose	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
investigation	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
homologous	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
4	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
alkylmorpholine	NN	compound	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
oxides	NNS	nmod	I-Simple_chemical
on	IN	case	O
ATP	NNP	npadvmod	B-Simple_chemical
-	HYPH	punct	O
producing	VBG	amod	O
processes	NNS	nmod	O
in	IN	case	O
Ehrlich	NN	compound	B-Cell
ascites	VBZ	nmod	I-Cell
and	CC	cc	O
L1210	NN	compound	B-Cell
murine	JJ	amod	I-Cell
leukaemia	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
computed	JJ	amod	O
tomography	NN	nsubj	O
(	-LRB-	punct	O
CT	NN	appos	O
)	-RRB-	punct	O
showed	VBD	ROOT	O
a	DT	det	O
complete	JJ	amod	O
regression	NN	dobj	O
of	IN	case	O
the	DT	det	O
extensive	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
diffuse	JJ	amod	O
lung	NN	compound	B-Organ
metastases	NNS	conj	O
,	,	punct	O
for	IN	case	O
a	DT	det	O
complete	JJ	amod	O
response	NN	nmod	O
(	-LRB-	punct	O
CR	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Ultraviolet	NN	compound	O
B	NN	compound	O
irradiation	NN	nsubj	O
promotes	VBZ	ROOT	O
tumorigenic	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
properties	NNS	dobj	O
in	IN	case	O
primary	JJ	amod	O
cutaneous	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
via	IN	case	O
induction	NN	nmod	O
of	IN	case	O
interleukin	NN	nmod	B-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
sinusoids	NNS	nsubj	B-Tissue
had	VBD	ROOT	O
a	DT	det	O
great	JJ	amod	O
deal	NN	dobj	O
of	IN	case	O
surface	NN	compound	O
area	NN	nmod	O
for	IN	case	O
potential	JJ	amod	O
contact	NN	nmod	O
with	IN	case	O
the	DT	det	O
fetal	JJ	amod	B-Developing_anatomical_structure
component	NN	nmod	O
.	.	punct	O

Inactivation	NN	nsubj	O
of	IN	case	O
androgen	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
regulator	NN	compound	O
ARD1	NN	nmod	B-Gene_or_gene_product
inhibits	VBZ	ROOT	O
androgen	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
acetylation	NN	dobj	O
and	CC	cc	O
prostate	NN	compound	B-Organ
tumorigenesis	NN	conj	O
.	.	punct	O

Pathological	JJ	amod	O
animal	NN	compound	O
models	NNS	ROOT	O
in	IN	case	O
the	DT	det	O
experimental	JJ	amod	O
evaluation	NN	nmod	O
of	IN	case	O
tumour	NN	compound	B-Tissue
microvasculature	NN	nmod	I-Tissue
with	IN	case	O
magnetic	JJ	amod	O
resonance	NN	compound	O
imaging	VBG	nmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	appos	I-Gene_or_gene_product
and	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	conj	I-Gene_or_gene_product
in	IN	case	O
relationship	NN	nmod	O
to	TO	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
pleomorphic	JJ	amod	B-Pathological_formation
adenoma	NN	nmod	I-Pathological_formation
.	.	punct	O

The	DT	det	O
similarity	NN	nsubj	O
between	IN	case	O
RhoA	NN	compound	B-Gene_or_gene_product
effects	NNS	nmod	O
and	CC	cc	O
thyroid	NN	compound	B-Cell
transformation	NN	conj	O
by	IN	case	O
Ras	NN	nmod	B-Gene_or_gene_product
suggests	VBZ	ROOT	O
that	IN	mark	O
RhoA	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
act	VB	ccomp	O
as	IN	case	O
a	DT	det	O
downstream	JJ	amod	O
effector	NN	nmod	O
of	IN	case	O
Ras	NN	nmod	B-Gene_or_gene_product
;	:	punct	O
in	IN	case	O
fact	NN	nmod	O
,	,	punct	O
the	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
RhoA	NN	compound	B-Gene_or_gene_product
N19	NN	nsubj	O
abolished	VBD	parataxis	O
the	DT	det	O
down	JJ	advmod	O
-	HYPH	punct	O
regulatory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
Ras	NN	compound	B-Gene_or_gene_product
V12	NN	nmod	O
over	IN	case	O
the	DT	det	O
Tg	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
meantime	NN	amod	O
preventive	JJ	amod	O
use	NN	nsubjpass	O
of	IN	case	O
bisphosphonates	NNS	nmod	B-Simple_chemical
in	IN	case	O
patients	NNS	nmod	B-Organism
without	IN	case	O
any	DT	det	O
bone	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
should	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
used	VBN	ROOT	O
outside	IN	case	O
the	DT	det	O
scope	NN	nmod	O
of	IN	case	O
a	DT	det	O
clinical	JJ	amod	O
trial	NN	nmod	O
.	.	punct	O

The	DT	det	O
development	NN	nsubj	O
of	IN	case	O
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
HCC	NN	appos	B-Cancer
)	-RRB-	punct	O
presumably	RB	advmod	O
occurs	VBZ	ROOT	O
in	IN	case	O
multiple	JJ	amod	O
steps	NNS	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
influenced	VBN	conj	O
by	IN	case	O
numerous	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

These	DT	det	O
parameters	NNS	nsubjpass	O
were	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
histology	NN	nmod	O
to	TO	mark	O
obtain	VB	xcomp	O
a	DT	det	O
radiological	JJ	amod	O
-	HYPH	punct	O
histological	JJ	amod	O
map	NN	dobj	O
of	IN	prep	O
tumour	NN	compound	B-Tissue
microvasculature	NN	pobj	I-Tissue
.	.	punct	O

One	CD	nummod	O
type	NN	nsubj	O
is	VBZ	ROOT	O
"	``	punct	O
glycolysis	NN	attr	O
,	,	punct	O
"	``	punct	O
the	DT	det	O
other	JJ	amod	O
the	DT	det	O
"	``	punct	O
mitochondria	NN	attr	B-Cellular_component
.	.	punct	O
"	''	ROOT	O
In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
most	RBS	advmod	O
normal	JJ	amod	O
cells	NNS	nmod	B-Cell
where	WRB	advmod	O
the	DT	det	O
mitochondria	NN	nsubj	B-Cellular_component
are	VBP	cop	O
the	DT	det	O
major	JJ	amod	O
ATP	NN	compound	B-Simple_chemical
producers	NNS	acl:relcl	O
(	-LRB-	punct	O
>	NN	dep	O
90	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
in	IN	mark	O
fueling	VBG	advcl	O
growth	NN	dobj	O
,	,	punct	O
human	JJ	amod	B-Organism
cancers	NNS	nsubj	B-Cancer
detected	VBN	acl	O
via	IN	case	O
Positron	NNP	compound	O
Emission	NNP	compound	O
Tomography	NN	nmod	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
rely	VBP	ROOT	O
on	IN	case	O
both	DT	det	O
types	NNS	nmod	O
of	IN	case	O
power	NN	compound	O
plants	NNS	nmod	O
.	.	punct	O

KISS1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	conj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
may	MD	aux	O
play	VB	ROOT	O
important	JJ	amod	O
roles	NNS	dobj	O
as	IN	case	O
metastasis	NN	compound	O
suppressor	NN	nmod	O
and	CC	cc	O
metastasis	NN	compound	O
promoter	NN	compound	O
genes	NNS	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
malignancies	NNS	nmod	B-Cancer
.	.	punct	O

Consistently	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
MOG	NN	nsubj	B-Simple_chemical
rapidly	RB	advmod	O
decreased	VBD	ccomp	O
the	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
glutathione	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
GSH	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
content	NN	dobj	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
and	CC	cc	O
the	DT	det	O
significance	NN	nsubjpass	O
of	IN	case	O
GSH	NN	compound	B-Simple_chemical
depletion	NN	nmod	O
in	IN	case	O
MOG	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
was	VBD	auxpass	O
further	RB	advmod	O
supported	VBN	conj	O
by	IN	case	O
the	DT	det	O
protective	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
tert	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butylhydroquinone	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
tBHQ	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
facilitative	JJ	amod	O
effects	NNS	conj	O
of	IN	case	O
DL	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
buthionine	NN	compound	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
S	NN	compound	I-Simple_chemical
,	,	punct	I-Simple_chemical
R	NN	conj	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
sulfoximine	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
BSO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
CXCR4	NN	nmod	B-Gene_or_gene_product
using	VBG	acl	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	dobj	O
,	,	punct	O
Western	NN	compound	O
blotting	NN	conj	O
,	,	punct	O
flow	NN	compound	O
cytometry	NN	conj	O
,	,	punct	O
and	CC	cc	O
confocal	JJ	amod	O
microscopy	NN	conj	O
in	IN	case	O
five	CD	nummod	O
gastric	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
VEGF	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
biology	NN	nmod	O
of	IN	case	O
CML	NN	nmod	B-Cancer
and	CC	cc	O
that	IN	mark	O
VEGF	NN	compound	B-Gene_or_gene_product
inhibitors	NNS	nsubjpass	O
should	MD	aux	O
be	VB	auxpass	O
investigated	VBN	conj	O
in	IN	case	O
CML	NN	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
,	,	punct	O
SDF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
migration	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
and	CC	cc	O
was	VBD	auxpass	O
blocked	VBN	conj	O
by	IN	case	O
AMD3100	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
specific	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
CXCR4	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Radiation	NN	nsubj	O
significantly	RB	advmod	O
affected	VBD	ROOT	O
DMBA	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
associated	VBN	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
volume	NN	dobj	O
and	CC	cc	O
permeability	NN	compound	O
changes	NNS	conj	O
during	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O

CD40	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
by	IN	case	O
CD154	NN	nmod	B-Gene_or_gene_product
may	MD	aux	O
trigger	VB	ROOT	O
diverse	JJ	amod	O
cellular	JJ	amod	B-Cell
responses	NNS	dobj	O
,	,	punct	O
ranging	VBG	advcl	O
from	IN	case	O
proliferation	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
to	TO	case	O
growth	NN	compound	O
suppression	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
death	NN	conj	O
,	,	punct	O
in	IN	case	O
normal	JJ	nmod	O
and	CC	cc	O
malignant	JJ	conj	B-Cell
cells	NNS	dep	I-Cell
.	.	punct	O

These	DT	det	O
two	CD	nummod	O
enzymes	NNS	nsubjpass	O
were	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
specificity	NN	dobj	O
for	IN	case	O
gelatin	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
K5CDK4	NN	compound	B-Gene_or_gene_product
mice	NNS	nsubj	O
show	VBP	ccomp	O
a	DT	det	O
decreased	VBN	amod	O
number	NN	dobj	O
of	IN	case	O
pituitary	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
even	RB	advmod	O
though	IN	mark	O
CDK4	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
not	RB	neg	O
expressed	VBN	advcl	O
in	IN	case	O
the	DT	det	O
stem	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
but	CC	cc	O
in	IN	case	O
transit	NN	compound	B-Cell
-	HYPH	punct	I-Cell
amplifying	VBG	dep	I-Cell
(	-LRB-	punct	I-Cell
TA	NN	conj	I-Cell
)	-RRB-	punct	I-Cell
-	:	punct	I-Cell
like	JJ	case	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Knowledge	NN	nsubjpass	O
of	IN	prep	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	pobj	I-Gene_or_gene_product
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
significance	NN	conj	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	B-Tissue
tumor	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
is	VBZ	auxpass	O
limited	JJ	ROOT	O
.	.	punct	O

Scanning	NN	compound	O
electron	NN	compound	O
microscopy	NN	ROOT	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
casts	NNS	nmod	O
in	IN	case	O
experimental	JJ	amod	O
ocular	JJ	amod	B-Organ
vasoproliferation	NN	nmod	O
.	.	punct	O

The	DT	det	O
central	JJ	amod	O
region	NN	nsubj	O
that	WDT	nsubj	O
is	VBZ	cop	O
sufficient	JJ	acl:relcl	O
for	IN	case	O
these	DT	det	O
activities	NNS	nmod	O
includes	VBZ	ROOT	O
the	DT	det	O
evolutionarily	RB	advmod	O
highly	RB	advmod	O
conserved	VBN	amod	O
region	NN	dobj	O
among	IN	case	O
human	JJ	amod	B-Organism
,	,	punct	O
mouse	NN	conj	B-Organism
and	CC	cc	O
chicken	NN	compound	B-Organism
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	conj	I-Gene_or_gene_product
proteins	NNS	nmod	O
.	.	punct	O

In	IN	case	O
fact	NN	nmod	O
,	,	punct	O
p75	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
depresses	VBZ	ROOT	O
the	DT	det	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	NNP	compound	I-Gene_or_gene_product
/	SYM	punct	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
eNOS	NN	compound	B-Gene_or_gene_product
/	:	punct	O
NO	NN	compound	B-Simple_chemical
pathway	NN	dobj	O
and	CC	cc	O
additionally	RB	advmod	O
reduces	VBZ	conj	O
the	DT	det	O
mRNA	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
ITGB1	NN	compound	B-Gene_or_gene_product
[	-LRB-	punct	O
beta	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
]	-RRB-	punct	O
,	,	punct	O
BIRC5	NN	dobj	B-Gene_or_gene_product
(	-LRB-	punct	O
survivin	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
PTTG1	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
securin	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
VEZF1	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Typically	RB	advmod	O
,	,	punct	O
proliferation	NN	nsubjpass	O
and	CC	cc	O
chemotaxis	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
is	VBZ	auxpass	O
driven	VBN	ROOT	O
by	IN	case	O
growth	NN	compound	O
factors	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
bFGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Following	VBG	prep	O
an	DT	det	O
overnight	JJ	amod	O
fast	NN	dobj	O
,	,	punct	O
blood	NN	compound	B-Organism_substance
samples	NNS	nsubjpass	I-Organism_substance
were	VBD	auxpass	O
obtained	VBN	ROOT	O
from	IN	case	O
14	CD	nummod	O
dogs	NNS	nmod	B-Organism
with	IN	case	O
previously	RB	advmod	O
untreated	JJ	amod	O
lymphoma	NN	nmod	B-Cancer
before	IN	advmod	O
and	CC	cc	O
5	CD	conj	O
,	,	punct	O
15	CD	conj	O
,	,	punct	O
30	CD	conj	O
,	,	punct	O
45	CD	conj	O
,	,	punct	O
60	CD	conj	O
,	,	punct	O
and	CC	cc	O
90	CD	nummod	O
minutes	NNS	conj	O
following	VBG	case	O
an	DT	det	O
intravenous	JJ	amod	B-Multi-tissue_structure
challenge	NN	nmod	O
with	IN	case	O
500	CD	nummod	O
mg	NN	nummod	O
/	:	punct	O
kg	NN	compound	O
dextrose	NN	nmod	B-Simple_chemical
.	.	punct	O

Interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nsubjpass	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
pro	NN	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
and	CC	cc	O
pro	NN	npadvmod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
cytokine	NN	xcomp	O
,	,	punct	O
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
8	CD	conj	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	conj	O
to	TO	mark	O
be	VB	auxpass	O
associated	VBN	xcomp	O
with	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
,	,	punct	O
prognosis	NN	conj	O
and	CC	cc	O
survival	NN	conj	O
in	IN	case	O
several	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

VEGFR1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
haematopoietic	JJ	amod	O
bone	NN	compound	O
marrow	NN	compound	O
progenitors	NNS	nsubj	O
initiate	VBP	ROOT	O
the	DT	det	O
pre	JJ	nmod:npmod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
niche	NN	dobj	O
.	.	punct	O

Samples	NNS	nsubjpass	B-Organism_substance
were	VBD	auxpass	O
assayed	VBN	ROOT	O
for	IN	case	O
glucose	NN	nmod	B-Simple_chemical
,	,	punct	O
lactate	NN	conj	B-Simple_chemical
,	,	punct	O
and	CC	cc	O
insulin	NN	compound	B-Gene_or_gene_product
concentrations	NNS	conj	O
and	CC	cc	O
compared	VBN	conj	O
statistically	RB	advmod	O
with	IN	case	O
ten	CD	nummod	O
control	NN	compound	O
dogs	NNS	nmod	B-Organism
of	IN	case	O
similar	JJ	amod	O
weight	NN	nmod	O
and	CC	cc	O
age	NN	conj	O
undergoing	VBG	acl	O
an	DT	det	O
identical	JJ	amod	O
dextrose	NN	compound	B-Simple_chemical
challenge	NN	dobj	O
.	.	punct	O

Therapy	NN	nsubj	O
was	VBD	cop	O
equally	RB	advmod	O
effective	JJ	ROOT	O
in	IN	case	O
this	DT	det	O
immunosuppressive	JJ	amod	O
setting	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
the	DT	det	O
revertant	JJ	amod	B-Cell
phenotype	NN	nsubj	O
resulted	VBD	ccomp	O
from	IN	case	O
mutations	NNS	nmod	O
that	WDT	nsubj	O
altered	VBD	acl:relcl	O
the	DT	det	O
expression	NN	dobj	O
or	CC	cc	O
activities	NNS	conj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
jun	NN	compound	I-Gene_or_gene_product
or	CC	cc	O
junB	NN	conj	B-Gene_or_gene_product
proto	NN	compound	O
-	:	punct	O
oncogenes	NNS	nmod	O
.	.	punct	O

The	DT	det	O
physiological	JJ	amod	O
significance	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
observations	NNS	nmod	O
are	VBP	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
KISS1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	dep	I-Gene_or_gene_product
in	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
their	PRP$	nmod:poss	O
relations	NNS	conj	O
to	TO	case	O
metastasis	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
.	.	punct	O

G45	NN	compound	B-Gene_or_gene_product
antibody	NN	compound	O
treatment	NN	nsubj	O
induced	VBD	ROOT	O
SCC	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
apoptosis	NN	dobj	O
,	,	punct	O
decreased	VBD	conj	O
SCC	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
proliferation	NN	dobj	O
,	,	punct	O
and	CC	cc	O
markedly	RB	advmod	O
impaired	JJ	conj	O
human	JJ	amod	B-Organism
SCC	NN	compound	B-Cancer
tumorigenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
without	IN	mark	O
affecting	VBG	advcl	O
normal	JJ	amod	B-Tissue
tissue	NN	compound	I-Tissue
adhesion	NN	dobj	O
.	.	punct	O

In	IN	case	O
concordance	NN	nmod	O
with	IN	case	O
its	PRP$	nmod:poss	O
higher	JJR	amod	O
affinity	NN	nmod	O
for	IN	case	O
tumor	NN	compound	B-Cancer
Hsp90	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
in	FW	amod	O
vivo	FW	dep	O
PU24FCl	NN	nsubj	B-Simple_chemical
accumulates	VBZ	ROOT	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
while	IN	mark	O
being	VBG	auxpass	O
rapidly	RB	advmod	O
cleared	VBN	advcl	O
from	IN	case	O
normal	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

